CA2777176A1 - Metathesis catalysts and processes for use thereof - Google Patents
Metathesis catalysts and processes for use thereof Download PDFInfo
- Publication number
- CA2777176A1 CA2777176A1 CA2777176A CA2777176A CA2777176A1 CA 2777176 A1 CA2777176 A1 CA 2777176A1 CA 2777176 A CA2777176 A CA 2777176A CA 2777176 A CA2777176 A CA 2777176A CA 2777176 A1 CA2777176 A1 CA 2777176A1
- Authority
- CA
- Canada
- Prior art keywords
- oil
- fatty acid
- olefin
- alpha
- catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003054 catalyst Substances 0.000 title claims abstract description 170
- 238000000034 method Methods 0.000 title claims abstract description 124
- 230000008569 process Effects 0.000 title claims abstract description 115
- 238000005649 metathesis reaction Methods 0.000 title claims abstract description 59
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 174
- 239000000194 fatty acid Substances 0.000 claims abstract description 174
- 229930195729 fatty acid Natural products 0.000 claims abstract description 174
- -1 fatty acid ester Chemical class 0.000 claims abstract description 115
- 150000001336 alkenes Chemical class 0.000 claims abstract description 95
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 79
- 150000001875 compounds Chemical class 0.000 claims abstract description 70
- 239000000463 material Substances 0.000 claims abstract description 64
- 150000003626 triacylglycerols Chemical class 0.000 claims abstract description 36
- 239000003225 biodiesel Substances 0.000 claims abstract description 28
- 239000004711 α-olefin Substances 0.000 claims description 103
- 239000003921 oil Substances 0.000 claims description 80
- 235000019198 oils Nutrition 0.000 claims description 76
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 claims description 74
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 55
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 54
- 239000000203 mixture Substances 0.000 claims description 47
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 41
- 229910052739 hydrogen Inorganic materials 0.000 claims description 31
- 239000001257 hydrogen Substances 0.000 claims description 31
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 claims description 30
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 30
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 claims description 30
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 27
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 26
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 24
- JRZJOMJEPLMPRA-UHFFFAOYSA-N 1-nonene Chemical compound CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 23
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 22
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 21
- 239000003446 ligand Substances 0.000 claims description 21
- 229910052707 ruthenium Inorganic materials 0.000 claims description 21
- 241001465754 Metazoa Species 0.000 claims description 17
- 125000005842 heteroatom Chemical group 0.000 claims description 17
- 125000004122 cyclic group Chemical group 0.000 claims description 16
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 16
- 229910052799 carbon Inorganic materials 0.000 claims description 15
- 235000019387 fatty acid methyl ester Nutrition 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 230000007306 turnover Effects 0.000 claims description 11
- 150000002367 halogens Chemical class 0.000 claims description 10
- 235000012424 soybean oil Nutrition 0.000 claims description 10
- 239000003549 soybean oil Substances 0.000 claims description 10
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 claims description 9
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 claims description 9
- 241000195493 Cryptophyta Species 0.000 claims description 9
- 235000019482 Palm oil Nutrition 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000002540 palm oil Substances 0.000 claims description 9
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 8
- 235000019485 Safflower oil Nutrition 0.000 claims description 8
- 235000019486 Sunflower oil Nutrition 0.000 claims description 8
- 239000000828 canola oil Substances 0.000 claims description 8
- 235000019519 canola oil Nutrition 0.000 claims description 8
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 235000005713 safflower oil Nutrition 0.000 claims description 8
- 239000003813 safflower oil Substances 0.000 claims description 8
- 239000002600 sunflower oil Substances 0.000 claims description 8
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical group [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 7
- 150000004703 alkoxides Chemical class 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 239000003784 tall oil Substances 0.000 claims description 7
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 claims description 6
- PKYOQQFAEDNYFD-UHFFFAOYSA-L Cl[Ru]Cl.CCCOC1=CC=C(S(=O)(=O)N(C)C)C=C1C=C1N(C=2C(=CC=CC=2C(C)C)C(C)C)CN(CC2CCCCC2)C1 Chemical compound Cl[Ru]Cl.CCCOC1=CC=C(S(=O)(=O)N(C)C)C=C1C=C1N(C=2C(=CC=CC=2C(C)C)C(C)C)CN(CC2CCCCC2)C1 PKYOQQFAEDNYFD-UHFFFAOYSA-L 0.000 claims description 6
- 240000000528 Ricinus communis Species 0.000 claims description 6
- 235000004443 Ricinus communis Nutrition 0.000 claims description 6
- 239000000944 linseed oil Substances 0.000 claims description 6
- 235000021388 linseed oil Nutrition 0.000 claims description 6
- 235000000832 Ayote Nutrition 0.000 claims description 5
- 240000004244 Cucurbita moschata Species 0.000 claims description 5
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 5
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 5
- 235000004347 Perilla Nutrition 0.000 claims description 5
- 244000124853 Perilla frutescens Species 0.000 claims description 5
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 claims description 5
- 235000015136 pumpkin Nutrition 0.000 claims description 5
- 150000008052 alkyl sulfonates Chemical class 0.000 claims description 4
- 125000000129 anionic group Chemical group 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 229910052762 osmium Inorganic materials 0.000 claims description 4
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 4
- 235000019871 vegetable fat Nutrition 0.000 claims description 4
- 240000008067 Cucumis sativus Species 0.000 claims description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 3
- 241001072282 Limnanthes Species 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 241000390166 Physaria Species 0.000 claims description 3
- 235000019498 Walnut oil Nutrition 0.000 claims description 3
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 claims description 3
- 235000012343 cottonseed oil Nutrition 0.000 claims description 3
- 239000002385 cottonseed oil Substances 0.000 claims description 3
- 239000008169 grapeseed oil Substances 0.000 claims description 3
- 150000002430 hydrocarbons Chemical group 0.000 claims description 3
- 239000008164 mustard oil Substances 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 239000010491 poppyseed oil Substances 0.000 claims description 3
- 239000008159 sesame oil Substances 0.000 claims description 3
- 235000011803 sesame oil Nutrition 0.000 claims description 3
- 239000002383 tung oil Substances 0.000 claims description 3
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 3
- 239000008170 walnut oil Substances 0.000 claims description 3
- 238000009482 thermal adhesion granulation Methods 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract description 36
- 239000005977 Ethylene Substances 0.000 abstract description 36
- ADLVDYMTBOSDFE-UHFFFAOYSA-N 5-chloro-6-nitroisoindole-1,3-dione Chemical class C1=C(Cl)C([N+](=O)[O-])=CC2=C1C(=O)NC2=O ADLVDYMTBOSDFE-UHFFFAOYSA-N 0.000 abstract description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 55
- 239000000047 product Substances 0.000 description 52
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 41
- 125000000217 alkyl group Chemical group 0.000 description 40
- 238000006243 chemical reaction Methods 0.000 description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- 238000005686 cross metathesis reaction Methods 0.000 description 23
- 150000002148 esters Chemical class 0.000 description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- 229940073769 methyl oleate Drugs 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 20
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 20
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 20
- 239000008158 vegetable oil Substances 0.000 description 19
- 238000005886 esterification reaction Methods 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000000376 reactant Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 238000005865 alkene metathesis reaction Methods 0.000 description 13
- 229920013639 polyalphaolefin Polymers 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 12
- 239000003925 fat Substances 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 12
- 238000005809 transesterification reaction Methods 0.000 description 11
- 150000001298 alcohols Chemical class 0.000 description 10
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 10
- 230000032050 esterification Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 125000003118 aryl group Chemical group 0.000 description 9
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 9
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000006317 isomerization reaction Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- SBIGSHCJXYGFMX-UHFFFAOYSA-N methyl dec-9-enoate Chemical compound COC(=O)CCCCCCCC=C SBIGSHCJXYGFMX-UHFFFAOYSA-N 0.000 description 8
- 229940049964 oleate Drugs 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- DHCWLIOIJZJFJE-UHFFFAOYSA-L dichlororuthenium Chemical compound Cl[Ru]Cl DHCWLIOIJZJFJE-UHFFFAOYSA-L 0.000 description 7
- 235000021588 free fatty acids Nutrition 0.000 description 7
- 150000002431 hydrogen Chemical class 0.000 description 7
- 239000007791 liquid phase Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 239000012279 sodium borohydride Substances 0.000 description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 6
- 150000001721 carbon Chemical group 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 5
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 5
- 125000005313 fatty acid group Chemical group 0.000 description 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 5
- 125000002524 organometallic group Chemical group 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- WKBALTUBRZPIPZ-UHFFFAOYSA-N 2,6-di(propan-2-yl)aniline Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N WKBALTUBRZPIPZ-UHFFFAOYSA-N 0.000 description 4
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 4
- 240000002791 Brassica napus Species 0.000 description 4
- 235000006008 Brassica napus var napus Nutrition 0.000 description 4
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 4
- 244000188595 Brassica sinapistrum Species 0.000 description 4
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- KVFDZFBHBWTVID-UHFFFAOYSA-N cyclohexanecarbaldehyde Chemical compound O=CC1CCCCC1 KVFDZFBHBWTVID-UHFFFAOYSA-N 0.000 description 4
- 239000002815 homogeneous catalyst Substances 0.000 description 4
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 4
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 125000006413 ring segment Chemical group 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- 150000004671 saturated fatty acids Chemical class 0.000 description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 3
- 241001133760 Acoelorraphe Species 0.000 description 3
- 229910015900 BF3 Inorganic materials 0.000 description 3
- 229940126062 Compound A Drugs 0.000 description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- 244000020551 Helianthus annuus Species 0.000 description 3
- 235000003222 Helianthus annuus Nutrition 0.000 description 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000002877 alkyl aryl group Chemical group 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 150000004985 diamines Chemical class 0.000 description 3
- 239000002638 heterogeneous catalyst Substances 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000004693 imidazolium salts Chemical class 0.000 description 3
- 125000000468 ketone group Chemical group 0.000 description 3
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 235000021313 oleic acid Nutrition 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- HSNQNPCNYIJJHT-ISLYRVAYSA-N trans-octadec-9-ene Chemical compound CCCCCCCC\C=C\CCCCCCCC HSNQNPCNYIJJHT-ISLYRVAYSA-N 0.000 description 3
- 229910052723 transition metal Inorganic materials 0.000 description 3
- 150000003624 transition metals Chemical class 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- GGQQNYXPYWCUHG-RMTFUQJTSA-N (3e,6e)-deca-3,6-diene Chemical compound CCC\C=C\C\C=C\CC GGQQNYXPYWCUHG-RMTFUQJTSA-N 0.000 description 2
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 2
- LSMWOQFDLBIYPM-UHFFFAOYSA-N 1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydro-2h-imidazol-1-ium-2-ide Chemical group CC1=CC(C)=CC(C)=C1N1[C-]=[N+](C=2C(=CC(C)=CC=2C)C)CC1 LSMWOQFDLBIYPM-UHFFFAOYSA-N 0.000 description 2
- YIQXHJZVIAAKSF-UHFFFAOYSA-N 1-(cyclohexylmethyl)-3-[2,6-di(propan-2-yl)phenyl]imidazolidine Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N1CN(CC2CCCCC2)CC1 YIQXHJZVIAAKSF-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- WJAXXWSZNSFVNG-UHFFFAOYSA-N 2-bromoethanamine;hydron;bromide Chemical compound [Br-].[NH3+]CCBr WJAXXWSZNSFVNG-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 235000019737 Animal fat Nutrition 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 229930194542 Keto Natural products 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 2
- 240000002834 Paulownia tomentosa Species 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- GLNYOGJOONJQJS-UHFFFAOYSA-L [Ru](Cl)Cl.C(CC)OC1=C(C=C(C=C1)S(=O)(=O)N(C)C)C=C1C(CCCC1)P(C1CCCCC1)C1CCCCC1 Chemical compound [Ru](Cl)Cl.C(CC)OC1=C(C=C(C=C1)S(=O)(=O)N(C)C)C=C1C(CCCC1)P(C1CCCCC1)C1CCCCC1 GLNYOGJOONJQJS-UHFFFAOYSA-L 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical compound CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N cycloheptane Chemical compound C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 2
- 150000008049 diazo compounds Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 229940087559 grape seed Drugs 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000010773 plant oil Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
- 125000006564 (C4-C8) cycloalkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- HMMGTMVCYYHBKS-UHFFFAOYSA-M 1-(cyclohexylmethyl)-3-[2,6-di(propan-2-yl)phenyl]-4,5-dihydroimidazol-1-ium;chloride Chemical compound [Cl-].CC(C)C1=CC=CC(C(C)C)=C1[N+](CC1)=CN1CC1CCCCC1 HMMGTMVCYYHBKS-UHFFFAOYSA-M 0.000 description 1
- DBNYDGGFHBGDFM-UHFFFAOYSA-M 1-[2,6-di(propan-2-yl)phenyl]-3-propyl-4,5-dihydroimidazol-3-ium;chloride Chemical compound [Cl-].CCCN1CC[N+](C=2C(=CC=CC=2C(C)C)C(C)C)=C1 DBNYDGGFHBGDFM-UHFFFAOYSA-M 0.000 description 1
- VFSODTOUXYOMAM-UHFFFAOYSA-N 1-[2,6-di(propan-2-yl)phenyl]ethane-1,2-diamine Chemical compound CC(C)C1=CC=CC(C(C)C)=C1C(N)CN VFSODTOUXYOMAM-UHFFFAOYSA-N 0.000 description 1
- DVWSXZIHSUZZKJ-UHFFFAOYSA-N 18:3n-3 Natural products CCC=CCC=CCC=CCCCCCCCC(=O)OC DVWSXZIHSUZZKJ-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- RRTLQRYOJOSPEA-UHFFFAOYSA-N 2-bromo-1,3,5-trimethylbenzene Chemical group CC1=CC(C)=C(Br)C(C)=C1 RRTLQRYOJOSPEA-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000006539 C12 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- 229910017971 NH4BF4 Inorganic materials 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000004435 Oxo alcohol Substances 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- PNPBGYBHLCEVMK-UHFFFAOYSA-N benzylidene(dichloro)ruthenium;tricyclohexylphosphanium Chemical compound Cl[Ru](Cl)=CC1=CC=CC=C1.C1CCCCC1[PH+](C1CCCCC1)C1CCCCC1.C1CCCCC1[PH+](C1CCCCC1)C1CCCCC1 PNPBGYBHLCEVMK-UHFFFAOYSA-N 0.000 description 1
- FCDPQMAOJARMTG-UHFFFAOYSA-L benzylidene-[1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-ylidene]-dichlororuthenium;tricyclohexylphosphane Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1.CC1=CC(C)=CC(C)=C1N(CCN1C=2C(=CC(C)=CC=2C)C)C1=[Ru](Cl)(Cl)=CC1=CC=CC=C1 FCDPQMAOJARMTG-UHFFFAOYSA-L 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000012018 catalyst precursor Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- UZAFZWUWHHFWOK-UHFFFAOYSA-L dichloro-(3-phenylinden-1-ylidene)ruthenium;tricyclohexylphosphane Chemical compound C12=CC=CC=C2C(=[Ru](Cl)Cl)C=C1C1=CC=CC=C1.C1CCCCC1P(C1CCCCC1)C1CCCCC1.C1CCCCC1P(C1CCCCC1)C1CCCCC1 UZAFZWUWHHFWOK-UHFFFAOYSA-L 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- HGGLIXDRUINGBB-ONEGZZNKSA-N dimethyl (e)-octadec-9-enedioate Chemical compound COC(=O)CCCCCCC\C=C\CCCCCCCC(=O)OC HGGLIXDRUINGBB-ONEGZZNKSA-N 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- ZYNDJIBBPLNPOW-UHFFFAOYSA-N eurucic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCCCCCC(=O)OC ZYNDJIBBPLNPOW-UHFFFAOYSA-N 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012968 metallocene catalyst Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- XEJYCWVISZMIDA-SEYXRHQNSA-N methyl (z)-icos-9-enoate Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(=O)OC XEJYCWVISZMIDA-SEYXRHQNSA-N 0.000 description 1
- ZYNDJIBBPLNPOW-KHPPLWFESA-N methyl erucate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OC ZYNDJIBBPLNPOW-KHPPLWFESA-N 0.000 description 1
- DVWSXZIHSUZZKJ-YSTUJMKBSA-N methyl linolenate Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OC DVWSXZIHSUZZKJ-YSTUJMKBSA-N 0.000 description 1
- IZFGRAGOVZCUFB-HJWRWDBZSA-N methyl palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC(=O)OC IZFGRAGOVZCUFB-HJWRWDBZSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- AICASVQCOYIMRH-UHFFFAOYSA-N n-methyl-n'-(2,4,6-trimethylphenyl)ethane-1,2-diamine Chemical compound CNCCNC1=C(C)C=C(C)C=C1C AICASVQCOYIMRH-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- DYIZHKNUQPHNJY-UHFFFAOYSA-N oxorhenium Chemical class [Re]=O DYIZHKNUQPHNJY-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- ZRLVQFQTCMUIRM-UHFFFAOYSA-N potassium;2-methylbutan-2-olate Chemical compound [K+].CCC(C)(C)[O-] ZRLVQFQTCMUIRM-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 229910003449 rhenium oxide Inorganic materials 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 238000005872 self-metathesis reaction Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical class 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000005829 trimerization reaction Methods 0.000 description 1
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229910001930 tungsten oxide Inorganic materials 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C6/00—Preparation of hydrocarbons from hydrocarbons containing a different number of carbon atoms by redistribution reactions
- C07C6/02—Metathesis reactions at an unsaturated carbon-to-carbon bond
- C07C6/04—Metathesis reactions at an unsaturated carbon-to-carbon bond at a carbon-to-carbon double bond
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
- B01J31/2208—Oxygen, e.g. acetylacetonates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2265—Carbenes or carbynes, i.e.(image)
- B01J31/2269—Heterocyclic carbenes
- B01J31/2273—Heterocyclic carbenes with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2265—Carbenes or carbynes, i.e.(image)
- B01J31/2278—Complexes comprising two carbene ligands differing from each other, e.g. Grubbs second generation catalysts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/002—Osmium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/50—Redistribution or isomerisation reactions of C-C, C=C or C-C triple bonds
- B01J2231/54—Metathesis reactions, e.g. olefin metathesis
- B01J2231/543—Metathesis reactions, e.g. olefin metathesis alkene metathesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0261—Complexes comprising ligands with non-tetrahedral chirality
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/825—Osmium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- C07C2531/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- C07C2531/22—Organic complexes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
This invention relates to a metathesis catalyst compound comprising an asymmetrically substituted N-heterocyclic carbene (NHC) metathesis catalyst and a process to make linear alpha-olefms comprising contacting a feed material and an optional alkene (such as ethylene) with said catalyst, where the feed material is a triacylglyceride, fatty acid, fatty acid alkyl ester, and/or fatty acid ester, typically derived from biodiesel.
Description
Title: METATHESIS CATALYSTS AND PROCESSES FOR USE THEREOF
Inventors: Matthew W. Holtcamp, Matthew S. Bedoya, Catherine A. Faler, Caol P.
Huff, John R. Hagadorn PRIORITY CLAIM
This invention claims priority to and the benefit of USSN 61/314,388, filed March 16, 2010.
This invention claims priority to and the benefit of USSN 12/705,136, filed February 12, 2010.
This invention claims priority to and the benefit of USSN 61/259,521, filed November 9, 2009.
STATEMENT OF RELATED APPLICATIONS
This invention is related to USSN 12/ (Attorney Docket No. 2009EM268/2), filed concurrently herewith and claiming priority to USSN 61/259,514, filed November 9, 2009. This invention is also related to USSN 12/ , filed concurrently herewith (Attorney Docket Number 2009EM273/2), claiming priority to USSN 61/259,521, filed November 9, 2009.
FIELD OF THE INVENTION
This invention relates to metathesis catalyst compounds and processes for the use thereof.
BACKGROUND OF THE INVENTION
The cross-metathesis of two reactant olefins, where each reactant olefin comprises at least one unsaturation site, to produce new olefins which are different from the reactant olefins is of significant commercial importance. The cross-metathesis reaction is usually catalyzed by one or more catalytic metals, usually one or more transition metals.
One such commercially significant application is the cross-metathesis of ethylene and internal olefins to produce alpha-olefins, which is generally referred to as ethenolysis. In particular, the cross-metathesis of ethylene and an internal olefin to produce linear alpha-olefins (LAOs) is of particular commercial significance. LAOs are useful as monomers or comonomers in certain (co)polymers (polyalphaolefins or PAOs) and/or as intermediates in the production of epoxides, amines, oxo alcohols, synthetic lubricants, synthetic fatty acids and alkylated aromatics. Olefins Conversion TechnologyTM, based upon the Phillips Triolefin Process, is an example of an ethenolysis reaction converting ethylene and 2-butene into propylene. These processes use heterogeneous catalysts, such as tungsten and rhenium oxides, which have not proven effective for internal olefins containing functional groups such as cis-methyl oleate, a fatty acid methyl ester.
Methods for the production of polyalpha-olefins are typically multi-step processes that often create unwanted by-products and waste of reactants and energy. Full range linear alpha-olefins plants are petroleum-based, are inefficient, and result in mixtures of oligomerization products that typically yield Schulz-Flory distributions producing large quantities of undesirable materials. In recent years there have been new technologies implemented to produce "on purpose" linear alpha-olefins such 1-hexene and 1-octene through chromium-based selective ethylene trimerization or tetramerization catalysts.
Alternatively, 1-octene has been produced via the telomerization of butadiene and methanol.
Similar strategies are not currently available for the production of 1-decene.
1-decene is a co-product typically produced in the cross-metathesis of ethylene and methyl oleate. Alkyl oleates are fatty acid esters that can be major components in biodiesel produced by the transesterification of alcohol and vegetable oils or animal fats. Vegetable oils containing at least one site of unsaturation include canola, soybean, palm, peanut, mustard, sunflower, tung, tall, perilla, grapeseed, rapeseed, linseed, safflower, pumpkin corn and many other oils extracted from plant seeds. Alkyl erucates similarly are fatty acid esters that can be major components in biodiesel. Useful biodiesel compositions are those which typically have high concentrations of oleate and erucate esters. These fatty acid esters preferably have one site of unsaturation such that cross-metathesis with ethylene yields 1-decene as a co-product.
Biodiesel is a fuel prepared from renewable sources, such as plant oils or animal fats.
To produce biodiesel, triacylglycerides ("TAG"), the major compound in plant oils and animal fats, are converted to fatty acid alkyl esters ("FAAE," i.e., biodiesel) and glycerol via reaction with an alcohol in the presence of a base, acid, or enzyme catalyst.
Biodiesel fuel can be used in diesel engines, either alone or in a blend with petroleum-based diesel, or can be further modified to produce other chemical products.
Cross-metathesis catalysts reported thus far for the ethenolysis of methyl oleate are typically ruthenium-based catalysts bearing phosphine or carbene ligands. Dow researchers in 2004 achieved catalysts turnovers of approximately 15,000 using the 1st generation Grubb's catalyst, bis(tricyclohexylphosphine)benzylidene ruthenium(IV) dichloride, (Organometallics 2004, 23, p. 2027). Researchers at Materia, Inc. have reported turnover numbers up to 35,000 using a ruthenium catalyst containing a cyclic alkyl amino carbene ligand, (WO 2008/010961). These turnovers were obtained with a catalyst reportedly too expensive for industrial consideration due to high costs associated with the catalysts being derived from a low yielding synthesis (See, Final Technical Report entitled "Platform Chemicals from an Oilseed Biorefinery" grant number DE-FG36-04GO14016 awarded by the Department of Energy). Additionally, the introduction of chelating isopropoxybenzylidene ligands has led to ruthenium catalysts with improved activities for metathesis reactions (J. Am.
Chem. Soc. 1999, 121, p. 791). However, these ruthenium alkylidene catalysts are usually prepared by the reaction of ruthenium species with diazo compounds. The concerns associated with industrial scale reactions comprising diazo compounds have led to increased efforts to prepare ruthenium alkylidenes via alternate synthetic routes, such as using terminal alkynes or propargyl alcohols.
The synthesis of RuC12(PCy3)2(3-phenylindenylene) has proven useful in providing an easy route to ruthenium alkylidenes which avoids costly diazo preparations (Platinum Metals Rev. 2005, 49, p. 33). Also, Furstner et at., J. Org. Chem., 2000, 65, pp. 2204-2207, have prepared (N,N'-bis(mesityl)imidazol-2-ylidene)RuC12(3-phenylindenylene).
However these types of complexes have not proven effective in ethenolysis reactions.
Unsymmetrical N-heterocyclic carbene ligands have been prepared by Blechert and coworkers and complexed to ruthenium alkylidenes to form active metathesis catalysts (Organometallics 2006, 25, pp. 25-28). It was hypothesized that these complexes would give improved activity to that of the symmetrical analogs previously prepared by Grubbs and coworkers (Org. Lett. 1999, 1, pp. 953-956). These complexes were tested for catalytic activity in ring closing and cross-metathesis reactions. However, the catalysts were reported to be similar in activity to the symmetrical analogs, namely the Grubbs catalyst, 2nd generation (1,3-bis-(2,4,6-trimethylphenyl)-2-(imidazolidinylidene)(dichlorophenylmethylene)(tricyclohexylphosphine)ruthenium ) and the expected improved activities were not observed.
In order to obtain an economically viable process for 1-decene production via the cross-metathesis of ethylene and biodiesel (derived from animal or vegetable oils), higher activity catalysts must be discovered. Thus there is a need for higher activity processes that produce desired products and co-products in commercially desirable ratios.
There remains a need for catalysts which demonstrate high activity and selectivity in ethenolysis which are capable of being synthesized by both mild and affordable synthetic routes. The instant invention's metathesis catalyst compounds provide both a mild and commercially economical and an "atom-economical" route to desirable olefins, in particular alpha-olefins, which in turn may be useful in the preparation of PAOs. More particularly, the instant invention's metathesis catalyst compounds demonstrate improved activity and selectivity towards ethenolysis products in ethylene cross-metathesis reactions.
The inventors have found that symmetrically substituted N-heterocyclic carbene ligands linked to ruthenium alkylidenes, though known to be cross-metathesis catalysts, tend to have low activity in the ethenolysis of methyl oleate. Surprisingly, an asymmetrically substituted N-heterocyclic carbene ligand linked to a ruthenium alkylidene yielded a catalyst that was more active than the symmetrical analog and very selective towards the ethenolysis of methyl oleate yielding 1-decene and methyl-9-decenoate.
Other references of interest include: US 7,119,216; US 7,205,424; US
2007/0043180;
WO 2006/138166; WO 2008/010961; US 2007/0043180; US 7,268,242; WO 2008/125568;
WO 2008/046106; WO 2008/095785; WO 2008/140468; US 7,312,331; and WO
2008/010961.
Other references of interest also include: a) "Synthesis and Reactivity of Olefin Metathesis Catalysts Bearing Cyclic (Alkyl)(Amino)Carbenes" Anderson et al., Angew.
Chem. Int. Ed. 2007, 46, pp. 7262-7265; b) "Intramolecular'Hydroiminiumation' of Alkenes:
Applications to the Synthesis of Conjugate Acids of Cyclic Alkyl Amino Carbenes (CAACs)"
Jazzar et al., Angew. Chem. Int. Ed. 2007, 46, pp. 2899-2902; c) "Kinetic Selectivity of Olefin Metathesis Catalysts Bearing Cyclic (Alkyl)(Amino)Carbenes" Anderson et al., Organometallics, 2008, 27, pp. 563-566; d) "A New Synthetic Method for the Preparation of Protonated-NHCs and Related Compounds" Jazzar et al., J. Organometallic Chemistry 691, 2006, pp. 3201-3205; e) "A Rigid Cyclic (Alkyl)(Amino)carbene Ligand Leads to Isolation of Low-Coordinate Transition Metal Complexes" Lavallo et al., Angew. Chem. Int.
Ed., 2005, 44, pp. 7236-7239; f) "Stable Cyclic (Alkyl)(Amino)carbenes as Rigid or Flexible, Bulky Electron-Rich Ligands for Transition Metal Catalysts: A Quaternary Carbon Atom Makes the Difference" Angew. Chem. Int. Ed., 2007, 44, pp. 5705-5709; g) "Synthesis and Activity of a New Generation of Ruthenium-Based Olefin Metathesis Catalysts Coordinated with 1,3-Dimesityl-4,5-dihydroimidazol-2-ylidene Ligands" Org. Letters, 1999, 1, pp.
953-956.
SUMMARY OF THE INVENTION
This invention relates to an asymmetrically substituted N-heterocyclic carbene (NHC) metathesis catalyst and process for use thereof in the production of olefins, where the metathesis catalyst is represented by the following formula:
/N N~
Rl R2 X1'Y_ Rs X 2 __'M L _~~<
where:
M is a Group 8 metal; preferably Ru or Os;
Xl and X2 are, independently, any anionic ligand, or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing ligand; preferably the heteroatom is N, 0, P, or S;
preferably P; optionally L may be joined to R7 and/or R8;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms; and wherein R1 and R2 are dissimilar to each other.
In alternate embodiments, when R7 and R8 form an unsubstituted phenyl group and R1 is mesityl, then R2 is not methyl or ethyl, preferably R2 is hydrogen or C1 to C30 substituted hydrocarbyl, or a C3 to C30 unsubstituted hydrocarbyl (preferably a C4 to C30 unsubstituted hydrocarbyl, preferably a C5 to C30 unsubstituted hydrocarbyl, preferably a C6 to C30 unsubstituted hydrocarbyl).
DETAILED DESCRIPTION
The present invention comprises a novel metathesis catalyst compound useful for the cross-metathesis of olefins, and processes for the use thereof. More particularly, the present invention comprises a novel metathesis catalyst compound which comprises an asymmetrically substituted N-heterocyclic carbene group. Even more particularly, the present invention comprises a novel metathesis catalyst compound which demonstrates improved activity and selectivity towards ethenolysis products in ethylene cross-metathesis reactions.
This invention also relates to a process comprising contacting a feed oil (typically a triglyceride or seed oil) or derivative thereof (and optional alkene) with an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin. The feed oil may be esterified or transesterified with an alcohol prior to contacting with the olefin metathesis catalyst.
This invention also relates to a process comprising contacting a triacylglyceride or a derivative thereof with an optional alkene (such as ethylene) and an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin, typically yielding a linear alpha-olefin (such as 1-decene, 1-heptene, and/or 1-butene) and an ester or acid functionalized olefin.
This invention further relates to a process for producing alpha-olefins (preferably linear alpha-olefins) comprising contacting a triacylglyceride with an alcohol (such as methanol) to produce a fatty acid alkyl ester and thereafter contacting the fatty acid alkyl ester with an olefin metathesis catalyst of the types described herein (and optional alkene, such as ethylene) under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an ester or acid functionalized olefin.
This invention further relates to a process for producing alpha-olefins (preferably linear alpha-olefins) comprising contacting a triacylglyceride with water and/or an alkaline reactant (such as sodium hydroxide) to produce a fatty acid and thereafter contacting the fatty acid with an olefin metathesis catalyst of the types described herein (and optional alkene, such as ethylene) under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an acid functionalized olefin.
This invention further relates to contacting unsaturated fatty acids with an alkene (such as ethylene) in the presence of an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an acid functionalized olefin.
This invention further relates to contacting an unsaturated fatty acid ester with an alkene (such as ethylene) in the presence of an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an ester functionalized olefin.
Inventors: Matthew W. Holtcamp, Matthew S. Bedoya, Catherine A. Faler, Caol P.
Huff, John R. Hagadorn PRIORITY CLAIM
This invention claims priority to and the benefit of USSN 61/314,388, filed March 16, 2010.
This invention claims priority to and the benefit of USSN 12/705,136, filed February 12, 2010.
This invention claims priority to and the benefit of USSN 61/259,521, filed November 9, 2009.
STATEMENT OF RELATED APPLICATIONS
This invention is related to USSN 12/ (Attorney Docket No. 2009EM268/2), filed concurrently herewith and claiming priority to USSN 61/259,514, filed November 9, 2009. This invention is also related to USSN 12/ , filed concurrently herewith (Attorney Docket Number 2009EM273/2), claiming priority to USSN 61/259,521, filed November 9, 2009.
FIELD OF THE INVENTION
This invention relates to metathesis catalyst compounds and processes for the use thereof.
BACKGROUND OF THE INVENTION
The cross-metathesis of two reactant olefins, where each reactant olefin comprises at least one unsaturation site, to produce new olefins which are different from the reactant olefins is of significant commercial importance. The cross-metathesis reaction is usually catalyzed by one or more catalytic metals, usually one or more transition metals.
One such commercially significant application is the cross-metathesis of ethylene and internal olefins to produce alpha-olefins, which is generally referred to as ethenolysis. In particular, the cross-metathesis of ethylene and an internal olefin to produce linear alpha-olefins (LAOs) is of particular commercial significance. LAOs are useful as monomers or comonomers in certain (co)polymers (polyalphaolefins or PAOs) and/or as intermediates in the production of epoxides, amines, oxo alcohols, synthetic lubricants, synthetic fatty acids and alkylated aromatics. Olefins Conversion TechnologyTM, based upon the Phillips Triolefin Process, is an example of an ethenolysis reaction converting ethylene and 2-butene into propylene. These processes use heterogeneous catalysts, such as tungsten and rhenium oxides, which have not proven effective for internal olefins containing functional groups such as cis-methyl oleate, a fatty acid methyl ester.
Methods for the production of polyalpha-olefins are typically multi-step processes that often create unwanted by-products and waste of reactants and energy. Full range linear alpha-olefins plants are petroleum-based, are inefficient, and result in mixtures of oligomerization products that typically yield Schulz-Flory distributions producing large quantities of undesirable materials. In recent years there have been new technologies implemented to produce "on purpose" linear alpha-olefins such 1-hexene and 1-octene through chromium-based selective ethylene trimerization or tetramerization catalysts.
Alternatively, 1-octene has been produced via the telomerization of butadiene and methanol.
Similar strategies are not currently available for the production of 1-decene.
1-decene is a co-product typically produced in the cross-metathesis of ethylene and methyl oleate. Alkyl oleates are fatty acid esters that can be major components in biodiesel produced by the transesterification of alcohol and vegetable oils or animal fats. Vegetable oils containing at least one site of unsaturation include canola, soybean, palm, peanut, mustard, sunflower, tung, tall, perilla, grapeseed, rapeseed, linseed, safflower, pumpkin corn and many other oils extracted from plant seeds. Alkyl erucates similarly are fatty acid esters that can be major components in biodiesel. Useful biodiesel compositions are those which typically have high concentrations of oleate and erucate esters. These fatty acid esters preferably have one site of unsaturation such that cross-metathesis with ethylene yields 1-decene as a co-product.
Biodiesel is a fuel prepared from renewable sources, such as plant oils or animal fats.
To produce biodiesel, triacylglycerides ("TAG"), the major compound in plant oils and animal fats, are converted to fatty acid alkyl esters ("FAAE," i.e., biodiesel) and glycerol via reaction with an alcohol in the presence of a base, acid, or enzyme catalyst.
Biodiesel fuel can be used in diesel engines, either alone or in a blend with petroleum-based diesel, or can be further modified to produce other chemical products.
Cross-metathesis catalysts reported thus far for the ethenolysis of methyl oleate are typically ruthenium-based catalysts bearing phosphine or carbene ligands. Dow researchers in 2004 achieved catalysts turnovers of approximately 15,000 using the 1st generation Grubb's catalyst, bis(tricyclohexylphosphine)benzylidene ruthenium(IV) dichloride, (Organometallics 2004, 23, p. 2027). Researchers at Materia, Inc. have reported turnover numbers up to 35,000 using a ruthenium catalyst containing a cyclic alkyl amino carbene ligand, (WO 2008/010961). These turnovers were obtained with a catalyst reportedly too expensive for industrial consideration due to high costs associated with the catalysts being derived from a low yielding synthesis (See, Final Technical Report entitled "Platform Chemicals from an Oilseed Biorefinery" grant number DE-FG36-04GO14016 awarded by the Department of Energy). Additionally, the introduction of chelating isopropoxybenzylidene ligands has led to ruthenium catalysts with improved activities for metathesis reactions (J. Am.
Chem. Soc. 1999, 121, p. 791). However, these ruthenium alkylidene catalysts are usually prepared by the reaction of ruthenium species with diazo compounds. The concerns associated with industrial scale reactions comprising diazo compounds have led to increased efforts to prepare ruthenium alkylidenes via alternate synthetic routes, such as using terminal alkynes or propargyl alcohols.
The synthesis of RuC12(PCy3)2(3-phenylindenylene) has proven useful in providing an easy route to ruthenium alkylidenes which avoids costly diazo preparations (Platinum Metals Rev. 2005, 49, p. 33). Also, Furstner et at., J. Org. Chem., 2000, 65, pp. 2204-2207, have prepared (N,N'-bis(mesityl)imidazol-2-ylidene)RuC12(3-phenylindenylene).
However these types of complexes have not proven effective in ethenolysis reactions.
Unsymmetrical N-heterocyclic carbene ligands have been prepared by Blechert and coworkers and complexed to ruthenium alkylidenes to form active metathesis catalysts (Organometallics 2006, 25, pp. 25-28). It was hypothesized that these complexes would give improved activity to that of the symmetrical analogs previously prepared by Grubbs and coworkers (Org. Lett. 1999, 1, pp. 953-956). These complexes were tested for catalytic activity in ring closing and cross-metathesis reactions. However, the catalysts were reported to be similar in activity to the symmetrical analogs, namely the Grubbs catalyst, 2nd generation (1,3-bis-(2,4,6-trimethylphenyl)-2-(imidazolidinylidene)(dichlorophenylmethylene)(tricyclohexylphosphine)ruthenium ) and the expected improved activities were not observed.
In order to obtain an economically viable process for 1-decene production via the cross-metathesis of ethylene and biodiesel (derived from animal or vegetable oils), higher activity catalysts must be discovered. Thus there is a need for higher activity processes that produce desired products and co-products in commercially desirable ratios.
There remains a need for catalysts which demonstrate high activity and selectivity in ethenolysis which are capable of being synthesized by both mild and affordable synthetic routes. The instant invention's metathesis catalyst compounds provide both a mild and commercially economical and an "atom-economical" route to desirable olefins, in particular alpha-olefins, which in turn may be useful in the preparation of PAOs. More particularly, the instant invention's metathesis catalyst compounds demonstrate improved activity and selectivity towards ethenolysis products in ethylene cross-metathesis reactions.
The inventors have found that symmetrically substituted N-heterocyclic carbene ligands linked to ruthenium alkylidenes, though known to be cross-metathesis catalysts, tend to have low activity in the ethenolysis of methyl oleate. Surprisingly, an asymmetrically substituted N-heterocyclic carbene ligand linked to a ruthenium alkylidene yielded a catalyst that was more active than the symmetrical analog and very selective towards the ethenolysis of methyl oleate yielding 1-decene and methyl-9-decenoate.
Other references of interest include: US 7,119,216; US 7,205,424; US
2007/0043180;
WO 2006/138166; WO 2008/010961; US 2007/0043180; US 7,268,242; WO 2008/125568;
WO 2008/046106; WO 2008/095785; WO 2008/140468; US 7,312,331; and WO
2008/010961.
Other references of interest also include: a) "Synthesis and Reactivity of Olefin Metathesis Catalysts Bearing Cyclic (Alkyl)(Amino)Carbenes" Anderson et al., Angew.
Chem. Int. Ed. 2007, 46, pp. 7262-7265; b) "Intramolecular'Hydroiminiumation' of Alkenes:
Applications to the Synthesis of Conjugate Acids of Cyclic Alkyl Amino Carbenes (CAACs)"
Jazzar et al., Angew. Chem. Int. Ed. 2007, 46, pp. 2899-2902; c) "Kinetic Selectivity of Olefin Metathesis Catalysts Bearing Cyclic (Alkyl)(Amino)Carbenes" Anderson et al., Organometallics, 2008, 27, pp. 563-566; d) "A New Synthetic Method for the Preparation of Protonated-NHCs and Related Compounds" Jazzar et al., J. Organometallic Chemistry 691, 2006, pp. 3201-3205; e) "A Rigid Cyclic (Alkyl)(Amino)carbene Ligand Leads to Isolation of Low-Coordinate Transition Metal Complexes" Lavallo et al., Angew. Chem. Int.
Ed., 2005, 44, pp. 7236-7239; f) "Stable Cyclic (Alkyl)(Amino)carbenes as Rigid or Flexible, Bulky Electron-Rich Ligands for Transition Metal Catalysts: A Quaternary Carbon Atom Makes the Difference" Angew. Chem. Int. Ed., 2007, 44, pp. 5705-5709; g) "Synthesis and Activity of a New Generation of Ruthenium-Based Olefin Metathesis Catalysts Coordinated with 1,3-Dimesityl-4,5-dihydroimidazol-2-ylidene Ligands" Org. Letters, 1999, 1, pp.
953-956.
SUMMARY OF THE INVENTION
This invention relates to an asymmetrically substituted N-heterocyclic carbene (NHC) metathesis catalyst and process for use thereof in the production of olefins, where the metathesis catalyst is represented by the following formula:
/N N~
Rl R2 X1'Y_ Rs X 2 __'M L _~~<
where:
M is a Group 8 metal; preferably Ru or Os;
Xl and X2 are, independently, any anionic ligand, or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing ligand; preferably the heteroatom is N, 0, P, or S;
preferably P; optionally L may be joined to R7 and/or R8;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms; and wherein R1 and R2 are dissimilar to each other.
In alternate embodiments, when R7 and R8 form an unsubstituted phenyl group and R1 is mesityl, then R2 is not methyl or ethyl, preferably R2 is hydrogen or C1 to C30 substituted hydrocarbyl, or a C3 to C30 unsubstituted hydrocarbyl (preferably a C4 to C30 unsubstituted hydrocarbyl, preferably a C5 to C30 unsubstituted hydrocarbyl, preferably a C6 to C30 unsubstituted hydrocarbyl).
DETAILED DESCRIPTION
The present invention comprises a novel metathesis catalyst compound useful for the cross-metathesis of olefins, and processes for the use thereof. More particularly, the present invention comprises a novel metathesis catalyst compound which comprises an asymmetrically substituted N-heterocyclic carbene group. Even more particularly, the present invention comprises a novel metathesis catalyst compound which demonstrates improved activity and selectivity towards ethenolysis products in ethylene cross-metathesis reactions.
This invention also relates to a process comprising contacting a feed oil (typically a triglyceride or seed oil) or derivative thereof (and optional alkene) with an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin. The feed oil may be esterified or transesterified with an alcohol prior to contacting with the olefin metathesis catalyst.
This invention also relates to a process comprising contacting a triacylglyceride or a derivative thereof with an optional alkene (such as ethylene) and an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin, typically yielding a linear alpha-olefin (such as 1-decene, 1-heptene, and/or 1-butene) and an ester or acid functionalized olefin.
This invention further relates to a process for producing alpha-olefins (preferably linear alpha-olefins) comprising contacting a triacylglyceride with an alcohol (such as methanol) to produce a fatty acid alkyl ester and thereafter contacting the fatty acid alkyl ester with an olefin metathesis catalyst of the types described herein (and optional alkene, such as ethylene) under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an ester or acid functionalized olefin.
This invention further relates to a process for producing alpha-olefins (preferably linear alpha-olefins) comprising contacting a triacylglyceride with water and/or an alkaline reactant (such as sodium hydroxide) to produce a fatty acid and thereafter contacting the fatty acid with an olefin metathesis catalyst of the types described herein (and optional alkene, such as ethylene) under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an acid functionalized olefin.
This invention further relates to contacting unsaturated fatty acids with an alkene (such as ethylene) in the presence of an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an acid functionalized olefin.
This invention further relates to contacting an unsaturated fatty acid ester with an alkene (such as ethylene) in the presence of an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an ester functionalized olefin.
This invention further relates to contacting an unsaturated fatty acid alkyl ester with an alkene (such as ethylene) in the presence of an olefin metathesis catalyst of the types described herein under conditions which yield an alpha-olefin (preferably a linear alpha-olefin, preferably 1-decene, 1-heptene, and/or 1-butene) and an ester functionalized olefin.
This invention also relates to a process to produce alpha olefins (preferably linear alpha olefins, preferably 1-decene, 1-heptene, and/or 1-butene) comprising contacting a metathesis catalyst of the types described herein with an alkene (preferably ethylene), and one or more fatty acid esters (preferably fatty acid methyl esters, preferably methyl oleate).
In a preferred embodiment, this invention relates to a process to produce alpha olefin (preferably linear alpha olefin, preferably 1-decene, 1-heptene, and/or 1-butene) comprising contacting a metathesis catalyst of the types described herein with an alkene (preferably ethylene), and one or more fatty acid esters (preferably fatty acid methyl esters, preferably methyl oleate) derived from biodiesel.
In a preferred embodiment, the olefin metathesis catalysts described herein may be combined directly with triacylglycerides, biodiesel, fatty acids, fatty acid esters, and/or fatty acid alkyl esters to produce alpha-olefins, preferably linear alpha olefins, preferably C4 to C24 alpha-olefins, preferably 1-decene, 1-heptene, and/or 1-butene.
In a preferred embodiment, a mixture of one or more triacylglyceride, biodiesel, fatty acids, and/or fatty acid esters is used to produce alpha-olefins, preferably linear alpha olefins, preferably C4 to C24 alpha-olefins, preferably C4 to C24 linear alpha-olefins.
In a preferred embodiment, a mixture of alpha olefins, preferably linear alpha olefins, preferably 1-decene, 1-heptene, and/or 1-butene is produced.
Metathesis Catalysts This invention relates to an asymmetrically substituted NHC metathesis catalyst compound represented by the following formula:
This invention also relates to a process to produce alpha olefins (preferably linear alpha olefins, preferably 1-decene, 1-heptene, and/or 1-butene) comprising contacting a metathesis catalyst of the types described herein with an alkene (preferably ethylene), and one or more fatty acid esters (preferably fatty acid methyl esters, preferably methyl oleate).
In a preferred embodiment, this invention relates to a process to produce alpha olefin (preferably linear alpha olefin, preferably 1-decene, 1-heptene, and/or 1-butene) comprising contacting a metathesis catalyst of the types described herein with an alkene (preferably ethylene), and one or more fatty acid esters (preferably fatty acid methyl esters, preferably methyl oleate) derived from biodiesel.
In a preferred embodiment, the olefin metathesis catalysts described herein may be combined directly with triacylglycerides, biodiesel, fatty acids, fatty acid esters, and/or fatty acid alkyl esters to produce alpha-olefins, preferably linear alpha olefins, preferably C4 to C24 alpha-olefins, preferably 1-decene, 1-heptene, and/or 1-butene.
In a preferred embodiment, a mixture of one or more triacylglyceride, biodiesel, fatty acids, and/or fatty acid esters is used to produce alpha-olefins, preferably linear alpha olefins, preferably C4 to C24 alpha-olefins, preferably C4 to C24 linear alpha-olefins.
In a preferred embodiment, a mixture of alpha olefins, preferably linear alpha olefins, preferably 1-decene, 1-heptene, and/or 1-butene is produced.
Metathesis Catalysts This invention relates to an asymmetrically substituted NHC metathesis catalyst compound represented by the following formula:
X1~ Rs X
Formula (I) where:
M is a Group 8 metal; preferably Ru or Os;
Xi and X2 are, independently, any anionic ligand, preferably a halogen (such as chlorine or bromine, preferably chlorine), an alkoxide or an alkyl sulfonate, or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing group; preferably the heteroatom is N, 0, P, or S;
preferably P; optionally L may be joined to R7 and/or R8, preferably L is L*(R)q_1 when L is not bound to R7 or R8 or L is L*(R)q_2 when L is bound to R7 or R8, where q is 1, 2, 3, or 4 depending on the valence of L* (which may be 2, 3, 4, or 5) and L* is N, 0, P, or S, preferably P and R is as defined for R3;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl, preferably R1, R2, R3, R4, R5, R6, R7, and R8 are selected from the group consisting of methyl, ethyl, propyl butyl, hexyl, octyl, nonyl, decyl, undecyl, dodecyl, indenylene, substituted indenylene, phenyl, substituted phenyl, and the linear, branched and cyclic isomers thereof (including mesityl, 3,5,5-trimethylhexyl, cyclohexyl, methyl cyclohexyl, cyclododecyl, diisopropylphenyl, cyclopentyl, and norbornyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
and wherein R1 and R2 are dissimilar to each other.
Preferably, any two adjacent R groups may form a fused ring having from 5 to 8 non-hydrogen atoms. Preferably, the non-hydrogen atoms are C and/or O. Preferably, the adjacent R groups form fused rings of 5 to 6 ring atoms, preferably 5 to 6 carbon atoms. By adjacent is meant any two R groups located next to each other, for example R7 and R8, can form a ring.
For purposes of this invention and claims thereto, a "Group 8 metal" is an element from Group 8 of the Periodic Table, as referenced by the IUPAC in Nomenclature of Inorganic Chemistry: Recommendations, G.J. Leigh, Editor, Blackwell Scientific Publications, 1990.
For purposes of this invention and claims thereto, a "substituted hydrocarbyl"
is a radical made of carbon and hydrogen where at least one hydrogen is replaced by a heteroatom.
For purposes of this invention and claims thereto, a "substituted alkyl or aryl" group is a radical made of carbon and hydrogen where at least one hydrogen is replaced by a heteroatom or a linear, branched, or cyclic substituted or unsubstituted hydrocarbyl group having 1 to 30 carbon atoms.
For purposes of this invention and claims thereto, "alkoxides" include those where the alkyl group is a C1 to C10 hydrocarbyl. The alkyl group may be straight chain or branched.
Preferred alkoxides include a C1 to C10 alkyl group, preferably methyl, ethyl, propyl, butyl, or isopropyl. Preferred alkoxides include those where the alkyl group is a phenol, substituted phenol (where the phenol may be substituted with up to 1, 2, 3, 4, or 5 C1 to C12 hydrocarbyl groups) or a C 1 to C10 hydrocarbyl, preferably a C 1 to C10 alkyl group, preferably methyl, ethyl, propyl, butyl, or phenyl.
Preferred alkyl sulfonates are represented by the Formula (II):
O S O-II
Formula (II) where R9 is a C1 to C30 hydrocarbyl group, fluoro-substituted hydrocarbyl group, chloro-substituted hydrocarbyl group, aryl group, or substituted aryl group, preferably a C1 to C12 alkyl or aryl group, preferably trifluoromethyl, methyl, phenyl, or para-methyl-phenyl.
In all embodiments herein, the invention relates to asymmetrically substituted NHC
metathesis catalyst compounds wherein R1 and R2 are dissimilar to each other, causing asymmetry in the NHC ligand. For purposes of this invention and the claims thereto, dissimilar means that R1 and R2 differ by at least 1 non-hydrogen atom (preferably by at least 2, preferably at least 3, preferably by at least 4, preferably by at least 5 non-hydrogen atoms) or if R1 and R2 have the same number of non-hydrogen atoms, then they differ in structure or saturation, e.g., if one is cyclic then the other is linear; or if one is linear then the other is branched; or if one is saturated (such as cyclohexyl) then the other is aromatic (such as phenyl), etc. In particular embodiments, where R1 and R2 are dissimilar to each other, R1 is an aromatic group, preferably phenyl, substituted phenyl, indenylenes, and substituted indenylenes; and R2 is an aliphatic group, preferably methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, pentyl, hexyl, cyclohexyl, cyclohexylmethyl, and so on. For example, in some embodiments, R1 is a mesityl group and R2 is a methyl group. In another embodiment, R1 is a 2,6-diisopropylphenyl group and R2 is a cyclohexylmethyl group. In yet another embodiment, R1 is a 2,6-diisopropylphenyl group and R2 is a propyl group. In alternate embodiments, when R7 and R8 form an unsubstituted phenyl group and R1 is mesityl, then R2 is not methyl or ethyl, preferably R2 is hydrogen or C1 to C30 substituted hydrocarbyl, or a C3 to C30 unsubstituted hydrocarbyl (preferably a C4 to C30 unsubstituted hydrocarbyl, preferably a C5 to C30 unsubstituted hydrocarbyl, preferably a C6 to C30 unsubstituted hydrocarbyl). In a preferred embodiment, both R1 and R2 are a C3 to C30 unsubstituted or substituted hydrocarbyl (preferably a C4 to C30 unsubstituted or substituted hydrocarbyl, preferably a C5 to C30 unsubstituted or substituted hydrocarbyl, preferably a C6 to C30 unsubstituted or substituted hydrocarbyl). In another embodiment, one of R1 and R2 is aromatic (such as phenyl, mesityl, cyclopentyl, indenyl, norbornyl) and the other is a C3 to C30 unsubstituted or substituted hydrocarbyl (preferably a C4 to C30 unsubstituted or substituted hydrocarbyl, preferably a C5 to C30 unsubstituted or substituted hydrocarbyl, preferably a C6 to C30 unsubstituted or substituted hydrocarbyl).
In particular embodiments, the invention relates to asymmetrically substituted NHC
metathesis catalyst compounds wherein R7 or R8 is not joined to L. In preferred embodiments, R7 or R8 is at least one of a phenyl, substituted phenyl, indenylene, and substituted indenylene group. For example, catalysts of the type below in Formula (III), where R7 is not joined to L, where each G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl, and R1 and R2 are dissimilar to each other are particularly useful herein. In a preferred embodiment, this invention relates to a compound represented by the formula:
Ri NCR
R
s G
Xl G
M
X2** I I
L
G G
G
Formula (III) where M, X1, X2, L, R1, R2, R3, R4, R5, R6, and R8 are as defined in Formula (I) and G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl.
Preferably any two adjacent G groups may form a fused ring having from 5 to 8 non-hydrogen atoms. Preferably the non-hydrogen atoms are C and/or O. Preferably the adjacent G groups form fused rings of 5 to 6 ring atoms, preferably 5 to 6 carbon atoms.
In other particular embodiments, R7 and R8 are fused such that the C(R7)(R8) group is a benzylidene, substituted benzylidene, indenylene, or substituted indenylene.
Even more particularly, a catalyst useful herein is (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-1-ylidene ruthenium (II) dichloride, shown below in Formula (IV), wherein R1 is a mesityl group, R2 is a methyl group, R7 and R8 are fused to form a phenyl-substituted indenylene group which does not join to L, L is a tricyclohexylphosphine group (represented as PCy3), and X1 and X2 are chloride groups. Ph = phenyl.
NN-, ~1.-_Ru PCy3 Ph Formula (IV) In other particular embodiments, the invention relates to asymmetrically substituted NHC metathesis catalyst compounds wherein a heteroatom of R7 or R8 is also joined to L, as represented below in Formula (V). In a preferred embodiment, this invention relates to a compound represented by the formula:
Ri R2 X1 " Rg X~ I
Y"~'LR7 Formula (V) where M, X1, X2, L, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in Formula (I). In preferred embodiments, R7 or R8 is at least one of a phenyl, substituted phenyl, indenylene, and substituted indenylene group. For example, catalysts of the type below in Formula (VI), where R7 is a phenyl group joined to L, where each G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl, and R1 and R2 are dissimilar to each other are particularly useful herein.
N-Ri R2 Rg X1//J" G
X2' M
I
L
G
G G
Formula (VI) where M, X1, X2, L, R1, R2, R3, R4, R5, R6, and R8 are as defined in Formula (I) and G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl.
Formula (I) where:
M is a Group 8 metal; preferably Ru or Os;
Xi and X2 are, independently, any anionic ligand, preferably a halogen (such as chlorine or bromine, preferably chlorine), an alkoxide or an alkyl sulfonate, or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing group; preferably the heteroatom is N, 0, P, or S;
preferably P; optionally L may be joined to R7 and/or R8, preferably L is L*(R)q_1 when L is not bound to R7 or R8 or L is L*(R)q_2 when L is bound to R7 or R8, where q is 1, 2, 3, or 4 depending on the valence of L* (which may be 2, 3, 4, or 5) and L* is N, 0, P, or S, preferably P and R is as defined for R3;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl, preferably R1, R2, R3, R4, R5, R6, R7, and R8 are selected from the group consisting of methyl, ethyl, propyl butyl, hexyl, octyl, nonyl, decyl, undecyl, dodecyl, indenylene, substituted indenylene, phenyl, substituted phenyl, and the linear, branched and cyclic isomers thereof (including mesityl, 3,5,5-trimethylhexyl, cyclohexyl, methyl cyclohexyl, cyclododecyl, diisopropylphenyl, cyclopentyl, and norbornyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
and wherein R1 and R2 are dissimilar to each other.
Preferably, any two adjacent R groups may form a fused ring having from 5 to 8 non-hydrogen atoms. Preferably, the non-hydrogen atoms are C and/or O. Preferably, the adjacent R groups form fused rings of 5 to 6 ring atoms, preferably 5 to 6 carbon atoms. By adjacent is meant any two R groups located next to each other, for example R7 and R8, can form a ring.
For purposes of this invention and claims thereto, a "Group 8 metal" is an element from Group 8 of the Periodic Table, as referenced by the IUPAC in Nomenclature of Inorganic Chemistry: Recommendations, G.J. Leigh, Editor, Blackwell Scientific Publications, 1990.
For purposes of this invention and claims thereto, a "substituted hydrocarbyl"
is a radical made of carbon and hydrogen where at least one hydrogen is replaced by a heteroatom.
For purposes of this invention and claims thereto, a "substituted alkyl or aryl" group is a radical made of carbon and hydrogen where at least one hydrogen is replaced by a heteroatom or a linear, branched, or cyclic substituted or unsubstituted hydrocarbyl group having 1 to 30 carbon atoms.
For purposes of this invention and claims thereto, "alkoxides" include those where the alkyl group is a C1 to C10 hydrocarbyl. The alkyl group may be straight chain or branched.
Preferred alkoxides include a C1 to C10 alkyl group, preferably methyl, ethyl, propyl, butyl, or isopropyl. Preferred alkoxides include those where the alkyl group is a phenol, substituted phenol (where the phenol may be substituted with up to 1, 2, 3, 4, or 5 C1 to C12 hydrocarbyl groups) or a C 1 to C10 hydrocarbyl, preferably a C 1 to C10 alkyl group, preferably methyl, ethyl, propyl, butyl, or phenyl.
Preferred alkyl sulfonates are represented by the Formula (II):
O S O-II
Formula (II) where R9 is a C1 to C30 hydrocarbyl group, fluoro-substituted hydrocarbyl group, chloro-substituted hydrocarbyl group, aryl group, or substituted aryl group, preferably a C1 to C12 alkyl or aryl group, preferably trifluoromethyl, methyl, phenyl, or para-methyl-phenyl.
In all embodiments herein, the invention relates to asymmetrically substituted NHC
metathesis catalyst compounds wherein R1 and R2 are dissimilar to each other, causing asymmetry in the NHC ligand. For purposes of this invention and the claims thereto, dissimilar means that R1 and R2 differ by at least 1 non-hydrogen atom (preferably by at least 2, preferably at least 3, preferably by at least 4, preferably by at least 5 non-hydrogen atoms) or if R1 and R2 have the same number of non-hydrogen atoms, then they differ in structure or saturation, e.g., if one is cyclic then the other is linear; or if one is linear then the other is branched; or if one is saturated (such as cyclohexyl) then the other is aromatic (such as phenyl), etc. In particular embodiments, where R1 and R2 are dissimilar to each other, R1 is an aromatic group, preferably phenyl, substituted phenyl, indenylenes, and substituted indenylenes; and R2 is an aliphatic group, preferably methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, pentyl, hexyl, cyclohexyl, cyclohexylmethyl, and so on. For example, in some embodiments, R1 is a mesityl group and R2 is a methyl group. In another embodiment, R1 is a 2,6-diisopropylphenyl group and R2 is a cyclohexylmethyl group. In yet another embodiment, R1 is a 2,6-diisopropylphenyl group and R2 is a propyl group. In alternate embodiments, when R7 and R8 form an unsubstituted phenyl group and R1 is mesityl, then R2 is not methyl or ethyl, preferably R2 is hydrogen or C1 to C30 substituted hydrocarbyl, or a C3 to C30 unsubstituted hydrocarbyl (preferably a C4 to C30 unsubstituted hydrocarbyl, preferably a C5 to C30 unsubstituted hydrocarbyl, preferably a C6 to C30 unsubstituted hydrocarbyl). In a preferred embodiment, both R1 and R2 are a C3 to C30 unsubstituted or substituted hydrocarbyl (preferably a C4 to C30 unsubstituted or substituted hydrocarbyl, preferably a C5 to C30 unsubstituted or substituted hydrocarbyl, preferably a C6 to C30 unsubstituted or substituted hydrocarbyl). In another embodiment, one of R1 and R2 is aromatic (such as phenyl, mesityl, cyclopentyl, indenyl, norbornyl) and the other is a C3 to C30 unsubstituted or substituted hydrocarbyl (preferably a C4 to C30 unsubstituted or substituted hydrocarbyl, preferably a C5 to C30 unsubstituted or substituted hydrocarbyl, preferably a C6 to C30 unsubstituted or substituted hydrocarbyl).
In particular embodiments, the invention relates to asymmetrically substituted NHC
metathesis catalyst compounds wherein R7 or R8 is not joined to L. In preferred embodiments, R7 or R8 is at least one of a phenyl, substituted phenyl, indenylene, and substituted indenylene group. For example, catalysts of the type below in Formula (III), where R7 is not joined to L, where each G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl, and R1 and R2 are dissimilar to each other are particularly useful herein. In a preferred embodiment, this invention relates to a compound represented by the formula:
Ri NCR
R
s G
Xl G
M
X2** I I
L
G G
G
Formula (III) where M, X1, X2, L, R1, R2, R3, R4, R5, R6, and R8 are as defined in Formula (I) and G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl.
Preferably any two adjacent G groups may form a fused ring having from 5 to 8 non-hydrogen atoms. Preferably the non-hydrogen atoms are C and/or O. Preferably the adjacent G groups form fused rings of 5 to 6 ring atoms, preferably 5 to 6 carbon atoms.
In other particular embodiments, R7 and R8 are fused such that the C(R7)(R8) group is a benzylidene, substituted benzylidene, indenylene, or substituted indenylene.
Even more particularly, a catalyst useful herein is (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-1-ylidene ruthenium (II) dichloride, shown below in Formula (IV), wherein R1 is a mesityl group, R2 is a methyl group, R7 and R8 are fused to form a phenyl-substituted indenylene group which does not join to L, L is a tricyclohexylphosphine group (represented as PCy3), and X1 and X2 are chloride groups. Ph = phenyl.
NN-, ~1.-_Ru PCy3 Ph Formula (IV) In other particular embodiments, the invention relates to asymmetrically substituted NHC metathesis catalyst compounds wherein a heteroatom of R7 or R8 is also joined to L, as represented below in Formula (V). In a preferred embodiment, this invention relates to a compound represented by the formula:
Ri R2 X1 " Rg X~ I
Y"~'LR7 Formula (V) where M, X1, X2, L, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in Formula (I). In preferred embodiments, R7 or R8 is at least one of a phenyl, substituted phenyl, indenylene, and substituted indenylene group. For example, catalysts of the type below in Formula (VI), where R7 is a phenyl group joined to L, where each G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl, and R1 and R2 are dissimilar to each other are particularly useful herein.
N-Ri R2 Rg X1//J" G
X2' M
I
L
G
G G
Formula (VI) where M, X1, X2, L, R1, R2, R3, R4, R5, R6, and R8 are as defined in Formula (I) and G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl.
Preferably any two adjacent G groups may form a fused ring having from 5 to 8 non-hydrogen atoms. Preferably the non-hydrogen atoms are C and/or O. Preferably the adjacent G groups form fused rings of 5 to 6 ring atoms, preferably 5 to 6 carbon atoms.
In other preferred embodiments, R7 and R8 are fused to form an indenylene group which is joined to L as shown in Formula (VII) below:
X1 iii,,, M G
X2*
L
G
G G
Formula (VII) where M, X1, X2, L, R1, R2, R3, R4, R5, and R6 are as defined in Formula (I) and G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl.
Preferably any two adjacent G groups may form a fused ring having from 5 to 8 non-hydrogen atoms. Preferably the non-hydrogen atoms are C and/or O. Preferably the adjacent G groups form fused rings of 5 to 6 ring atoms, preferably 5 to 6 carbon atoms.
Even more particularly, a catalyst useful herein is 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(1- cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride, shown below in Formula (VIII), wherein R1 is a 2,6-diisopropylphenyl group, R2 is a cyclohexylmethyl group, R7 is a dimethylaminosulfonyl-substituted phenyl group which joins to L, L is an isopropoxy group, and X1 and X2 are chloride groups.
In other preferred embodiments, R7 and R8 are fused to form an indenylene group which is joined to L as shown in Formula (VII) below:
X1 iii,,, M G
X2*
L
G
G G
Formula (VII) where M, X1, X2, L, R1, R2, R3, R4, R5, and R6 are as defined in Formula (I) and G is independently, hydrogen, halogen, or C1-C30 substituted or unsubstituted hydrocarbyl.
Preferably any two adjacent G groups may form a fused ring having from 5 to 8 non-hydrogen atoms. Preferably the non-hydrogen atoms are C and/or O. Preferably the adjacent G groups form fused rings of 5 to 6 ring atoms, preferably 5 to 6 carbon atoms.
Even more particularly, a catalyst useful herein is 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(1- cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride, shown below in Formula (VIII), wherein R1 is a 2,6-diisopropylphenyl group, R2 is a cyclohexylmethyl group, R7 is a dimethylaminosulfonyl-substituted phenyl group which joins to L, L is an isopropoxy group, and X1 and X2 are chloride groups.
N
CI - ,Ru_ CI`
O
SO2N(CH3)2 Formula (VIII) Preferred metathesis catalysts useful herein include: 2-(i-propoxy)-5-(N,N-dimethyl-aminosulfonyl)phenylmethylene(l- cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-1H-imidazole) ruthenium (II) chloride, (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-1-ylidene ruthenium (II) dichloride, and mixtures thereof.
The catalyst compounds described herein may be synthesized as follows. The NHC
precursor, as the imidazolium salt, can be synthesized as known in the art.
For example, 2,6-diisopropylaniline (R1) is reacted with 2-bromoethylamine hydrobromide at reflux for four days. The resulting diamine is condensed with a suitable reagent such as cyclohexylcarboxaldehyde (R2) to give the imine. The resulting imine is reduced to the corresponding diamine using any suitable reducing agent, such as sodium borohydride.
Treatment with triethyl formate and ammonium chloride yields the imidazolium salt. The imidazolium salt upon deprotonation with the appropriate base such as lithium bis(trimethylsilyl)amide generates the NHC ligand. This carbene can be reacted with ruthenium alkylidene complexes such as 2-(i-propoxy)-5-(N,N-dimethyl-aminosulfonyl)phenylmethylene(tricyclohexylphosphine) ruthenium dichloride to generate the asymmetrically substituted NHC ruthenium complex, 2-(i-propoxy)-5-(N,N-dimethyl-aminosulfonyl)phenylmethylene(1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-1H-imidazole) ruthenium (II) chloride.
The resulting ruthenium alkylidene complex is an efficient catalyst or catalyst precursor towards for the cross-metathesis of ethylene and methyl oleate, a component of biodiesel, to generate with good selectivity 1-decene and methyl-9-decenoate.
Process In a preferred embodiment, the metathesis catalysts described herein may be combined directly with feed oils, seed oils, triacylglycerides, biodiesel, fatty acids, fatty acid esters and/or fatty acid alkyl esters ("feed materials") to produce alpha-olefins, preferably linear alpha olefins, preferably C4 to C24 alpha-olefins, preferably C4 to C24 linear alpha-olefins, such as preferably 1-decene, 1-heptene, and/or 1-butene.
Typically, the molar ratio of alkene to unsaturated feed material (such as unsaturated fatty acid or fatty acid ester) is greater than about 0.8/1.0, preferably, greater than about 0.9/1Ø Typically, the molar ratio of alkene to feed material (such as unsaturated fatty acid or fatty acid ester) is less than about 3.0/1.0, preferably, less than about 2.0/1Ø Depending upon the specific reagents, other molar ratios may also be suitable. With ethylene, for example, a significantly higher molar ratio can be used, because the self-metathesis of ethylene produces only ethylene again; no undesirable co-product olefins are formed.
Accordingly, the molar ratio of ethylene to feed material (such as unsaturated fatty acid or fatty acid ester) may range from greater than about 0.8/1 to typically less than about 20/1.
The quantity of metathesis catalyst that is employed in the process of this invention is any quantity that provides for an operable metathesis reaction. Preferably, the ratio of moles of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) to moles of metathesis catalyst is typically greater than about 10:1, preferably greater than about 100:1, preferably greater than about 1000:1, preferably greater than about 10,000:1, preferably greater than about 25,000:1, preferably greater than about 50,000:1, preferably greater than about 100,000:1. Alternately, the molar ratio of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) to metathesis catalyst is typically less than about 10,000,000:1, preferably less than about 1,000,000:1, and more preferably less than about 500,000:1.
The contacting time of the reagents and catalyst in a batch reactor can be any duration, provided that the desired olefin metathesis products are obtained. Generally, the contacting time in a reactor is greater than about 5 minutes, and preferably greater than about 10 minutes.
Generally, the contacting time in a reactor is less than about 25 hours, preferably less than about 15 hours, and more preferably less than about 10 hours.
In a preferred embodiment, the reactants (for example, metathesis catalyst;
feed materials; optional alkene, optional alcohol, optional water, etc.) are combined in a reaction vessel at a temperature of 20 to 300 C (preferably 20 to 200 C, preferably 30 to 100 C, preferably 40 to 60 C) and an alkene (such as ethylene) at a pressure of 0.1 to 1000 psi (0.7 kPa to 6.9 MPa), preferably 20 to 400 psi (0.14 MPa to 2.8MPa), preferably 50 to 250 psi (0.34 MPa to 1.7MPa), if the alkene is present, for a residence time of 0.5 seconds to 48 hours (preferably 0.25 to 5 hours, preferably 30 minutes to 2 hours).
CI - ,Ru_ CI`
O
SO2N(CH3)2 Formula (VIII) Preferred metathesis catalysts useful herein include: 2-(i-propoxy)-5-(N,N-dimethyl-aminosulfonyl)phenylmethylene(l- cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-1H-imidazole) ruthenium (II) chloride, (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-1-ylidene ruthenium (II) dichloride, and mixtures thereof.
The catalyst compounds described herein may be synthesized as follows. The NHC
precursor, as the imidazolium salt, can be synthesized as known in the art.
For example, 2,6-diisopropylaniline (R1) is reacted with 2-bromoethylamine hydrobromide at reflux for four days. The resulting diamine is condensed with a suitable reagent such as cyclohexylcarboxaldehyde (R2) to give the imine. The resulting imine is reduced to the corresponding diamine using any suitable reducing agent, such as sodium borohydride.
Treatment with triethyl formate and ammonium chloride yields the imidazolium salt. The imidazolium salt upon deprotonation with the appropriate base such as lithium bis(trimethylsilyl)amide generates the NHC ligand. This carbene can be reacted with ruthenium alkylidene complexes such as 2-(i-propoxy)-5-(N,N-dimethyl-aminosulfonyl)phenylmethylene(tricyclohexylphosphine) ruthenium dichloride to generate the asymmetrically substituted NHC ruthenium complex, 2-(i-propoxy)-5-(N,N-dimethyl-aminosulfonyl)phenylmethylene(1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-1H-imidazole) ruthenium (II) chloride.
The resulting ruthenium alkylidene complex is an efficient catalyst or catalyst precursor towards for the cross-metathesis of ethylene and methyl oleate, a component of biodiesel, to generate with good selectivity 1-decene and methyl-9-decenoate.
Process In a preferred embodiment, the metathesis catalysts described herein may be combined directly with feed oils, seed oils, triacylglycerides, biodiesel, fatty acids, fatty acid esters and/or fatty acid alkyl esters ("feed materials") to produce alpha-olefins, preferably linear alpha olefins, preferably C4 to C24 alpha-olefins, preferably C4 to C24 linear alpha-olefins, such as preferably 1-decene, 1-heptene, and/or 1-butene.
Typically, the molar ratio of alkene to unsaturated feed material (such as unsaturated fatty acid or fatty acid ester) is greater than about 0.8/1.0, preferably, greater than about 0.9/1Ø Typically, the molar ratio of alkene to feed material (such as unsaturated fatty acid or fatty acid ester) is less than about 3.0/1.0, preferably, less than about 2.0/1Ø Depending upon the specific reagents, other molar ratios may also be suitable. With ethylene, for example, a significantly higher molar ratio can be used, because the self-metathesis of ethylene produces only ethylene again; no undesirable co-product olefins are formed.
Accordingly, the molar ratio of ethylene to feed material (such as unsaturated fatty acid or fatty acid ester) may range from greater than about 0.8/1 to typically less than about 20/1.
The quantity of metathesis catalyst that is employed in the process of this invention is any quantity that provides for an operable metathesis reaction. Preferably, the ratio of moles of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) to moles of metathesis catalyst is typically greater than about 10:1, preferably greater than about 100:1, preferably greater than about 1000:1, preferably greater than about 10,000:1, preferably greater than about 25,000:1, preferably greater than about 50,000:1, preferably greater than about 100,000:1. Alternately, the molar ratio of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) to metathesis catalyst is typically less than about 10,000,000:1, preferably less than about 1,000,000:1, and more preferably less than about 500,000:1.
The contacting time of the reagents and catalyst in a batch reactor can be any duration, provided that the desired olefin metathesis products are obtained. Generally, the contacting time in a reactor is greater than about 5 minutes, and preferably greater than about 10 minutes.
Generally, the contacting time in a reactor is less than about 25 hours, preferably less than about 15 hours, and more preferably less than about 10 hours.
In a preferred embodiment, the reactants (for example, metathesis catalyst;
feed materials; optional alkene, optional alcohol, optional water, etc.) are combined in a reaction vessel at a temperature of 20 to 300 C (preferably 20 to 200 C, preferably 30 to 100 C, preferably 40 to 60 C) and an alkene (such as ethylene) at a pressure of 0.1 to 1000 psi (0.7 kPa to 6.9 MPa), preferably 20 to 400 psi (0.14 MPa to 2.8MPa), preferably 50 to 250 psi (0.34 MPa to 1.7MPa), if the alkene is present, for a residence time of 0.5 seconds to 48 hours (preferably 0.25 to 5 hours, preferably 30 minutes to 2 hours).
In certain embodiments, where the alkene is a gaseous olefin, the olefin pressure is greater than about 5 psig (34.5 kPa), preferably, greater than about 10 psig (68.9 kPa), and more preferably, greater than about 45 psig (310 kPa). When a diluent is used with the gaseous alkene, the aforementioned pressure ranges may also be suitably employed as the total pressure of olefin and diluent. Likewise, when a liquid alkene is employed and the process is conducted under an inert gaseous atmosphere, then the aforementioned pressure ranges may be suitably employed for the inert gas pressure.
In a preferred embodiment, from about 0.005 nmoles to about 500 nmoles, preferably from about 0.1 to about 250 nmoles, and most preferably from about 1 to about 50 nmoles of the metathesis catalyst are charged to the reactor per 3 mmoles of feed material (such as TAGs, biodiesel, fatty acids, fatty acid esters, and/or fatty acid alkyl esters or mixtures thereof, preferably fatty acid esters) charged.
In a preferred embodiment, the process is typically a solution process, although it may be a bulk or high pressure process. Homogeneous processes are preferred. (A
homogeneous process is defined to be a process where at least 90 wt% of the product is soluble in the reaction media.) A bulk homogeneous process is particularly preferred. (A bulk process is defined to be a process where reactant concentration in all feeds to the reactor is 70 volume %
or more.) Alternately, no solvent or diluent is present or added in the reaction medium, (except for the small amounts used as the carrier for the catalyst or other additives, or amounts typically found with the reactants, e.g., propane in propylene).
Suitable diluents/solvents for the process include non-coordinating, inert liquids.
Examples include straight and branched-chain hydrocarbons such as isobutane, butane, pentane, isopentane, hexanes, isohexane, heptane, octane, dodecane, and mixtures thereof, cyclic and alicyclic hydrocarbons such as cyclohexane, cycloheptane, methylcyclohexane, methylcycloheptane, and mixtures thereof such as can be found commercially (IsoparTM);
perhalogenated hydrocarbons such as perfluorinated C4-10 alkanes, chlorobenzene, and aromatic and alkylsubstituted aromatic compounds such as benzene, toluene, mesitylene, and xylene. Suitable diluents/solvents also include aromatic hydrocarbons, such as toluene or xylenes, and chlorinated solvents, such as dichloromethane. In a preferred embodiment, the feed concentration for the process is 60 volume % solvent or less, preferably 40 volume % or less, preferably 20 volume % or less.
The process may be batch, semi-batch or continuous. As used herein, the term continuous means a system that operates without interruption or cessation. For example, a continuous process to produce a polymer would be one where the reactants are continually introduced into one or more reactors and polymer product is continually withdrawn.
Useful reaction vessels include reactors (including continuous stirred tank reactors, batch reactors, reactive extruder, pipe, or pump.
The processes may be conducted in either glass lined, stainless steel, or similar type reaction equipment. Useful reaction vessels include reactors (including continuous stirred tank reactors, batch reactors, reactive extruder, pipe, or pump, continuous flow fixed bed reactors, slurry reactors, fluidized bed reactors, and catalytic distillation reactors). The reaction zone may be fitted with one or more internal and/or external heat exchanger(s) in order to control undue temperature fluctuations, or to prevent "runaway"
reaction temperatures.
If the process is conducted in a continuous flow reactor, then the weight hourly space velocity, given in units of grams feed material (preferably fatty acid ester and/or fatty acid alkyl ester) per gram catalyst per hour (h-i), will determine the relative quantities of feed material to catalyst employed, as well as the residence time in the reactor of the unsaturated starting compound. In a flow reactor, the weight hourly space velocity of the unsaturated feed material (preferably fatty acid ester and/or fatty acid alkyl ester) is typically greater than about 0.04 g feed material (preferably fatty acid ester and/or fatty acid alkyl ester) per g catalyst per hour (h-i), and preferably, greater than about 0.1 h-i. In a flow reactor, the weight hourly space velocity of the feed material (preferably fatty acid ester and/or fatty acid alkyl ester) is typically less than about 100 h-i, and preferably, less than about 20 h-i.
In certain embodiments, reactions utilizing the catalytic complexes of the present invention can be run in a biphasic mixture of solvents, in an emulsion or suspension, or in a lipid vesicle or bilayer.
The feed material is typically provided as a liquid phase, preferably neat. In particular embodiments, the feed material is provided in a liquid phase, preferably neat;
while the alkene is provided as a gas that is dissolved in the liquid phase. In certain embodiments, feed material is an unsaturated fatty acid ester or unsaturated fatty acid and is provided in a liquid phase, preferably neat; while the alkene is a gaseous alpha-olefin, such as for example, ethylene, which is dissolved in the liquid phase.
Generally, the feed material is an unsaturated fatty acid ester or unsaturated fatty acid and is provided as a liquid at the process temperature, and it is generally preferred to be used neat, that is, without a diluent or solvent. The use of a solvent usually increases recycle requirements and increases costs. Optionally, however, if desired, a solvent can be employed with the alkene and/or feed material. A solvent may be desirable, for instance, where liquid feed material and alkene are not entirely miscible, and both then can be solubilized in a suitable solvent.
In a preferred embodiment, the alkene and an unsaturated fatty acid ester or unsaturated fatty acid are co-metathesized to form first and second product olefins, preferably, a reduced chain first product alpha-olefin and a second product reduced chain terminal ester or acid-functionalized alpha-olefin. As a preferred example, the metathesis of methyloleate with ethylene will yield cross-metathesis products of 1-decene and methyl-9-decenoate. Both products are alpha-olefins; the decenoate also terminates in an ester moiety at the opposite end of the chain from the carbon-carbon double bond. In addition to the desired products, the methyloleate may self-metathesize to produce small amounts of 9-octadecene, a less desirable product, and dimethyl-9-octadecene-1,18-dioate, CH3OC(O) (CH2)7CH=CH(CH2) 7QO)O
CH3, a second less desirable product.
In the process of this invention, the conversion of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) can vary widely depending upon the specific reagent olefins, the specific catalyst, and specific process conditions employed. For the purpose of this invention, "conversion" is defined as the mole percentage of feed material that is converted or reacted to the cross-metathesis alpha-olefin products. Typically, the conversion of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) is greater than about 50 mole %, preferably, greater than about 60 mole %, and more preferably, greater than about 70 mole %.
In the process of this invention, the yields of first product olefin and ester or acid-functionalized second product olefin can also vary depending upon the specific reagent olefins, catalyst, and process conditions employed. For the purposes of this invention "yield"
will be defined as the mole percentage of cross-metathesis alpha-olefin product olefin formed relative to the initial moles of feed material (such as fatty acid ester and/or fatty acid alkyl ester) in the feed. Typically, the yield of alpha-olefin will be greater than about 35 mole %, preferably, greater than about 50 mole %. Typically, the yield of ester or acid-functionalized alpha-olefin will be 30% or more, preferably 40% or more, preferably 45% or more, preferably 50% or more, preferably 55% or more, preferably 60% or more.
In a preferred embodiment, the yield for reactions (when converting TAGs as represented in the formula below), is defined as the moles of alpha olefin formed divided by (the moles of unsaturated Ra + moles of unsaturated Rb + moles of unsaturated Rc) introduced into the reactor is 30% or more, preferably 40% or more, preferably 45% or more, preferably 50% or more, preferably 55% or more, preferably 60% or more.
- Ra HC-O-C-Rb H2C - O - C- Rc where Ra, Rb, and Rc each, independently, represent a saturated or unsaturated hydrocarbon chain (preferably Ra, Rb, and Rc each, independently, are a C12 to C28 alkyl or alkene, preferably C16 to C22 alkyl or alkene).
For the purposes of this invention, "productivity" is defined to be the amount in grams of linear alpha-olefin produced per mmol of catalyst introduced into the reactor, per hour. In a preferred embodiment, the productivity of the process is at least 200 g of linear alpha-olefin (such as decene-1) per mmol of catalyst per hour, preferably at least 5000 g/mmol/hour, preferably at least 10,000 g/mmol/hour, preferably at least 300,000 g/mmol/hour.
For the purposes of this invention, "selectivity" is a measure of conversion of alkene and feed material to the cross-metathesis alpha-olefin product, and is defined by the mole percentage of product olefin formed relative to the initial moles of alkene or feed material. In a preferred embodiment, the selectivity of the process is at least 20 wt%
linear alpha-olefin, based upon the weight to the material exiting the reactor, preferably at least 25 wt%, preferably at least 30 wt%, preferably at least 35 wt%, preferably at least 40 wt%, preferably at least 45 wt%, preferably at least 50 wt%, preferably at least 60 wt%, preferably at least 70 wt%, preferably at least 80 wt%, preferably at least 85 wt%, preferably at least 90 wt%, preferably at least wt95%.
For the purpose of this invention, "catalyst turnover number" (TON) is a measure of how active the catalyst compound is and is defined as the number of moles of cross-metathesis alpha-olefin product formed per mole of catalyst compound. In a preferred embodiment, the (TON), of the process is at least 5,000, preferably at least 10,000, preferably at least 50,000, preferably at least 100,000, preferably at least 1,000,000.
In a preferred embodiment, from about 0.005 nmoles to about 500 nmoles, preferably from about 0.1 to about 250 nmoles, and most preferably from about 1 to about 50 nmoles of the metathesis catalyst are charged to the reactor per 3 mmoles of feed material (such as TAGs, biodiesel, fatty acids, fatty acid esters, and/or fatty acid alkyl esters or mixtures thereof, preferably fatty acid esters) charged.
In a preferred embodiment, the process is typically a solution process, although it may be a bulk or high pressure process. Homogeneous processes are preferred. (A
homogeneous process is defined to be a process where at least 90 wt% of the product is soluble in the reaction media.) A bulk homogeneous process is particularly preferred. (A bulk process is defined to be a process where reactant concentration in all feeds to the reactor is 70 volume %
or more.) Alternately, no solvent or diluent is present or added in the reaction medium, (except for the small amounts used as the carrier for the catalyst or other additives, or amounts typically found with the reactants, e.g., propane in propylene).
Suitable diluents/solvents for the process include non-coordinating, inert liquids.
Examples include straight and branched-chain hydrocarbons such as isobutane, butane, pentane, isopentane, hexanes, isohexane, heptane, octane, dodecane, and mixtures thereof, cyclic and alicyclic hydrocarbons such as cyclohexane, cycloheptane, methylcyclohexane, methylcycloheptane, and mixtures thereof such as can be found commercially (IsoparTM);
perhalogenated hydrocarbons such as perfluorinated C4-10 alkanes, chlorobenzene, and aromatic and alkylsubstituted aromatic compounds such as benzene, toluene, mesitylene, and xylene. Suitable diluents/solvents also include aromatic hydrocarbons, such as toluene or xylenes, and chlorinated solvents, such as dichloromethane. In a preferred embodiment, the feed concentration for the process is 60 volume % solvent or less, preferably 40 volume % or less, preferably 20 volume % or less.
The process may be batch, semi-batch or continuous. As used herein, the term continuous means a system that operates without interruption or cessation. For example, a continuous process to produce a polymer would be one where the reactants are continually introduced into one or more reactors and polymer product is continually withdrawn.
Useful reaction vessels include reactors (including continuous stirred tank reactors, batch reactors, reactive extruder, pipe, or pump.
The processes may be conducted in either glass lined, stainless steel, or similar type reaction equipment. Useful reaction vessels include reactors (including continuous stirred tank reactors, batch reactors, reactive extruder, pipe, or pump, continuous flow fixed bed reactors, slurry reactors, fluidized bed reactors, and catalytic distillation reactors). The reaction zone may be fitted with one or more internal and/or external heat exchanger(s) in order to control undue temperature fluctuations, or to prevent "runaway"
reaction temperatures.
If the process is conducted in a continuous flow reactor, then the weight hourly space velocity, given in units of grams feed material (preferably fatty acid ester and/or fatty acid alkyl ester) per gram catalyst per hour (h-i), will determine the relative quantities of feed material to catalyst employed, as well as the residence time in the reactor of the unsaturated starting compound. In a flow reactor, the weight hourly space velocity of the unsaturated feed material (preferably fatty acid ester and/or fatty acid alkyl ester) is typically greater than about 0.04 g feed material (preferably fatty acid ester and/or fatty acid alkyl ester) per g catalyst per hour (h-i), and preferably, greater than about 0.1 h-i. In a flow reactor, the weight hourly space velocity of the feed material (preferably fatty acid ester and/or fatty acid alkyl ester) is typically less than about 100 h-i, and preferably, less than about 20 h-i.
In certain embodiments, reactions utilizing the catalytic complexes of the present invention can be run in a biphasic mixture of solvents, in an emulsion or suspension, or in a lipid vesicle or bilayer.
The feed material is typically provided as a liquid phase, preferably neat. In particular embodiments, the feed material is provided in a liquid phase, preferably neat;
while the alkene is provided as a gas that is dissolved in the liquid phase. In certain embodiments, feed material is an unsaturated fatty acid ester or unsaturated fatty acid and is provided in a liquid phase, preferably neat; while the alkene is a gaseous alpha-olefin, such as for example, ethylene, which is dissolved in the liquid phase.
Generally, the feed material is an unsaturated fatty acid ester or unsaturated fatty acid and is provided as a liquid at the process temperature, and it is generally preferred to be used neat, that is, without a diluent or solvent. The use of a solvent usually increases recycle requirements and increases costs. Optionally, however, if desired, a solvent can be employed with the alkene and/or feed material. A solvent may be desirable, for instance, where liquid feed material and alkene are not entirely miscible, and both then can be solubilized in a suitable solvent.
In a preferred embodiment, the alkene and an unsaturated fatty acid ester or unsaturated fatty acid are co-metathesized to form first and second product olefins, preferably, a reduced chain first product alpha-olefin and a second product reduced chain terminal ester or acid-functionalized alpha-olefin. As a preferred example, the metathesis of methyloleate with ethylene will yield cross-metathesis products of 1-decene and methyl-9-decenoate. Both products are alpha-olefins; the decenoate also terminates in an ester moiety at the opposite end of the chain from the carbon-carbon double bond. In addition to the desired products, the methyloleate may self-metathesize to produce small amounts of 9-octadecene, a less desirable product, and dimethyl-9-octadecene-1,18-dioate, CH3OC(O) (CH2)7CH=CH(CH2) 7QO)O
CH3, a second less desirable product.
In the process of this invention, the conversion of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) can vary widely depending upon the specific reagent olefins, the specific catalyst, and specific process conditions employed. For the purpose of this invention, "conversion" is defined as the mole percentage of feed material that is converted or reacted to the cross-metathesis alpha-olefin products. Typically, the conversion of feed material (preferably fatty acid ester and/or fatty acid alkyl ester) is greater than about 50 mole %, preferably, greater than about 60 mole %, and more preferably, greater than about 70 mole %.
In the process of this invention, the yields of first product olefin and ester or acid-functionalized second product olefin can also vary depending upon the specific reagent olefins, catalyst, and process conditions employed. For the purposes of this invention "yield"
will be defined as the mole percentage of cross-metathesis alpha-olefin product olefin formed relative to the initial moles of feed material (such as fatty acid ester and/or fatty acid alkyl ester) in the feed. Typically, the yield of alpha-olefin will be greater than about 35 mole %, preferably, greater than about 50 mole %. Typically, the yield of ester or acid-functionalized alpha-olefin will be 30% or more, preferably 40% or more, preferably 45% or more, preferably 50% or more, preferably 55% or more, preferably 60% or more.
In a preferred embodiment, the yield for reactions (when converting TAGs as represented in the formula below), is defined as the moles of alpha olefin formed divided by (the moles of unsaturated Ra + moles of unsaturated Rb + moles of unsaturated Rc) introduced into the reactor is 30% or more, preferably 40% or more, preferably 45% or more, preferably 50% or more, preferably 55% or more, preferably 60% or more.
- Ra HC-O-C-Rb H2C - O - C- Rc where Ra, Rb, and Rc each, independently, represent a saturated or unsaturated hydrocarbon chain (preferably Ra, Rb, and Rc each, independently, are a C12 to C28 alkyl or alkene, preferably C16 to C22 alkyl or alkene).
For the purposes of this invention, "productivity" is defined to be the amount in grams of linear alpha-olefin produced per mmol of catalyst introduced into the reactor, per hour. In a preferred embodiment, the productivity of the process is at least 200 g of linear alpha-olefin (such as decene-1) per mmol of catalyst per hour, preferably at least 5000 g/mmol/hour, preferably at least 10,000 g/mmol/hour, preferably at least 300,000 g/mmol/hour.
For the purposes of this invention, "selectivity" is a measure of conversion of alkene and feed material to the cross-metathesis alpha-olefin product, and is defined by the mole percentage of product olefin formed relative to the initial moles of alkene or feed material. In a preferred embodiment, the selectivity of the process is at least 20 wt%
linear alpha-olefin, based upon the weight to the material exiting the reactor, preferably at least 25 wt%, preferably at least 30 wt%, preferably at least 35 wt%, preferably at least 40 wt%, preferably at least 45 wt%, preferably at least 50 wt%, preferably at least 60 wt%, preferably at least 70 wt%, preferably at least 80 wt%, preferably at least 85 wt%, preferably at least 90 wt%, preferably at least wt95%.
For the purpose of this invention, "catalyst turnover number" (TON) is a measure of how active the catalyst compound is and is defined as the number of moles of cross-metathesis alpha-olefin product formed per mole of catalyst compound. In a preferred embodiment, the (TON), of the process is at least 5,000, preferably at least 10,000, preferably at least 50,000, preferably at least 100,000, preferably at least 1,000,000.
Feed Materials Feed materials useful in metathesis processes described herein include feed oils, fatty acids, fatty acid esters, triacylglycerides, and biodiesel.
Feed Oils The fatty acid rich material useful in the processes described herein can be derived from plant, animal, microbial, or other sources (feed oil). Preferred feed oils include vegetable oils such as corn, soy, rapeseed, canola, sunflower, palm and other oils that are readily available; however, any vegetable oil or animal fat can be employed.
Raw or unrefined oil can be used in certain embodiments; however, filtered and refined oils are typically preferred. Use of degummed and filtered feedstock minimizes the potential for emulsification and blockage in the reactors. Feedstock with high water content can be dried before basic catalyst processing. Feedstock with high free fatty acid content can be passed through an esterification process to reduce the free fatty acid content before the process of esterification to convert fatty acid glycerides to monoalkyl esters. The reduction of free fatty acids and the conversion of fatty acid glycerides can also in the same processing step.
Feedstock containing other organic compounds (such as hexane, heptane, isohexane, etc.) can typically be processed without significant modifications to the reactor. Other materials containing fatty acid glycerides or other fatty acid esters can also be employed, including phospholipids, lysophospholipids, and fatty acid wax esters. The fatty acid rich material useful in the processes described herein typically includes a mixture of fatty acids. For example, the fatty acid profiles of several potential feedstocks are shown in Table 1. The feed oil can also include a mixture of fatty acid glycerides from different sources. The free fatty acid content of useful vegetable oils is preferably about 0.1 wt% or less when employed in a basic homogeneous catalyst esterification reaction. Higher levels can be utilized as well, and levels up to about 3 wt%, or even as high as 15 wt% or more can typically be tolerated.
For purposes of this invention and the claims thereto the term "feed oil"
refers to one or more vegetable or animal oils, such as canola oil, corn oil, soybean oil, beef tallow, tall oil, animal fats, waste oils/greases, rapeseed oil, algae oil, peanut oil, mustard oil, sunflower oil, tung oil, perilla oil, grapeseed oil, linseed oil, safflower oil, pumpkin oil, palm oil, Jathropa oil, high-oleic soybean oil, high-oleic safflower oil, high-oleic sunflower oil, mixtures of animal and/or vegetable fats and oils, castor bean oil, dehydrated castor bean oil, cucumber oil, poppyseed oil, flaxseed oil, lesquerella oil, walnut oil, cottonseed oil, meadowfoam, tuna oil, and sesame oils.
Feed Oils The fatty acid rich material useful in the processes described herein can be derived from plant, animal, microbial, or other sources (feed oil). Preferred feed oils include vegetable oils such as corn, soy, rapeseed, canola, sunflower, palm and other oils that are readily available; however, any vegetable oil or animal fat can be employed.
Raw or unrefined oil can be used in certain embodiments; however, filtered and refined oils are typically preferred. Use of degummed and filtered feedstock minimizes the potential for emulsification and blockage in the reactors. Feedstock with high water content can be dried before basic catalyst processing. Feedstock with high free fatty acid content can be passed through an esterification process to reduce the free fatty acid content before the process of esterification to convert fatty acid glycerides to monoalkyl esters. The reduction of free fatty acids and the conversion of fatty acid glycerides can also in the same processing step.
Feedstock containing other organic compounds (such as hexane, heptane, isohexane, etc.) can typically be processed without significant modifications to the reactor. Other materials containing fatty acid glycerides or other fatty acid esters can also be employed, including phospholipids, lysophospholipids, and fatty acid wax esters. The fatty acid rich material useful in the processes described herein typically includes a mixture of fatty acids. For example, the fatty acid profiles of several potential feedstocks are shown in Table 1. The feed oil can also include a mixture of fatty acid glycerides from different sources. The free fatty acid content of useful vegetable oils is preferably about 0.1 wt% or less when employed in a basic homogeneous catalyst esterification reaction. Higher levels can be utilized as well, and levels up to about 3 wt%, or even as high as 15 wt% or more can typically be tolerated.
For purposes of this invention and the claims thereto the term "feed oil"
refers to one or more vegetable or animal oils, such as canola oil, corn oil, soybean oil, beef tallow, tall oil, animal fats, waste oils/greases, rapeseed oil, algae oil, peanut oil, mustard oil, sunflower oil, tung oil, perilla oil, grapeseed oil, linseed oil, safflower oil, pumpkin oil, palm oil, Jathropa oil, high-oleic soybean oil, high-oleic safflower oil, high-oleic sunflower oil, mixtures of animal and/or vegetable fats and oils, castor bean oil, dehydrated castor bean oil, cucumber oil, poppyseed oil, flaxseed oil, lesquerella oil, walnut oil, cottonseed oil, meadowfoam, tuna oil, and sesame oils.
Vegetable oils useful herein preferably contain at least one site of unsaturation and include, but are not limited to, canola, soybean, palm, peanut, mustard, sunflower, tung, tall, perilla, grapeseed, rapeseed, linseed, safflower, pumpkin corn and other oils extracted from plant seeds.
In a preferred embodiment, a combination of oils is used herein. Preferred combinations include two (three or four) or more of tall oil, palm oil, tallow, waste grease, rapeseed oil, canola oil, soy oil and algae oil. Alternate useful combinations include two (three or four) or more of soy oil, canola oil, rapeseed oil, algae oil, and tallow.
In certain embodiments, processed oils, such as blown oils, are the source of fatty acids useful herein. While vegetable oils are preferred sources of fatty acids for practicing disclosed embodiments of the present process, fatty acids also are available from animal fats including, without limitation, lard and fish oils, such as sardine oil and herring oil, and the like. As noted above, in certain embodiments, a desired fatty acid or fatty acid precursor is produced by a plant or animal found in nature. However, particular fatty acids or fatty acid precursors are advantageously available from genetically modified organisms, such as a genetically modified plants, particularly genetically modified algae. Such genetically modified organisms are designed to produce a desired fatty acid or fatty acid precursor biosynthetically or to produce increased amounts of such compounds.
Fatty Acid Profile of Several Typical Feed Oils Fatty Acid Palm Oil Soy Oil High Oleic Rapeseed Yellow Grease O wt% O wt% O wt% O wt%
C6:0 0 wt% 0 wt% 0 wt% 0 wt%
C8:0 O wt% O wt% O wt% O wt%
C10:0 0 wt% 0 wt% 0 wt% 0 wt%
C12:0 0 wt% 0 wt% 0 wt% 0 wt%
C14:0 1 wt% 0 wt% 0 wt% 2 wt%
C16:0 44 wt% 7 wt% 4 wt% 23 wt%
C18:0 5 wt% 5 wt% l wt% 13 wt%
C18:1 39 wt% 28 wt% 60 wt% 44 wt%
C 18:2 10 wt% 53 wt% 21 wt% 7 wt%
C 18:3 0 wt% 0 wt% 13 wt% 1 wt%
C20:0 0 wt% 0 wt% 0 wt% 0 wt%
C22:1 0 wt% 0 wt% 0 wt% 0 wt%
Misc. 1 wt% 8 wt% 0 wt% 9 wt%
In a preferred embodiment, a combination of oils is used herein. Preferred combinations include two (three or four) or more of tall oil, palm oil, tallow, waste grease, rapeseed oil, canola oil, soy oil and algae oil. Alternate useful combinations include two (three or four) or more of soy oil, canola oil, rapeseed oil, algae oil, and tallow.
In certain embodiments, processed oils, such as blown oils, are the source of fatty acids useful herein. While vegetable oils are preferred sources of fatty acids for practicing disclosed embodiments of the present process, fatty acids also are available from animal fats including, without limitation, lard and fish oils, such as sardine oil and herring oil, and the like. As noted above, in certain embodiments, a desired fatty acid or fatty acid precursor is produced by a plant or animal found in nature. However, particular fatty acids or fatty acid precursors are advantageously available from genetically modified organisms, such as a genetically modified plants, particularly genetically modified algae. Such genetically modified organisms are designed to produce a desired fatty acid or fatty acid precursor biosynthetically or to produce increased amounts of such compounds.
Fatty Acid Profile of Several Typical Feed Oils Fatty Acid Palm Oil Soy Oil High Oleic Rapeseed Yellow Grease O wt% O wt% O wt% O wt%
C6:0 0 wt% 0 wt% 0 wt% 0 wt%
C8:0 O wt% O wt% O wt% O wt%
C10:0 0 wt% 0 wt% 0 wt% 0 wt%
C12:0 0 wt% 0 wt% 0 wt% 0 wt%
C14:0 1 wt% 0 wt% 0 wt% 2 wt%
C16:0 44 wt% 7 wt% 4 wt% 23 wt%
C18:0 5 wt% 5 wt% l wt% 13 wt%
C18:1 39 wt% 28 wt% 60 wt% 44 wt%
C 18:2 10 wt% 53 wt% 21 wt% 7 wt%
C 18:3 0 wt% 0 wt% 13 wt% 1 wt%
C20:0 0 wt% 0 wt% 0 wt% 0 wt%
C22:1 0 wt% 0 wt% 0 wt% 0 wt%
Misc. 1 wt% 8 wt% 0 wt% 9 wt%
Fatty Acids and Fatty Acid Esters Fatty acids are carboxylic acids with a saturated or unsaturated aliphatic tails that are found naturally in many different fats and oils. Any unsaturated fatty acid can be suitably employed in the process of this invention, provided that the unsaturated fatty acid can be metathesized in the manner disclosed herein. An unsaturated fatty acid comprises a long carbon chain containing at least one carbon-carbon double bond and terminating in a carboxylic acid group. Typically, the unsaturated fatty acid will contain greater than about 8 carbon atoms, preferably, greater than about 10 carbon atoms, and more preferably, greater than about 12 carbon atoms. Typically, the unsaturated fatty acid will contain less than about 50 carbon atoms, preferably, less than about 35 carbon atoms, and more preferably, less than about 25 carbon atoms. At least one carbon-carbon double bond is present along the carbon chain, this double bond usually occurring about the middle of the chain, but not necessarily.
The carbon-carbon double bond may also occur at any other internal location along the chain.
A terminal carbon-carbon double bond, at the opposite end of the carbon chain relative to the terminal carboxylic acid group, is also suitably employed, although terminal carbon-carbon double bonds occur less commonly in fatty acids. Unsaturated fatty acids containing the terminal carboxylic acid functionality and two or more carbon-carbon double bonds may also be suitably employed in the process of this invention.
Because metathesis can occur at any of the carbon-carbon double bonds, a fatty acid having more than one double bond may produce a variety of metathesis products.
The unsaturated fatty acid may be straight or branched and substituted along the fatty acid chain with one or more substituents, provided that the one or more substituents are substantially inert with respect to the metathesis process. Non-limiting examples of suitable substituents include alkyl moieties, preferably C1-10 alkyl moieties, including, for example, methyl, ethyl, propyl, butyl, and the like; cycloalkyl moieties, preferably, C4-8 cycloalkyl moieties, including for example, cyclopentyl and cyclohexyl; monocyclic aromatic moieties, preferably, C6 aromatic moieties, that is, phenyl; arylalkyl moieties, preferably, C7-16 arylalkyl moieties, including, for example, benzyl; and alkylaryl moieties, preferably, C7-16 alkylaryl moieties, including, for example, tolyl, ethylphenyl, xylyl, and the like; as well as hydroxyl, ether, keto, aldehyde, and halide, preferably, chloro and bromo, functionalities.
Non-limiting examples of suitable unsaturated fatty acids include 3-hexenoic (hydrosorbic), trans-2-heptenoic, 2-octenoic, 2-nonenoic, cis-and trans-4-decenoic, 9-decenoic (caproleic), l0-undecenoic (undecylenic), trans-3-dodecenoic (linderic), tridecenoic, cis-9-tetradeceonic (myristoleic), pentadecenoic, cis-9-hexadecenoic (cis-9-palmitoelic), trans-9-hexadecenoic (trans-9-palmitoleic), 9-heptadecenoic, cis-6-octadecenoic (petroselinic), trans-6-octadecenoic (petroselaidic), cis-9-octadecenoic (oleic), trans-9-octadecenoic (elaidic), cis-11-octadecenoic, trans- ll-octadecenoic (vaccenic), cis-5-eicosenoic, cis-9-eicosenoic (gadoleic), cis-i i-docosenoic (cetoleic), cis-13-docosenoic (erucic), trans- l3-docosenoic (brassidic), cis-15-tetracosenoic (selacholeic), cis-17-hexacosenoic (ximenic), and cis-21-triacontenoic (lumequeic) acids, as well as 2,4-hexadienoic (sorbic), cis-9-cis-l2-octadecadienoic (linoleic), cis-9-cis-12-cis-15-octadecatrienoic (linolenic), eleostearic, 12-hydroxy-cis-9-octadecenoic (ricinoleic), and like acids. Oleic acid is most preferred. Unsaturated fatty acids can be obtained commercially or synthesized by saponifying fatty acid esters, this method being known to those skilled in the art.
Fatty acid esters are formed by condensation of a fatty acid and an alcohol.
Fatty acid alkyl esters are fatty acids where the hydrogen of the -OH of the acid group is replaced by a hydrocarbyl group, typically a C1 to C30 alkyl group, preferably a C1 to C20 alkyl.
Fatty acid alkyl esters are fatty acids where the hydrogen of the -OH of the acid group is replaced by an alkyl group. Fatty acid alkyl esters useful herein are typically represented by the formula: R^-C(O)-O-R*, where R^ is a C1 to C100 hydrocarbyl group, preferably a C6 to C22 group, preferably a C6 to C14 1-alkene group, and R* is an alkyl group, preferably a C1 to C20 alkyl group, preferably methyl, ethyl, butyl, pentyl and hexyl.
Preferred fatty acid alkyl esters useful herein are typically represented by the formula: R"-CH2=CH2-R^-C(O)-O-R*, where each R^ is, independently a C1 to C100 alkyl group, preferably a C6 to C20, preferably a C8 to C14 alkyl group, preferably a C9 group and R* is an alkyl group, preferably a C1 to C20 alkyl group, preferably methyl, ethyl, butyl, pentyl and hexyl.
Particularly preferred fatty acid alkyl esters useful herein are represented by the formula:
CH3-(CH2)n-C=C-(CH2)m-C(O)-O-R*, where and R* is an alkyl group, preferably a C1 to C20 alkyl group, preferably methyl, ethyl, butyl pentyl and hexyl, m and n are, independently 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, preferably 5, 7, 9, or 11, preferably 7.
Fatty acid methyl esters are fatty acids where the hydrogen of the -OH of the acid group is replaced by methyl group. Fatty acid methyl esters useful herein are typically represented by the formula: R^-C(O)-O-CH3, where R^ is a C1 to C100 hydrocarbyl group, preferably a C6 to C22 group, preferably a C6 to C14 1-alkene group. Preferred fatty acid methyl esters useful herein are typically represented by the formula: R"-CH2=CH2-R^-C(O)-O-CH3, where each R^ is, independently a C1 to C100 alkyl group, preferably a C6 to C20, preferably a C8 to C14 alkyl group, preferably a C9 group. Particularly preferred fatty acid methyl esters useful herein are represented by the formula: CH3-(CH2)n-C=C-(CH2)m-C(O)-O-CH3, where m and n are, independently 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, preferably 5, 7, 9, or 11, preferably 7.
Preferred fatty acid methyl esters include methyl palmitoleate, methyl oleate, methyl gadoleate, methyl erucate, methyl linoleate, methyl linolenate, methyl soyate, and mixtures of methyl esters derived from soybean oil, beef tallow, tall oil, animal fats, waste oils/greases, rapeseed oil, algae oil, Canola oil, palm oil, Jathropa oil, high-oleic soybean oil (e.g., 75 mole % or more, preferably 85 mole % or more, preferably 90 mole % or more), high-oleic safflower oil (e.g., 75 mole % or more, preferably 85 mole % or more, preferably 90 mole %
or more), high-oleic sunflower oil (e.g., 75 mole % or more, preferably 85 mole % or more, preferably 90 mole % or more), and other plant or animal derived sources containing fatty acids.
Alcohol (also referred to as Alkanols) Fatty acid esters are formed by condensation of a fatty acid and an alcohol.
The alcohol used herein can be any monohydric, dihydric, or polyhydric alcohol that is capable of condensing with the feed material (such as the unsaturated fatty acid) to form the corresponding unsaturated ester (such as the fatty acid ester). Typically, the alcohol contains at least one carbon atom. Typically, the alcohol contains less than about 20 carbon atoms, preferably, less than about 12 carbon atoms, and more preferably, less than about 8 carbon atoms. The carbon atoms may be arranged in a straight-chain or branched structure, and may be substituted with a variety of substituents, such as those previously disclosed hereinabove in connection with the fatty acid, including the aforementioned alkyl, cycloalkyl, monocyclic aromatic, arylalkyl, alkylaryl, hydroxyl, halogen, ether, ester, aldehyde and keto substituents.
Preferably, the alcohol is a straight-chain or a branched C1.12 alkanol. A
preferred alcohol is the trihydric alcohol glycerol, the fatty acid esters of which are known as "glycerides." Other preferred alcohols include methanol and ethanol.
Preferably, the alcohol employed in the esterification and/or transesterification reactions is preferably a low molecular weight monohydric alcohol such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, or t-butanol. The alcohol is preferably anhydrous; however, a small amount of water in the alcohol may be present (e.g., less than about 2 wt%, preferably less than about 1 wt%, and most preferably less than about 0.5 wt%;
however, in certain embodiments, higher amounts can be tolerated). Acid esterification reactions are more tolerant of the presence of small amounts of water in the alcohol than are basic transesterification reactions. While specific monohydric alcohols are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific monohydric alcohols. Other suitable monohydric alcohols can also be employed in the preferred embodiments.
Preferred sources of fatty acid esters for use herein include TAGs and biodiesel sources.
Biodiesel Biodiesel is a mono-alkyl ester derived from the processing of vegetable oils and alcohols. The processing is typically carried out by an esterification reaction mechanism, and typically is performed in an excess of alcohol to maximize conversion.
Esterification can refer to direct esterification, such as between a free fatty acid and an alcohol, as well as transesterification, such as between an ester and an alcohol. While vegetable oil and alcohols are commonly employed as reactants in esterification reactions, a fatty acid source such as free fatty acids, soaps, esters, glycerides (mono-, di- tri-), phospholipids, lysophospholipids, or amides and a monohydric alcohol source, such as an alcohol or an ester, can be esterified.
In addition, various combinations of these reagents can be employed in an esterification reaction.
Alkyl oleates and alkyl erucates are fatty acid esters that are often major components in biodiesel produced by the transesterification of alcohol and vegetable oils (preferably the alkyls are a Ci to C30 alkyl group, alternately a C1 to C20 alkyl group).
Biodiesel compositions that are particularly useful in this invention are those which have high concentrations of alkyl oleate and alkyl erucate esters. These fatty acid esters preferably have one site of unsaturation such that cross-metathesis with ethylene yields 1-decene as the coproduct. Biodiesel compositions that are particularly useful are those produced from vegetable oils such as canola, rapeseed oil, palm oil, and other high oleate oil, high erucate oils. Particularly preferred vegetable oils include those having at least 50%
(on a molar basis) combined oleic and erucic fatty acid chains of all fatty acid chains, preferably 60%, preferably 70%, preferably 80%, preferably 90%.
The carbon-carbon double bond may also occur at any other internal location along the chain.
A terminal carbon-carbon double bond, at the opposite end of the carbon chain relative to the terminal carboxylic acid group, is also suitably employed, although terminal carbon-carbon double bonds occur less commonly in fatty acids. Unsaturated fatty acids containing the terminal carboxylic acid functionality and two or more carbon-carbon double bonds may also be suitably employed in the process of this invention.
Because metathesis can occur at any of the carbon-carbon double bonds, a fatty acid having more than one double bond may produce a variety of metathesis products.
The unsaturated fatty acid may be straight or branched and substituted along the fatty acid chain with one or more substituents, provided that the one or more substituents are substantially inert with respect to the metathesis process. Non-limiting examples of suitable substituents include alkyl moieties, preferably C1-10 alkyl moieties, including, for example, methyl, ethyl, propyl, butyl, and the like; cycloalkyl moieties, preferably, C4-8 cycloalkyl moieties, including for example, cyclopentyl and cyclohexyl; monocyclic aromatic moieties, preferably, C6 aromatic moieties, that is, phenyl; arylalkyl moieties, preferably, C7-16 arylalkyl moieties, including, for example, benzyl; and alkylaryl moieties, preferably, C7-16 alkylaryl moieties, including, for example, tolyl, ethylphenyl, xylyl, and the like; as well as hydroxyl, ether, keto, aldehyde, and halide, preferably, chloro and bromo, functionalities.
Non-limiting examples of suitable unsaturated fatty acids include 3-hexenoic (hydrosorbic), trans-2-heptenoic, 2-octenoic, 2-nonenoic, cis-and trans-4-decenoic, 9-decenoic (caproleic), l0-undecenoic (undecylenic), trans-3-dodecenoic (linderic), tridecenoic, cis-9-tetradeceonic (myristoleic), pentadecenoic, cis-9-hexadecenoic (cis-9-palmitoelic), trans-9-hexadecenoic (trans-9-palmitoleic), 9-heptadecenoic, cis-6-octadecenoic (petroselinic), trans-6-octadecenoic (petroselaidic), cis-9-octadecenoic (oleic), trans-9-octadecenoic (elaidic), cis-11-octadecenoic, trans- ll-octadecenoic (vaccenic), cis-5-eicosenoic, cis-9-eicosenoic (gadoleic), cis-i i-docosenoic (cetoleic), cis-13-docosenoic (erucic), trans- l3-docosenoic (brassidic), cis-15-tetracosenoic (selacholeic), cis-17-hexacosenoic (ximenic), and cis-21-triacontenoic (lumequeic) acids, as well as 2,4-hexadienoic (sorbic), cis-9-cis-l2-octadecadienoic (linoleic), cis-9-cis-12-cis-15-octadecatrienoic (linolenic), eleostearic, 12-hydroxy-cis-9-octadecenoic (ricinoleic), and like acids. Oleic acid is most preferred. Unsaturated fatty acids can be obtained commercially or synthesized by saponifying fatty acid esters, this method being known to those skilled in the art.
Fatty acid esters are formed by condensation of a fatty acid and an alcohol.
Fatty acid alkyl esters are fatty acids where the hydrogen of the -OH of the acid group is replaced by a hydrocarbyl group, typically a C1 to C30 alkyl group, preferably a C1 to C20 alkyl.
Fatty acid alkyl esters are fatty acids where the hydrogen of the -OH of the acid group is replaced by an alkyl group. Fatty acid alkyl esters useful herein are typically represented by the formula: R^-C(O)-O-R*, where R^ is a C1 to C100 hydrocarbyl group, preferably a C6 to C22 group, preferably a C6 to C14 1-alkene group, and R* is an alkyl group, preferably a C1 to C20 alkyl group, preferably methyl, ethyl, butyl, pentyl and hexyl.
Preferred fatty acid alkyl esters useful herein are typically represented by the formula: R"-CH2=CH2-R^-C(O)-O-R*, where each R^ is, independently a C1 to C100 alkyl group, preferably a C6 to C20, preferably a C8 to C14 alkyl group, preferably a C9 group and R* is an alkyl group, preferably a C1 to C20 alkyl group, preferably methyl, ethyl, butyl, pentyl and hexyl.
Particularly preferred fatty acid alkyl esters useful herein are represented by the formula:
CH3-(CH2)n-C=C-(CH2)m-C(O)-O-R*, where and R* is an alkyl group, preferably a C1 to C20 alkyl group, preferably methyl, ethyl, butyl pentyl and hexyl, m and n are, independently 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, preferably 5, 7, 9, or 11, preferably 7.
Fatty acid methyl esters are fatty acids where the hydrogen of the -OH of the acid group is replaced by methyl group. Fatty acid methyl esters useful herein are typically represented by the formula: R^-C(O)-O-CH3, where R^ is a C1 to C100 hydrocarbyl group, preferably a C6 to C22 group, preferably a C6 to C14 1-alkene group. Preferred fatty acid methyl esters useful herein are typically represented by the formula: R"-CH2=CH2-R^-C(O)-O-CH3, where each R^ is, independently a C1 to C100 alkyl group, preferably a C6 to C20, preferably a C8 to C14 alkyl group, preferably a C9 group. Particularly preferred fatty acid methyl esters useful herein are represented by the formula: CH3-(CH2)n-C=C-(CH2)m-C(O)-O-CH3, where m and n are, independently 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16, preferably 5, 7, 9, or 11, preferably 7.
Preferred fatty acid methyl esters include methyl palmitoleate, methyl oleate, methyl gadoleate, methyl erucate, methyl linoleate, methyl linolenate, methyl soyate, and mixtures of methyl esters derived from soybean oil, beef tallow, tall oil, animal fats, waste oils/greases, rapeseed oil, algae oil, Canola oil, palm oil, Jathropa oil, high-oleic soybean oil (e.g., 75 mole % or more, preferably 85 mole % or more, preferably 90 mole % or more), high-oleic safflower oil (e.g., 75 mole % or more, preferably 85 mole % or more, preferably 90 mole %
or more), high-oleic sunflower oil (e.g., 75 mole % or more, preferably 85 mole % or more, preferably 90 mole % or more), and other plant or animal derived sources containing fatty acids.
Alcohol (also referred to as Alkanols) Fatty acid esters are formed by condensation of a fatty acid and an alcohol.
The alcohol used herein can be any monohydric, dihydric, or polyhydric alcohol that is capable of condensing with the feed material (such as the unsaturated fatty acid) to form the corresponding unsaturated ester (such as the fatty acid ester). Typically, the alcohol contains at least one carbon atom. Typically, the alcohol contains less than about 20 carbon atoms, preferably, less than about 12 carbon atoms, and more preferably, less than about 8 carbon atoms. The carbon atoms may be arranged in a straight-chain or branched structure, and may be substituted with a variety of substituents, such as those previously disclosed hereinabove in connection with the fatty acid, including the aforementioned alkyl, cycloalkyl, monocyclic aromatic, arylalkyl, alkylaryl, hydroxyl, halogen, ether, ester, aldehyde and keto substituents.
Preferably, the alcohol is a straight-chain or a branched C1.12 alkanol. A
preferred alcohol is the trihydric alcohol glycerol, the fatty acid esters of which are known as "glycerides." Other preferred alcohols include methanol and ethanol.
Preferably, the alcohol employed in the esterification and/or transesterification reactions is preferably a low molecular weight monohydric alcohol such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, or t-butanol. The alcohol is preferably anhydrous; however, a small amount of water in the alcohol may be present (e.g., less than about 2 wt%, preferably less than about 1 wt%, and most preferably less than about 0.5 wt%;
however, in certain embodiments, higher amounts can be tolerated). Acid esterification reactions are more tolerant of the presence of small amounts of water in the alcohol than are basic transesterification reactions. While specific monohydric alcohols are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific monohydric alcohols. Other suitable monohydric alcohols can also be employed in the preferred embodiments.
Preferred sources of fatty acid esters for use herein include TAGs and biodiesel sources.
Biodiesel Biodiesel is a mono-alkyl ester derived from the processing of vegetable oils and alcohols. The processing is typically carried out by an esterification reaction mechanism, and typically is performed in an excess of alcohol to maximize conversion.
Esterification can refer to direct esterification, such as between a free fatty acid and an alcohol, as well as transesterification, such as between an ester and an alcohol. While vegetable oil and alcohols are commonly employed as reactants in esterification reactions, a fatty acid source such as free fatty acids, soaps, esters, glycerides (mono-, di- tri-), phospholipids, lysophospholipids, or amides and a monohydric alcohol source, such as an alcohol or an ester, can be esterified.
In addition, various combinations of these reagents can be employed in an esterification reaction.
Alkyl oleates and alkyl erucates are fatty acid esters that are often major components in biodiesel produced by the transesterification of alcohol and vegetable oils (preferably the alkyls are a Ci to C30 alkyl group, alternately a C1 to C20 alkyl group).
Biodiesel compositions that are particularly useful in this invention are those which have high concentrations of alkyl oleate and alkyl erucate esters. These fatty acid esters preferably have one site of unsaturation such that cross-metathesis with ethylene yields 1-decene as the coproduct. Biodiesel compositions that are particularly useful are those produced from vegetable oils such as canola, rapeseed oil, palm oil, and other high oleate oil, high erucate oils. Particularly preferred vegetable oils include those having at least 50%
(on a molar basis) combined oleic and erucic fatty acid chains of all fatty acid chains, preferably 60%, preferably 70%, preferably 80%, preferably 90%.
In another embodiment, useful fatty acid ester containing mixtures include those having at least 50% (on a molar basis) alkyl oleate fatty acid esters, preferably 60% of alkyl oleate fatty acid esters, preferably 70% of alkyl oleate fatty acid esters, preferably 80% of alkyl oleate fatty acid esters, preferably 90% of alkyl oleate fatty acid esters.
In another embodiment, useful fatty acid ester containing mixtures include those having at least 50% (on a molar basis) alkyl erucate fatty acid esters, preferably 60% of alkyl erucate fatty acid esters, preferably 70% of alkyl erucate fatty acid esters, preferably 80% of alkyl erucate fatty acid esters, preferably 90% of alkyl erucate fatty acid esters.
In another embodiment, useful fatty acid ester containing mixtures include those having at least 50% (on a molar basis) combined oleic and erucic fatty acid esters of all fatty acid ester chains, preferably 60%, preferably 70%, preferably 80%, preferably 90%.
TriacylOyicerides (TAGS) Triacylglycerides (TAGs), also called triglycerides, are a naturally occurring ester of three fatty acids and glycerol that is the chief constituent of natural fats and oils. The three fatty acids can be all different, all the same, or only two the same, they can be saturated or unsaturated fatty acids, and the saturated fatty acids may have one or multiple unsaturations.
Chain lengths of the fatty acids in naturally occurring triacylglycerides can be of varying lengths but 16, 18, and 20 carbons are the most common. Natural fatty acids found in plants and animals are typically composed only of even numbers of carbon atoms due to the way they are bio-synthesized. Most natural fats contain a complex mixture of individual triglycerides and because of this, they melt over a broad range of temperatures.
Vegetable oils include triglycerides and neutral fats, such as triacylglycerides, the main energy storage form of fat in animals and plants. These typically have the chemical structure:
-Ra HC -0-C-Rb H2C - 0 - C- Rc where Ra, Rb, and Rc each, independently, represent a saturated or non-saturated hydrocarbon chain (preferably Ra, Rb, and Rc each, independently, are a C12 to C28 alkyl or alkene, preferably C16 to C22 alkyl or alkene). Different vegetable oils have different fatty acid profiles, with the same or different fatty acids occurring on a single glycerol. For example, an oil can have linoleic, oleic, and stearic acids attached to the same glycerol, with each of Ra, Rb, and Rc representing one of these three fatty acids. In another example, there can be two oleic acids and one stearic acid attached to the same glycerol, each of Ra, Rb, and Rc representing one of these fatty acids. A particularly useful triglyceride consists of three fatty acids (e.g., saturated fatty acids of general structure of CH3(CH2),1000H, wherein n is typically an integer of from 4 to 28 or higher) attached to a glycerol (C3H5(OH)3) backbone by ester linkages.
Transesterification /Esterification Reactions In the esterification process, vegetable oils and short chain alcohols are reacted to form mono-alkyl esters of the fatty acid and glycerol (also referred to as glycerin). When the alcohol used is methanol (CH3OH), a methyl ester is created with the general form CH3(CH2)n000CH3 for saturated fatty acids. Typically, but not always, the length of the carbon backbone chain is from 12 to 24 carbon atoms.
The esterification process can be catalyzed or non-catalyzed. Catalyzed processes are categorized into chemical and enzyme based processes. Chemical catalytic methods can employ acid and/or base catalyst mechanisms. The catalysts can be homogeneous and/or heterogeneous catalysts. Homogeneous catalysts are typically liquid phase mixtures, whereas heterogeneous catalysts are solid phase catalysts mixed with the liquid phase reactants, oils and alcohols.
In processes herein, the conversion of TAGs to fatty acid alkyl esters ("FAAE") through transesterification of the TAG typically involves forming a reactant stream, which includes TAG (e.g., at least about 75 wt%), alkanol (e.g., about 5 to 20 wt%), a transesterification catalyst (e.g., about 0.05 to 1 wt%), and optionally, glycerol (typically up to about 10 wt%). Suitable alkanols may include C1-C6 alkanols and commonly may include methanol, ethanol, or mixtures thereof. Suitable transesterification catalysts may include alkali metal alkoxides having from 1 to 6 carbon atoms and commonly may include alkali metal methoxide, such as sodium methoxide and/or potassium methoxide. The basic catalyst is desirably selected such that the alkali metal alkoxide may suitably contain an alkoxide group which is the counterpart of the alkanol employed in the reaction stream (e.g., a combination of methanol and an alkali metal methoxide such as sodium methoxide and/or potassium methoxide). The reactant stream may suitably include about 0.05 to 0.3 wt%
In another embodiment, useful fatty acid ester containing mixtures include those having at least 50% (on a molar basis) alkyl erucate fatty acid esters, preferably 60% of alkyl erucate fatty acid esters, preferably 70% of alkyl erucate fatty acid esters, preferably 80% of alkyl erucate fatty acid esters, preferably 90% of alkyl erucate fatty acid esters.
In another embodiment, useful fatty acid ester containing mixtures include those having at least 50% (on a molar basis) combined oleic and erucic fatty acid esters of all fatty acid ester chains, preferably 60%, preferably 70%, preferably 80%, preferably 90%.
TriacylOyicerides (TAGS) Triacylglycerides (TAGs), also called triglycerides, are a naturally occurring ester of three fatty acids and glycerol that is the chief constituent of natural fats and oils. The three fatty acids can be all different, all the same, or only two the same, they can be saturated or unsaturated fatty acids, and the saturated fatty acids may have one or multiple unsaturations.
Chain lengths of the fatty acids in naturally occurring triacylglycerides can be of varying lengths but 16, 18, and 20 carbons are the most common. Natural fatty acids found in plants and animals are typically composed only of even numbers of carbon atoms due to the way they are bio-synthesized. Most natural fats contain a complex mixture of individual triglycerides and because of this, they melt over a broad range of temperatures.
Vegetable oils include triglycerides and neutral fats, such as triacylglycerides, the main energy storage form of fat in animals and plants. These typically have the chemical structure:
-Ra HC -0-C-Rb H2C - 0 - C- Rc where Ra, Rb, and Rc each, independently, represent a saturated or non-saturated hydrocarbon chain (preferably Ra, Rb, and Rc each, independently, are a C12 to C28 alkyl or alkene, preferably C16 to C22 alkyl or alkene). Different vegetable oils have different fatty acid profiles, with the same or different fatty acids occurring on a single glycerol. For example, an oil can have linoleic, oleic, and stearic acids attached to the same glycerol, with each of Ra, Rb, and Rc representing one of these three fatty acids. In another example, there can be two oleic acids and one stearic acid attached to the same glycerol, each of Ra, Rb, and Rc representing one of these fatty acids. A particularly useful triglyceride consists of three fatty acids (e.g., saturated fatty acids of general structure of CH3(CH2),1000H, wherein n is typically an integer of from 4 to 28 or higher) attached to a glycerol (C3H5(OH)3) backbone by ester linkages.
Transesterification /Esterification Reactions In the esterification process, vegetable oils and short chain alcohols are reacted to form mono-alkyl esters of the fatty acid and glycerol (also referred to as glycerin). When the alcohol used is methanol (CH3OH), a methyl ester is created with the general form CH3(CH2)n000CH3 for saturated fatty acids. Typically, but not always, the length of the carbon backbone chain is from 12 to 24 carbon atoms.
The esterification process can be catalyzed or non-catalyzed. Catalyzed processes are categorized into chemical and enzyme based processes. Chemical catalytic methods can employ acid and/or base catalyst mechanisms. The catalysts can be homogeneous and/or heterogeneous catalysts. Homogeneous catalysts are typically liquid phase mixtures, whereas heterogeneous catalysts are solid phase catalysts mixed with the liquid phase reactants, oils and alcohols.
In processes herein, the conversion of TAGs to fatty acid alkyl esters ("FAAE") through transesterification of the TAG typically involves forming a reactant stream, which includes TAG (e.g., at least about 75 wt%), alkanol (e.g., about 5 to 20 wt%), a transesterification catalyst (e.g., about 0.05 to 1 wt%), and optionally, glycerol (typically up to about 10 wt%). Suitable alkanols may include C1-C6 alkanols and commonly may include methanol, ethanol, or mixtures thereof. Suitable transesterification catalysts may include alkali metal alkoxides having from 1 to 6 carbon atoms and commonly may include alkali metal methoxide, such as sodium methoxide and/or potassium methoxide. The basic catalyst is desirably selected such that the alkali metal alkoxide may suitably contain an alkoxide group which is the counterpart of the alkanol employed in the reaction stream (e.g., a combination of methanol and an alkali metal methoxide such as sodium methoxide and/or potassium methoxide). The reactant stream may suitably include about 0.05 to 0.3 wt%
sodium methoxide, at least about 75 wt% triacylglyceride, about 1 to 7 wt%
glycerol, and at least about 10 wt% methanol. In some embodiments, the reactant stream may desirably include about 0.05 to 0.25 wt% sodium methoxide, at least about 75 wt%
triacylglyceride, about 2 to 5 wt% glycerol, and about 10 to 15 wt% methanol.
The rate and extent of reaction for esterification of the fatty acid glycerides or other fatty acid derivates with monohydric alcohol in the presence of a catalyst depends upon factors including but not limited to the concentration of the reagents, the concentration and type of catalyst, and the temperature and pressure conditions, and time of reaction. The reaction generally proceeds at temperatures above about 50 C, preferably at temperatures above 65 C; however, the catalyst selected or the amount of catalyst employed can affect this temperature to some extent. Higher temperatures generally result in faster reaction rates.
However, the use of very high temperatures, such as those in excess of about 300 C, or even those in excess of 250 C, can lead to increased generation of side products, which can be undesirable as their presence can increase downstream purification costs.
Higher temperatures can be advantageously employed; however, e.g., in situations where the side products do not present an issue.
The reaction temperature can be achieved by preheating one or more of the feed materials or by heating a mixture of the feed materials. Heating can be achieved using apparatus known in the art, e.g., heat exchangers, jacketed vessels, submerged coils, and the like. While specific temperatures and methods of obtaining the specific temperatures are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific temperatures and methods of obtaining the specific temperatures. Other temperatures and methods of obtaining temperatures can also be employed in the preferred embodiments.
The amount of alcohol employed in the reaction is preferably in excess of the amount of fatty acid present on a molar basis. The fatty acid can be free or combined, such as to alcohol, glycol, or glycerol, with up to three fatty acid moieties being attached to a glycerol.
Additional amounts of alcohol above stoichiometric provide the advantage of assisting in driving the equilibrium of the reaction to produce more of the fatty acid ester product.
However, greater excesses of alcohol can result in greater processing costs and larger capital investment for the larger volumes of reagents employed in the process, as well as greater energy costs associated with recovering, purifying, and recycling this excess alcohol.
Accordingly, it is generally preferred to employ an amount of alcohol yielding a molar ratio of alcohol to fatty acid of from about 15:1 to about 1:1 (stoichiometric), and more preferably from about 4:1 to about 2:1; however the process can operate over a much wider range of alcohol to fatty acid ratios, with nonreacted materials subjected to recycling or other processing steps. Generally, lower relative levels of alcohol to fatty acid result in decreased yield and higher relative levels of alcohol levels to fatty acid result in increased capital and operating expense. Some instances of operation at ratios of alcohol to fatty acid over a wider range include when first starting up the process or shutting down the process, when balancing the throughput of the reactor to other processing steps or other processing facilities, such as one that produces alcohol or utilizes a side stream, or when process upsets occur. When a molar ratio of 2:1 methanol to fatty acid is employed and a sodium hydroxide concentration of about 0.5 wt% of the total reaction mixture is employed, the ratio of sodium hydroxide to methanol is about 2 wt% entering the reactor and about 4 wt% at the exit because about half of the alcohol is consumed in the esterification reaction.
Similarly, higher amounts of catalyst generally result in faster reactions.
However, higher amounts of catalyst can lead to higher downstream separation costs and a different profile of side reaction products. The amount of homogeneous catalyst is preferably from about 0.2 wt% to about 1.0 wt% of the reaction mixture when the catalyst is sodium hydroxide; at typical concentration of 0.5 wt% when a 2:1 molar ratio of methanol to fatty acid is used; however, in certain embodiments, higher or lower amounts can be employed.
The amount of catalyst employed can also vary depending upon the nature of the catalyst, feed materials, operating conditions, and other factors. Specifically, the temperature, pressure, free fatty acid content of the feed, and degree of mixing can change the amount of catalyst preferably employed. While specific catalyst amounts are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific catalyst amounts. Other suitable catalyst amounts can also be employed in the preferred embodiments.
The esterification reaction can be performed batchwise, such as in a stirred tank, or it can be performed continuously, such as in a continuous stirred tank reactor (CSTR) or a plug flow reactor (PFR). When operated in continuous mode, a series of continuous reactors (including CSTRs, PFRs, or combinations thereof) can advantageously operate in series.
Alternatively, batch reactors can be arranged in parallel and/or series.
When the reactor is operated in a continuous fashion, one or more of the feed materials is preferably metered into the process. Various techniques for metering can be employed (e.g., metering pumps, positive displacement pumps, control valves, flow meters, and the like). While specific types of reactors are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific reactors. Other suitable types of reactors can also be employed in the preferred embodiments.
As described above, biodiesel refers to a transesterified vegetable oil or animal fat based diesel fuel containing long-chain alkyl (typically methyl, propyl, or ethyl) esters.
Biodiesel is typically made by chemically reacting lipids (such as vegetable oil) with an alcohol. Biodiesel, TAG's and derivatives thereof may be used in the processes described herein. Likewise, preferred fatty acid methyl esters useful herein may be obtained by reacting canola oil, corn oil, soybean oil, beef tallow, tall oil, animal fats, waste oils/greases, rapeseed oil, algae oil, Canola oil, palm oil, Jathropa oil, high-oleic soybean oil, high-oleic safflower oil, high-oleic sunflower oil, or mixtures of animal and/or vegetable fats, and oils with one or more alcohols (as described above), preferably methanol.
Isomerization In another embodiment, the feed material is first isomerized, then combined with a metathesis catalyst as described herein. For example, the processes disclosed herein may comprise providing a feed material (typically a fatty acid or fatty acid derivative), isomerizing a site of unsaturation in the feed material (typically a fatty acid or fatty acid derivative) to produce an isomerized feed material (typically a fatty acid or fatty acid derivative), and then contacting the isomerized material with an alkene in the presence of a metathesis catalyst.
The isomerized material can be produced by isomerization with or without subsequent esterification or transesterification. Isomerization can be catalyzed by known biochemical or chemical techniques. For example, an isomerase enzyme, such as a linoleate isomerase, can be used to isomerize linoleic acid from the cis 9, cis 12 isomer to the cis 9, trans 11 isomer.
This isomerization process is stereospecific, however, nonstereospecific processes can be used because both cis and trans isomers are suitable for metathesis. For example, an alternative process employs a chemical isomerization catalyst, such as an acidic or basic catalyst, can be used to isomerize an unsaturated feed material (typically a fatty acid or fatty acid derivative) having a site of unsaturation at one location in the molecule into an isomerized, feed material (typically a fatty acid or fatty acid derivative) having a site of unsaturation at a different location in the molecule. Metal or organometallic catalysts also can be used to isomerize an unsaturated feed material (typically a fatty acid or fatty acid derivative). For example, nickel catalysts are known to catalyze positional isomerization of unsaturated sites in fatty acid derivatives. Similarly, esterification, transesterification, reduction, oxidation, and/or other modifications of the starting compound or products, such as a fatty acid or fatty acid derivative, can be catalyzed by biochemical or chemical techniques.
For example, a fatty acid or fatty acid derivative can be modified by a lipase, esterase, reductase or other enzyme before or after isomerization. In another embodiment, the isomerization described above may be practiced with any triacylglycerides, biodiesel, fatty acids, fatty acid esters, and/or fatty acid alkyl esters described herein, typically before contacting with the metathesis catalyst.
Alkenes Besides the feed materials, the metathesis process of this invention may require an alkene as a reactant. The term "alkene" shall imply an organic compound containing at least one carbon-carbon double bond and typically having less than about 10 carbon atoms. The alkene may have one carbon-carbon unsaturated bond, or alternatively, two or more carbon-carbon unsaturated bonds. Since the metathesis reaction can occur at any double bond, alkenes having more than one double bond will produce more metathesis products.
Accordingly, in some embodiments, it is preferred to employ an alkene having only one carbon-carbon double bond. The double bond may be, without limitation, a terminal double bond or an internal double bond. The alkene may also be substituted at any position along the carbon chain with one or more substituents, provided that the one or more substituents are essentially inert with respect to the metathesis process. Suitable substituents include, without limitation, alkyl, preferably, C1_6 alkyl; cycloalkyl, preferably, C3_6 cycloalkyl; as well as hydroxy, ether, keto, aldehyde, and halogen functionalities. Non-limiting examples of suitable alkenes include ethylene, propylene, butene, butadiene, pentene, hexene, the various isomers thereof, as well as higher homologues thereof. Preferably, the alkene is a C2_8 alkene.
More preferably, the alkene is a C2_6 alkene, even more preferably, a C24 alkene, and most preferably, ethylene.
Useful alkenes include those represented by the formula: R*-HC=CH-R*, wherein each R* is independently, hydrogen or a C1 to C20 hydrocarbyl, preferably hydrogen or a C1 to C6 hydrocarbyl, preferably hydrogen, methyl, ethyl, propyl or butyl, more preferably R* is hydrogen. In a preferred embodiment, both R* are the same, preferably both R*are hydrogen.
Ethylene, propylene, butene, pentene, hexene, octane, nonene and decene (preferably ethylene) are alkenes useful herein.
glycerol, and at least about 10 wt% methanol. In some embodiments, the reactant stream may desirably include about 0.05 to 0.25 wt% sodium methoxide, at least about 75 wt%
triacylglyceride, about 2 to 5 wt% glycerol, and about 10 to 15 wt% methanol.
The rate and extent of reaction for esterification of the fatty acid glycerides or other fatty acid derivates with monohydric alcohol in the presence of a catalyst depends upon factors including but not limited to the concentration of the reagents, the concentration and type of catalyst, and the temperature and pressure conditions, and time of reaction. The reaction generally proceeds at temperatures above about 50 C, preferably at temperatures above 65 C; however, the catalyst selected or the amount of catalyst employed can affect this temperature to some extent. Higher temperatures generally result in faster reaction rates.
However, the use of very high temperatures, such as those in excess of about 300 C, or even those in excess of 250 C, can lead to increased generation of side products, which can be undesirable as their presence can increase downstream purification costs.
Higher temperatures can be advantageously employed; however, e.g., in situations where the side products do not present an issue.
The reaction temperature can be achieved by preheating one or more of the feed materials or by heating a mixture of the feed materials. Heating can be achieved using apparatus known in the art, e.g., heat exchangers, jacketed vessels, submerged coils, and the like. While specific temperatures and methods of obtaining the specific temperatures are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific temperatures and methods of obtaining the specific temperatures. Other temperatures and methods of obtaining temperatures can also be employed in the preferred embodiments.
The amount of alcohol employed in the reaction is preferably in excess of the amount of fatty acid present on a molar basis. The fatty acid can be free or combined, such as to alcohol, glycol, or glycerol, with up to three fatty acid moieties being attached to a glycerol.
Additional amounts of alcohol above stoichiometric provide the advantage of assisting in driving the equilibrium of the reaction to produce more of the fatty acid ester product.
However, greater excesses of alcohol can result in greater processing costs and larger capital investment for the larger volumes of reagents employed in the process, as well as greater energy costs associated with recovering, purifying, and recycling this excess alcohol.
Accordingly, it is generally preferred to employ an amount of alcohol yielding a molar ratio of alcohol to fatty acid of from about 15:1 to about 1:1 (stoichiometric), and more preferably from about 4:1 to about 2:1; however the process can operate over a much wider range of alcohol to fatty acid ratios, with nonreacted materials subjected to recycling or other processing steps. Generally, lower relative levels of alcohol to fatty acid result in decreased yield and higher relative levels of alcohol levels to fatty acid result in increased capital and operating expense. Some instances of operation at ratios of alcohol to fatty acid over a wider range include when first starting up the process or shutting down the process, when balancing the throughput of the reactor to other processing steps or other processing facilities, such as one that produces alcohol or utilizes a side stream, or when process upsets occur. When a molar ratio of 2:1 methanol to fatty acid is employed and a sodium hydroxide concentration of about 0.5 wt% of the total reaction mixture is employed, the ratio of sodium hydroxide to methanol is about 2 wt% entering the reactor and about 4 wt% at the exit because about half of the alcohol is consumed in the esterification reaction.
Similarly, higher amounts of catalyst generally result in faster reactions.
However, higher amounts of catalyst can lead to higher downstream separation costs and a different profile of side reaction products. The amount of homogeneous catalyst is preferably from about 0.2 wt% to about 1.0 wt% of the reaction mixture when the catalyst is sodium hydroxide; at typical concentration of 0.5 wt% when a 2:1 molar ratio of methanol to fatty acid is used; however, in certain embodiments, higher or lower amounts can be employed.
The amount of catalyst employed can also vary depending upon the nature of the catalyst, feed materials, operating conditions, and other factors. Specifically, the temperature, pressure, free fatty acid content of the feed, and degree of mixing can change the amount of catalyst preferably employed. While specific catalyst amounts are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific catalyst amounts. Other suitable catalyst amounts can also be employed in the preferred embodiments.
The esterification reaction can be performed batchwise, such as in a stirred tank, or it can be performed continuously, such as in a continuous stirred tank reactor (CSTR) or a plug flow reactor (PFR). When operated in continuous mode, a series of continuous reactors (including CSTRs, PFRs, or combinations thereof) can advantageously operate in series.
Alternatively, batch reactors can be arranged in parallel and/or series.
When the reactor is operated in a continuous fashion, one or more of the feed materials is preferably metered into the process. Various techniques for metering can be employed (e.g., metering pumps, positive displacement pumps, control valves, flow meters, and the like). While specific types of reactors are discussed herein with reference to certain embodiments and examples, the preferred embodiments are not limited to such specific reactors. Other suitable types of reactors can also be employed in the preferred embodiments.
As described above, biodiesel refers to a transesterified vegetable oil or animal fat based diesel fuel containing long-chain alkyl (typically methyl, propyl, or ethyl) esters.
Biodiesel is typically made by chemically reacting lipids (such as vegetable oil) with an alcohol. Biodiesel, TAG's and derivatives thereof may be used in the processes described herein. Likewise, preferred fatty acid methyl esters useful herein may be obtained by reacting canola oil, corn oil, soybean oil, beef tallow, tall oil, animal fats, waste oils/greases, rapeseed oil, algae oil, Canola oil, palm oil, Jathropa oil, high-oleic soybean oil, high-oleic safflower oil, high-oleic sunflower oil, or mixtures of animal and/or vegetable fats, and oils with one or more alcohols (as described above), preferably methanol.
Isomerization In another embodiment, the feed material is first isomerized, then combined with a metathesis catalyst as described herein. For example, the processes disclosed herein may comprise providing a feed material (typically a fatty acid or fatty acid derivative), isomerizing a site of unsaturation in the feed material (typically a fatty acid or fatty acid derivative) to produce an isomerized feed material (typically a fatty acid or fatty acid derivative), and then contacting the isomerized material with an alkene in the presence of a metathesis catalyst.
The isomerized material can be produced by isomerization with or without subsequent esterification or transesterification. Isomerization can be catalyzed by known biochemical or chemical techniques. For example, an isomerase enzyme, such as a linoleate isomerase, can be used to isomerize linoleic acid from the cis 9, cis 12 isomer to the cis 9, trans 11 isomer.
This isomerization process is stereospecific, however, nonstereospecific processes can be used because both cis and trans isomers are suitable for metathesis. For example, an alternative process employs a chemical isomerization catalyst, such as an acidic or basic catalyst, can be used to isomerize an unsaturated feed material (typically a fatty acid or fatty acid derivative) having a site of unsaturation at one location in the molecule into an isomerized, feed material (typically a fatty acid or fatty acid derivative) having a site of unsaturation at a different location in the molecule. Metal or organometallic catalysts also can be used to isomerize an unsaturated feed material (typically a fatty acid or fatty acid derivative). For example, nickel catalysts are known to catalyze positional isomerization of unsaturated sites in fatty acid derivatives. Similarly, esterification, transesterification, reduction, oxidation, and/or other modifications of the starting compound or products, such as a fatty acid or fatty acid derivative, can be catalyzed by biochemical or chemical techniques.
For example, a fatty acid or fatty acid derivative can be modified by a lipase, esterase, reductase or other enzyme before or after isomerization. In another embodiment, the isomerization described above may be practiced with any triacylglycerides, biodiesel, fatty acids, fatty acid esters, and/or fatty acid alkyl esters described herein, typically before contacting with the metathesis catalyst.
Alkenes Besides the feed materials, the metathesis process of this invention may require an alkene as a reactant. The term "alkene" shall imply an organic compound containing at least one carbon-carbon double bond and typically having less than about 10 carbon atoms. The alkene may have one carbon-carbon unsaturated bond, or alternatively, two or more carbon-carbon unsaturated bonds. Since the metathesis reaction can occur at any double bond, alkenes having more than one double bond will produce more metathesis products.
Accordingly, in some embodiments, it is preferred to employ an alkene having only one carbon-carbon double bond. The double bond may be, without limitation, a terminal double bond or an internal double bond. The alkene may also be substituted at any position along the carbon chain with one or more substituents, provided that the one or more substituents are essentially inert with respect to the metathesis process. Suitable substituents include, without limitation, alkyl, preferably, C1_6 alkyl; cycloalkyl, preferably, C3_6 cycloalkyl; as well as hydroxy, ether, keto, aldehyde, and halogen functionalities. Non-limiting examples of suitable alkenes include ethylene, propylene, butene, butadiene, pentene, hexene, the various isomers thereof, as well as higher homologues thereof. Preferably, the alkene is a C2_8 alkene.
More preferably, the alkene is a C2_6 alkene, even more preferably, a C24 alkene, and most preferably, ethylene.
Useful alkenes include those represented by the formula: R*-HC=CH-R*, wherein each R* is independently, hydrogen or a C1 to C20 hydrocarbyl, preferably hydrogen or a C1 to C6 hydrocarbyl, preferably hydrogen, methyl, ethyl, propyl or butyl, more preferably R* is hydrogen. In a preferred embodiment, both R* are the same, preferably both R*are hydrogen.
Ethylene, propylene, butene, pentene, hexene, octane, nonene and decene (preferably ethylene) are alkenes useful herein.
For purposes of this invention and the claims thereto, the term lower olefin means an alkene represented by the formula: R*-HC=CH-R*, wherein each R* is independently, hydrogen or a C1 to C6 hydrocarbyl, preferably hydrogen or a C1 to C3 hydrocarbyl, preferably hydrogen, methyl, ethyl, propyl, or butyl, more preferably R* is hydrogen. In a preferred embodiment, both R* are the same, preferably both R* are hydrogen.
Ethylene, propylene, butene, pentene, hexene, and octene (preferably ethylene) are lower olefins useful herein.
Alpha-Olefin Products of the Metathesis Reaction In a preferred embodiment, the processes described herein produce a linear alpha olefin. The alpha-olefin, preferably linear alpha-olefin, produced herein contains at least one more carbon than the alkene used in the reaction to make the alpha-olefin.
In another embodiment, the processes described herein produce a blend of an alpha olefin and an ester-functionalized alpha olefin. Generally a mixture of non-ester-containing alpha olefins will be produced due to the presence of mono-, di-, and tri-unsubstituted fatty acid chains. The major alpha olefin products are expected to be 1-decene, 1-heptene, and 1-butene. The major ester-containing alpha olefin product is methyl dec-9-enoate.
In a preferred embodiment, the alpha olefin produced herein is 1-decene.
Typically the 1-decene is produced with an ester.
In a preferred embodiment, the major alpha olefin produced herein is 1-decene.
Typically the 1-decene is produced with an ester.
In a preferred embodiment, ethylene and methyl oleate are combined with the metathesis catalysts described herein (such as 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(1- cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride, (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-1-ylidene ruthenium (II) dichloride, and mixtures thereof) to produce 1-decene and methyl dec-9-enoate.
Separation of the 1-olefin (such as the 1-decene) from the ester may be by means typically known in the art such as distillation or filtration.
The linear alpha-olefin (such as 1-decene or a mixture of C8, C10, C12 linear alpha olefins) is then separated from any esters present and preferably used to make poly-alpha-olefins(PAOs). Specifically, PAOs may be produced by the polymerization of olefin feed in the presence of a catalyst such as A1C13, BF3, or BF3 complexes. Processes for the production of PAOs are disclosed, for example, in the following patents: US
3,149,178;
Ethylene, propylene, butene, pentene, hexene, and octene (preferably ethylene) are lower olefins useful herein.
Alpha-Olefin Products of the Metathesis Reaction In a preferred embodiment, the processes described herein produce a linear alpha olefin. The alpha-olefin, preferably linear alpha-olefin, produced herein contains at least one more carbon than the alkene used in the reaction to make the alpha-olefin.
In another embodiment, the processes described herein produce a blend of an alpha olefin and an ester-functionalized alpha olefin. Generally a mixture of non-ester-containing alpha olefins will be produced due to the presence of mono-, di-, and tri-unsubstituted fatty acid chains. The major alpha olefin products are expected to be 1-decene, 1-heptene, and 1-butene. The major ester-containing alpha olefin product is methyl dec-9-enoate.
In a preferred embodiment, the alpha olefin produced herein is 1-decene.
Typically the 1-decene is produced with an ester.
In a preferred embodiment, the major alpha olefin produced herein is 1-decene.
Typically the 1-decene is produced with an ester.
In a preferred embodiment, ethylene and methyl oleate are combined with the metathesis catalysts described herein (such as 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(1- cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride, (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-1-ylidene ruthenium (II) dichloride, and mixtures thereof) to produce 1-decene and methyl dec-9-enoate.
Separation of the 1-olefin (such as the 1-decene) from the ester may be by means typically known in the art such as distillation or filtration.
The linear alpha-olefin (such as 1-decene or a mixture of C8, C10, C12 linear alpha olefins) is then separated from any esters present and preferably used to make poly-alpha-olefins(PAOs). Specifically, PAOs may be produced by the polymerization of olefin feed in the presence of a catalyst such as A1C13, BF3, or BF3 complexes. Processes for the production of PAOs are disclosed, for example, in the following patents: US
3,149,178;
3,382,291; 3,742,082; 3,769,363; 3,780,128; 4,172,855; and 4,956,122; which are fully incorporated by reference. PAOs are also discussed in: Will, J.G. Lubrication Fundamentals, Marcel Dekker: New York, 1980. Certain high viscosity index PAO's may also be conveniently made by the polymerization of an alpha-olefin in the presence of a polymerization catalyst such as Friedel-Crafts catalysts. These include, for example, aluminum trichloride, boron trifluoride, aluminum trichloride, or boron trifluoride promoted with water, with alcohols such as ethanol, propanol, or butanol, with carboxylic acids, or with esters such as ethyl acetate or ethyl propionate or ether such as diethyl ether, diisopropyl ether, etc., see for example, the methods disclosed by US 4,149,178; US 3,382,291; US
3,742,082;
US 3,769,363 (Brennan); US 3,876,720; US 4,239,930; US 4,367,352; US
4,413,156; US
4,434,408; US 4,910,355; US 4,956,122; US 5,068,487; US 4,827,073; US
4,827,064; US
4,967,032; US 4,926,004; and US 4,914,254. PAO's can also be made using various metallocene catalyst systems. Examples include US 6,706,828; WO 96/2375 1; EP
0 613 873;
US 5,688,887; US 6,043,401; WO 03/020856; US 6,548,724; US 5,087,788; US
6,414,090;
US 6,414,091; US 4,704,491; US 6,133,209; and US 6,713,438.
PAOs are often used as additives and base stocks for lubricants, among other things.
Additional information on the use of PAO's in the formulations of full synthetic, semi-synthetic or part synthetic lubricant or functional fluids can be found in "Synthetic Lubricants and High-Performance Functional Fluids", 2nd Ed., L. Rudnick et al., Marcel Dekker, Inc., N.Y. (1999). Additional information on additives used in product formulation can be found in "Lubricants and Lubrications", Ed. By T. Mang and W. Dresel, by Wiley-VCH
GmbH, Weinheim 2001.
In another embodiment, this invention relates to:
1. An asymmetrically substituted NHC metathesis catalyst compound represented by the formula:
Ri R2 X1"Y' Rs X 2 --~-M -~~<
where:
3,742,082;
US 3,769,363 (Brennan); US 3,876,720; US 4,239,930; US 4,367,352; US
4,413,156; US
4,434,408; US 4,910,355; US 4,956,122; US 5,068,487; US 4,827,073; US
4,827,064; US
4,967,032; US 4,926,004; and US 4,914,254. PAO's can also be made using various metallocene catalyst systems. Examples include US 6,706,828; WO 96/2375 1; EP
0 613 873;
US 5,688,887; US 6,043,401; WO 03/020856; US 6,548,724; US 5,087,788; US
6,414,090;
US 6,414,091; US 4,704,491; US 6,133,209; and US 6,713,438.
PAOs are often used as additives and base stocks for lubricants, among other things.
Additional information on the use of PAO's in the formulations of full synthetic, semi-synthetic or part synthetic lubricant or functional fluids can be found in "Synthetic Lubricants and High-Performance Functional Fluids", 2nd Ed., L. Rudnick et al., Marcel Dekker, Inc., N.Y. (1999). Additional information on additives used in product formulation can be found in "Lubricants and Lubrications", Ed. By T. Mang and W. Dresel, by Wiley-VCH
GmbH, Weinheim 2001.
In another embodiment, this invention relates to:
1. An asymmetrically substituted NHC metathesis catalyst compound represented by the formula:
Ri R2 X1"Y' Rs X 2 --~-M -~~<
where:
M is a Group 8 metal; preferably Ru or Os, preferably Ru;
X1 and X2 are, independently, any anionic ligand (preferably halogen, an alkoxide or an alkyl sulfonate), or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing ligand; preferably the heteroatom is N, 0, P, or S;
preferably P, optionally L may be joined to R7 and/or R8, preferably L is L*(R)q_1 when L is not bound to R7 or Rs or L is L*(R)q_2 when L is bound to R7 or R8, where q is 1, 2, 3, or 4 depending on the valence of L* (which may be 2, 3, 4, or 5) and L* is N, 0, P, or S, (preferably P) and R is as defined for R3;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms; and wherein R1 and R2 are dissimilar to each other.
2. The catalyst compound of paragraph 1, wherein M is ruthenium.
3. The catalyst compound of paragraph 1 or 2, wherein when R7 and R8 form an unsubstituted phenyl group and R1 is mesityl, then R2 is not methyl or ethyl, preferably R2 is hydrogen or C1 to C30 substituted hydrocarbyl, or a C3 to C30 unsubstituted hydrocarbyl (preferably a C4 to C30 unsubstituted hydrocarbyl, preferably a C5 to C30 unsubstituted hydrocarbyl, preferably a C6 to C30 unsubstituted hydrocarbyl).
4. The catalyst compound of any of paragraphs 1 to 3, wherein X1 and X2 are Cl.
5. The catalyst compound of any of paragraphs 1 to 4, wherein the heteroatom in L is N, O, or P.
6. The catalyst compound of any of paragraphs 1 to 5, wherein R1, R2, R7, and R8 are, independently, C1 to C30 hydrocarbyl.
7. The catalyst compound of any of paragraphs 1 to 6, wherein R3, R4, R5, and R6 are, independently, hydrogen.
8. The catalyst compound of any of paragraphs 1 to 7, wherein R1 is an aromatic hydrocarbyl or substituted hydrocarbyl and R2 is an aliphatic hydrocarbyl or substituted hydrocarbyl, (preferably R1 is a substituted or unsubstituted C6 to C30 aryl, and R2 is a C1 to C30 substituted or unsubstituted alkyl, preferably C3 to C30 substituted or unsubstituted alkyl, preferably C4 to C30 substituted or unsubstituted alkyl, C5 to C30 substituted or unsubstituted alkyl, C6 to C30 substituted or unsubstituted alkyl).
9. The catalyst compound of paragraph 1, wherein the metathesis catalyst compound comprises one or more of. 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(l-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride, (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-1 H-inden- l -ylidene ruthenium (II) dichloride, and mixtures thereof.
10. A process to produce alpha-olefin comprising contacting a feed material (such as a feed oil) with the catalyst compound of any of paragraphs 1 to 9.
11. The process of paragraph 10, wherein the feed material is selected from the group consisting of canola oil, corn oil, soybean oil, rapeseed oil, algae oil, peanut oil, mustard oil, sunflower oil, tung oil, perilla oil, tall oil, grapeseed oil, linseed oil, safflower oil, pumpkin oil, palm oil, Jathropa oil, high-oleic soybean oil, high-oleic safflower oil, high-oleic sunflower oil, mixtures of animal and vegetable fats and oils, castor bean oil, dehydrated castor bean oil, cucumber oil, poppyseed oil, flaxseed oil, lesquerella oil, walnut oil, cottonseed oil, meadowfoam, tuna oil, sesame oils and mixtures thereof.
12. The process of paragraph 10, wherein the feed material is selected from the group consisting of tall oil, palm oil and algae oil.
13. A process to produce alpha-olefin comprising contacting a triacylglyceride with an alkene and the catalyst compound of any of paragraphs 1 to 9, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
14. The process of paragraph 13, wherein the triacylglyceride is contacted with alcohol and converted to a fatty acid ester or fatty acid alkyl ester prior to contacting with the catalyst compound of any of paragraphs 1 to 9.
15. The process of paragraph 13, wherein the triacylglyceride is contacted with water and/or an alkaline reagent and converted to a fatty acid prior to contacting with the catalyst compound of any of paragraphs 1 to 9.
16. A process to produce alpha-olefin comprising contacting an unsaturated fatty acid with an alkene and the catalyst compound of any of paragraphs 1 to 9, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
X1 and X2 are, independently, any anionic ligand (preferably halogen, an alkoxide or an alkyl sulfonate), or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing ligand; preferably the heteroatom is N, 0, P, or S;
preferably P, optionally L may be joined to R7 and/or R8, preferably L is L*(R)q_1 when L is not bound to R7 or Rs or L is L*(R)q_2 when L is bound to R7 or R8, where q is 1, 2, 3, or 4 depending on the valence of L* (which may be 2, 3, 4, or 5) and L* is N, 0, P, or S, (preferably P) and R is as defined for R3;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms; and wherein R1 and R2 are dissimilar to each other.
2. The catalyst compound of paragraph 1, wherein M is ruthenium.
3. The catalyst compound of paragraph 1 or 2, wherein when R7 and R8 form an unsubstituted phenyl group and R1 is mesityl, then R2 is not methyl or ethyl, preferably R2 is hydrogen or C1 to C30 substituted hydrocarbyl, or a C3 to C30 unsubstituted hydrocarbyl (preferably a C4 to C30 unsubstituted hydrocarbyl, preferably a C5 to C30 unsubstituted hydrocarbyl, preferably a C6 to C30 unsubstituted hydrocarbyl).
4. The catalyst compound of any of paragraphs 1 to 3, wherein X1 and X2 are Cl.
5. The catalyst compound of any of paragraphs 1 to 4, wherein the heteroatom in L is N, O, or P.
6. The catalyst compound of any of paragraphs 1 to 5, wherein R1, R2, R7, and R8 are, independently, C1 to C30 hydrocarbyl.
7. The catalyst compound of any of paragraphs 1 to 6, wherein R3, R4, R5, and R6 are, independently, hydrogen.
8. The catalyst compound of any of paragraphs 1 to 7, wherein R1 is an aromatic hydrocarbyl or substituted hydrocarbyl and R2 is an aliphatic hydrocarbyl or substituted hydrocarbyl, (preferably R1 is a substituted or unsubstituted C6 to C30 aryl, and R2 is a C1 to C30 substituted or unsubstituted alkyl, preferably C3 to C30 substituted or unsubstituted alkyl, preferably C4 to C30 substituted or unsubstituted alkyl, C5 to C30 substituted or unsubstituted alkyl, C6 to C30 substituted or unsubstituted alkyl).
9. The catalyst compound of paragraph 1, wherein the metathesis catalyst compound comprises one or more of. 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(l-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride, (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-1 H-inden- l -ylidene ruthenium (II) dichloride, and mixtures thereof.
10. A process to produce alpha-olefin comprising contacting a feed material (such as a feed oil) with the catalyst compound of any of paragraphs 1 to 9.
11. The process of paragraph 10, wherein the feed material is selected from the group consisting of canola oil, corn oil, soybean oil, rapeseed oil, algae oil, peanut oil, mustard oil, sunflower oil, tung oil, perilla oil, tall oil, grapeseed oil, linseed oil, safflower oil, pumpkin oil, palm oil, Jathropa oil, high-oleic soybean oil, high-oleic safflower oil, high-oleic sunflower oil, mixtures of animal and vegetable fats and oils, castor bean oil, dehydrated castor bean oil, cucumber oil, poppyseed oil, flaxseed oil, lesquerella oil, walnut oil, cottonseed oil, meadowfoam, tuna oil, sesame oils and mixtures thereof.
12. The process of paragraph 10, wherein the feed material is selected from the group consisting of tall oil, palm oil and algae oil.
13. A process to produce alpha-olefin comprising contacting a triacylglyceride with an alkene and the catalyst compound of any of paragraphs 1 to 9, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
14. The process of paragraph 13, wherein the triacylglyceride is contacted with alcohol and converted to a fatty acid ester or fatty acid alkyl ester prior to contacting with the catalyst compound of any of paragraphs 1 to 9.
15. The process of paragraph 13, wherein the triacylglyceride is contacted with water and/or an alkaline reagent and converted to a fatty acid prior to contacting with the catalyst compound of any of paragraphs 1 to 9.
16. A process to produce alpha-olefin comprising contacting an unsaturated fatty acid with an alkene and the catalyst compound of any of paragraphs 1 to 9, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
17. A process to produce alpha-olefin comprising contacting a triacylglyceride with the catalyst compound of any of paragraphs 1 to 9, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
18. A process to produce alpha-olefin comprising contacting an unsaturated fatty acid ester and or unsaturated fatty acid alkyl ester with an alkene and the catalyst compound of any of paragraphs 1 to 9, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
19. The process of any of paragraphs 11 to 18, wherein the alpha olefin is a linear alpha-olefin having 4 to 24 carbon atoms.
20. The process of any of paragraphs 11 to 19, wherein the alkene is ethylene, propylene, butene, hexene, or octene.
21. The process of any of paragraphs 19 to 20, wherein the fatty acid ester is a fatty acid methyl ester.
22. The process of any of paragraphs 13 to 21, wherein the triacylglyceride, fatty acid, fatty acid alkyl ester, fatty acid ester is derived from biodiesel.
23. The process of any of paragraphs 10 to 22, wherein the alpha-olefin is butene-1, decene- 1, and/or heptene- 1.
24. The process of any of paragraphs 10 to 23, wherein the productivity of the process is at least 200 g of linear alpha-olefin per mmol of catalyst per hour.
25. The process of any of paragraphs 10 to 24, wherein the selectivity of the process is at least 20 wt% linear alpha-olefin, based upon the weight to the material exiting the reactor.
26. The process of any of paragraphs 10 to 25, wherein the turnover number of the process is at least 5,000.
27. The process of any of paragraphs 10 to 26, wherein the yield, when converting unsaturated fatty acids, unsaturated fatty acid esters, unsaturated fatty acid alkyl esters, or mixtures thereof, is 30% or more, said yield being defined as defined as the moles of alpha olefin formed per mol of unsaturated fatty acids, unsaturated fatty acid esters, unsaturated fatty acid alkyl esters, or mixtures thereof introduced into the reactor.
28. The process of any of paragraphs 10 to 26, wherein the yield, when converting TAGs as represented in the formula below, is 30% or more, said yield being defined as defined as the moles of alpha olefin formed divided by (the moles of unsaturated Ra +
moles of unsaturated Rb + moles of unsaturated Rc) introduced into the reactor, H2C -O - C- Ra HC-O-C-Rb H2C - O - C- Rc where Ra, Rb, and Rc each, independently, represent a saturated or unsaturated hydrocarbon chain.
29. The process of paragraph 27, wherein the yield is 60% or more.
30. A process to produce C4 to C24 linear alpha-olefin comprising contacting a feed material with an alkene selected from the group consisting of ethylene, propylene butene, pentene, hexene, heptene, octene, nonene, decene, and mixtures thereof and a metathesis catalyst compound of any of paragraphs 1 to 10, wherein the feed material is a triacylglyceride, fatty acid, fatty acid alkyl ester, and/or fatty acid ester derived from seed oil.
31. The process of paragraph 30, wherein the alkene is ethylene, the alpha olefin is 1-butene, 1-heptene, and/or -decene, and the feed material is a fatty acid methyl ester, and/or fatty acid ester.
EXPERIMENTAL SECTION
Tests and Materials All molecular weights are number average unless otherwise noted. All molecular weights are reported in g/mol unless otherwise noted.
For purposes of this invention and the claims thereto, Et is ethyl, Me is methyl, Ph is phenyl, Cy is cyclohexyl, THE is tetrahydrofuran, MeOH is methanol, DCM is dichloromethane, and TLC is thin layer chromatography.
Typical dry-box procedures for synthesis of air-sensitive compounds were followed including using dried glassware (90 C, 4 hours) and anhydrous solvents purchased from Sigma Aldrich (St. Louis, MO) which were further dried over 3 A sieves. All reagents were purchased from Sigma-Aldrich, unless otherwise noted. 1H, 13C, and 31P spectra were recorded on Bruker 250 and 500 spectrometers. IR data was recorded on Bruker Tensor 27 FT-IR spectrometer. Yields of metathesis product and catalyst turnover numbers were calculated from data recorded on an Agilent 6890 GC spectrometer as shown below.
Typically, a sample of the metathesis product will be taken and analyzed by GC. An internal standard, usually tetradecane, is used to derive the amount of metathesis product that is obtained. The amount of metathesis product is calculated from the area under the desired peak on the GC trace, relative to the internal standard.
Yield is reported as a percentage and is generally calculated as 100 x [micromoles of metathesis products obtained by GC]/[micromoles of feed material weighed into reactor].
Selectivity is reported as a percentage and was calculated as 100 x [area under the peak of desired metathesis products]/[sum of peak areas of cross-metathesis and the homometathesis products].
Catalyst turnovers (TON) for production of the metathesis products is defined as the [micromoles of metathesis product]/([micromoles of catalyst].
In a particular embodiment, the metathesis of methyl oleate with ethylene will yield cross-metathesis products of 1-decene and methyl-9-decenoate. In addition to the desired products, the methyl oleate may homometathesize to produce small amounts of 9-octadecene, a less desirable product, and 1,18-dimethyl-9-octadecenedioate, a second less desirable product. Yield was calculated as 100 x [micromoles of ethenolysis products obtained from the GC]/[micromoles of methyl oleate weighed into reactor]. 1-decene selectivity is shown as a percentage and was calculated as 100 x [GC peak area of 1-decene & methyl-9-decenoate]/[sum of GC peak areas of 1-decene, methyl-9-decenoate, and the homometathesis products, 9-octadecene, and 1,18-dimethyl-9-octadecenedioate]. Catalyst turnovers for production of the 1-decene was calculated as the [micromoles of 1-decene obtained from the gas chromatograph]/([micromoles of catalyst].
Products were analyzed by gas chromatography (Agilent 6890N with auto-injector) using helium as a carrier gas at 38 cm/sec. A column having a length of 60 m(J
& W
Scientific DB-1, 60 in x 0.25 mm I.D.x 1.0 m film thickness) packed with a flame ionization detector (FID), an Injector temperature of 250 C, and a Detector temperature of 250 C were used. The sample injected into the column in an oven at 70 C, then heated to 275 C over 22 minutes (ramp rate 10 C/minute to 100 C, 30 C/minute to 275 C, hold).
EXAMPLES
Synthesis of Catalyst 1: (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-l-ylideneruthenium(II) dichloride:
18. A process to produce alpha-olefin comprising contacting an unsaturated fatty acid ester and or unsaturated fatty acid alkyl ester with an alkene and the catalyst compound of any of paragraphs 1 to 9, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
19. The process of any of paragraphs 11 to 18, wherein the alpha olefin is a linear alpha-olefin having 4 to 24 carbon atoms.
20. The process of any of paragraphs 11 to 19, wherein the alkene is ethylene, propylene, butene, hexene, or octene.
21. The process of any of paragraphs 19 to 20, wherein the fatty acid ester is a fatty acid methyl ester.
22. The process of any of paragraphs 13 to 21, wherein the triacylglyceride, fatty acid, fatty acid alkyl ester, fatty acid ester is derived from biodiesel.
23. The process of any of paragraphs 10 to 22, wherein the alpha-olefin is butene-1, decene- 1, and/or heptene- 1.
24. The process of any of paragraphs 10 to 23, wherein the productivity of the process is at least 200 g of linear alpha-olefin per mmol of catalyst per hour.
25. The process of any of paragraphs 10 to 24, wherein the selectivity of the process is at least 20 wt% linear alpha-olefin, based upon the weight to the material exiting the reactor.
26. The process of any of paragraphs 10 to 25, wherein the turnover number of the process is at least 5,000.
27. The process of any of paragraphs 10 to 26, wherein the yield, when converting unsaturated fatty acids, unsaturated fatty acid esters, unsaturated fatty acid alkyl esters, or mixtures thereof, is 30% or more, said yield being defined as defined as the moles of alpha olefin formed per mol of unsaturated fatty acids, unsaturated fatty acid esters, unsaturated fatty acid alkyl esters, or mixtures thereof introduced into the reactor.
28. The process of any of paragraphs 10 to 26, wherein the yield, when converting TAGs as represented in the formula below, is 30% or more, said yield being defined as defined as the moles of alpha olefin formed divided by (the moles of unsaturated Ra +
moles of unsaturated Rb + moles of unsaturated Rc) introduced into the reactor, H2C -O - C- Ra HC-O-C-Rb H2C - O - C- Rc where Ra, Rb, and Rc each, independently, represent a saturated or unsaturated hydrocarbon chain.
29. The process of paragraph 27, wherein the yield is 60% or more.
30. A process to produce C4 to C24 linear alpha-olefin comprising contacting a feed material with an alkene selected from the group consisting of ethylene, propylene butene, pentene, hexene, heptene, octene, nonene, decene, and mixtures thereof and a metathesis catalyst compound of any of paragraphs 1 to 10, wherein the feed material is a triacylglyceride, fatty acid, fatty acid alkyl ester, and/or fatty acid ester derived from seed oil.
31. The process of paragraph 30, wherein the alkene is ethylene, the alpha olefin is 1-butene, 1-heptene, and/or -decene, and the feed material is a fatty acid methyl ester, and/or fatty acid ester.
EXPERIMENTAL SECTION
Tests and Materials All molecular weights are number average unless otherwise noted. All molecular weights are reported in g/mol unless otherwise noted.
For purposes of this invention and the claims thereto, Et is ethyl, Me is methyl, Ph is phenyl, Cy is cyclohexyl, THE is tetrahydrofuran, MeOH is methanol, DCM is dichloromethane, and TLC is thin layer chromatography.
Typical dry-box procedures for synthesis of air-sensitive compounds were followed including using dried glassware (90 C, 4 hours) and anhydrous solvents purchased from Sigma Aldrich (St. Louis, MO) which were further dried over 3 A sieves. All reagents were purchased from Sigma-Aldrich, unless otherwise noted. 1H, 13C, and 31P spectra were recorded on Bruker 250 and 500 spectrometers. IR data was recorded on Bruker Tensor 27 FT-IR spectrometer. Yields of metathesis product and catalyst turnover numbers were calculated from data recorded on an Agilent 6890 GC spectrometer as shown below.
Typically, a sample of the metathesis product will be taken and analyzed by GC. An internal standard, usually tetradecane, is used to derive the amount of metathesis product that is obtained. The amount of metathesis product is calculated from the area under the desired peak on the GC trace, relative to the internal standard.
Yield is reported as a percentage and is generally calculated as 100 x [micromoles of metathesis products obtained by GC]/[micromoles of feed material weighed into reactor].
Selectivity is reported as a percentage and was calculated as 100 x [area under the peak of desired metathesis products]/[sum of peak areas of cross-metathesis and the homometathesis products].
Catalyst turnovers (TON) for production of the metathesis products is defined as the [micromoles of metathesis product]/([micromoles of catalyst].
In a particular embodiment, the metathesis of methyl oleate with ethylene will yield cross-metathesis products of 1-decene and methyl-9-decenoate. In addition to the desired products, the methyl oleate may homometathesize to produce small amounts of 9-octadecene, a less desirable product, and 1,18-dimethyl-9-octadecenedioate, a second less desirable product. Yield was calculated as 100 x [micromoles of ethenolysis products obtained from the GC]/[micromoles of methyl oleate weighed into reactor]. 1-decene selectivity is shown as a percentage and was calculated as 100 x [GC peak area of 1-decene & methyl-9-decenoate]/[sum of GC peak areas of 1-decene, methyl-9-decenoate, and the homometathesis products, 9-octadecene, and 1,18-dimethyl-9-octadecenedioate]. Catalyst turnovers for production of the 1-decene was calculated as the [micromoles of 1-decene obtained from the gas chromatograph]/([micromoles of catalyst].
Products were analyzed by gas chromatography (Agilent 6890N with auto-injector) using helium as a carrier gas at 38 cm/sec. A column having a length of 60 m(J
& W
Scientific DB-1, 60 in x 0.25 mm I.D.x 1.0 m film thickness) packed with a flame ionization detector (FID), an Injector temperature of 250 C, and a Detector temperature of 250 C were used. The sample injected into the column in an oven at 70 C, then heated to 275 C over 22 minutes (ramp rate 10 C/minute to 100 C, 30 C/minute to 275 C, hold).
EXAMPLES
Synthesis of Catalyst 1: (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-l-ylideneruthenium(II) dichloride:
Br H Pd2(dba)3, H
+ H2N~~ ( )-BINAP, NaOtBu H A
triethyl NN KOtPn N__ orthoformate Ny I
F-B F PCY3 E}~Ru formic acid F C}%Ru PC
B Y3 Ph PCy3 Ph Catalyst 1 Synthesis of Compound A: N-methyl-N'-mesityl-1,2-ethylenediamine:
In a 100 mL round-bottom flask tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) (110 mg, 0.120 mmol) and ( )-2,2'-Bis(diphenylphosphino)-1,l'-binaphthalene (( )-BINAP) (230 mg, 0.37 mmol) were added to 25 mL toluene and stirred for 20 minutes.
Next, 2-bromomesitylene (2.45 g, 12.3 mmol), N-methylethylenediamine (1.01 g, 13.6 mmol) and sodium t-butoxide (NaOtBu) (3.56 g, 37 mmol) were added along with 25 mL
toluene. This was stirred for 72 hours at 80 C. The flask was then removed from heat, cooled to room temperature and diluted with 20 mL diethyl ether. The solution was then washed with 5 x 30 mL water and 3 x 15 mL brine, and dried over magnesium sulfate. After filtering and vacuum removal of solvent, a dark red oil was recovered and used without further purification.
Synthesis of Compound B: 1-Mesityl-3-methyl-2H-4,5-dihydroimidazolium tetrafluoroborate:
Compound A (2.07 g, 10.8 mmol) oil was diluted in 10 mL toluene and stirred with triethylorthoformate (15.98 g, 108 mmol), ammonium tetrafluoroborate (NH4BF4) (4.51 g, 43 mmol) and 5 drops of formic acid at 130 C for 18 hours. After cooling to room temperature the solution was filtered and solids were dissolved in dichloromethane and precipitate filtered off. The solvent was removed by purging with nitrogen and the residue was recrystallized from acetone/methyl tert-butyl ether. A total of 0.39 g (25.1%) of Compound B
was obtained.
Synthesis of Catalyst 1: (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-1H-inden-1-ylideneruthenium(II) dichloride:
To a solution of Compound B (50 mg, 0.172 mmol) in 5 mL hexanes was added potassium tert-pentoxide (KOtPn) (0.172 mmol) from a 15% solution in hexanes.
To this solution was added bis(tricyclohexylphosphine)-3-phenyl-1H-inden-1-ylideneruthenium (II) dichloride (purchased from Strem Chemicals, (Newburyport, MA)) (145 mg, 0.156 mmol) and the solution then stirred for 12 hours at 50 C. After cooling to room temperature, the solution was concentrated to approximately 2 mL under a stream of nitrogen, then filtered and washed with hexanes, yielding 105 mg (79 %) of Catalyst 1 as a brown powder.
Methyl Oleate Ethynolysis (Cross-metathesis of methyl oleate with ethylene):
Catalyst 1: The ethynolysis of methyl oleate was used as a test to determine the activity of the (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-l-ylideneruthenium(II) dichloride complex (Catalyst 1). A
0.120 mM stock solution was made by dissolving Catalyst 1 in dichloromethane. Methyl oleate (0.87g, 1.0 mL), Catalyst 1 stock solution (125 nmol, 1.04 mL), dichloromethane (2.91 mL) and of tetradecane (0.152 g, used as an internal standard) were weighed out and then placed in a Fisher-Porter bottle equipped with a stir bar. The Fisher-Porter bottle was then filled with ethylene to 150 psig and placed in an oil bath heated to 40 C for 3 hours. The vessel was depressurized and 5 drops of ethyl vinyl ether was added to stop the reaction.
A sample was removed and analyzed by GC.
Comparative Catalyst A: Tricyclohexylphosphine[3-phenyl-lH-inden-1-ylidene][1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene]ruthenium(II) dichloride (Comparative Catalyst A) is a symmetrical annolog of Catalyst 1 and was purchased from Strem Chemicals. The structure of Comparative Catalyst A is shown below.
Ph Ru Cl1 PCy3 Comparative Catalyst A
A 0.139 mM solution of the Comparative Catalyst A complex in dichloromethane was prepared. Comparative Catalyst A stock solution (94.4 nmol, 0.679 mL), dichloromethane (3.12 mL), methyl oleate (0.87g, 1.0 mL) and tetradecane (0.152 g, used as an internal standard) were weighed out and then placed in a Fisher-Porter bottle equipped with a stir bar.
The Fisher-Porter bottle was filled with 150 psig of ethylene and heated to 40 C for 3 hours.
A sample was removed and analyzed by GC.
+ H2N~~ ( )-BINAP, NaOtBu H A
triethyl NN KOtPn N__ orthoformate Ny I
F-B F PCY3 E}~Ru formic acid F C}%Ru PC
B Y3 Ph PCy3 Ph Catalyst 1 Synthesis of Compound A: N-methyl-N'-mesityl-1,2-ethylenediamine:
In a 100 mL round-bottom flask tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) (110 mg, 0.120 mmol) and ( )-2,2'-Bis(diphenylphosphino)-1,l'-binaphthalene (( )-BINAP) (230 mg, 0.37 mmol) were added to 25 mL toluene and stirred for 20 minutes.
Next, 2-bromomesitylene (2.45 g, 12.3 mmol), N-methylethylenediamine (1.01 g, 13.6 mmol) and sodium t-butoxide (NaOtBu) (3.56 g, 37 mmol) were added along with 25 mL
toluene. This was stirred for 72 hours at 80 C. The flask was then removed from heat, cooled to room temperature and diluted with 20 mL diethyl ether. The solution was then washed with 5 x 30 mL water and 3 x 15 mL brine, and dried over magnesium sulfate. After filtering and vacuum removal of solvent, a dark red oil was recovered and used without further purification.
Synthesis of Compound B: 1-Mesityl-3-methyl-2H-4,5-dihydroimidazolium tetrafluoroborate:
Compound A (2.07 g, 10.8 mmol) oil was diluted in 10 mL toluene and stirred with triethylorthoformate (15.98 g, 108 mmol), ammonium tetrafluoroborate (NH4BF4) (4.51 g, 43 mmol) and 5 drops of formic acid at 130 C for 18 hours. After cooling to room temperature the solution was filtered and solids were dissolved in dichloromethane and precipitate filtered off. The solvent was removed by purging with nitrogen and the residue was recrystallized from acetone/methyl tert-butyl ether. A total of 0.39 g (25.1%) of Compound B
was obtained.
Synthesis of Catalyst 1: (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-1H-inden-1-ylideneruthenium(II) dichloride:
To a solution of Compound B (50 mg, 0.172 mmol) in 5 mL hexanes was added potassium tert-pentoxide (KOtPn) (0.172 mmol) from a 15% solution in hexanes.
To this solution was added bis(tricyclohexylphosphine)-3-phenyl-1H-inden-1-ylideneruthenium (II) dichloride (purchased from Strem Chemicals, (Newburyport, MA)) (145 mg, 0.156 mmol) and the solution then stirred for 12 hours at 50 C. After cooling to room temperature, the solution was concentrated to approximately 2 mL under a stream of nitrogen, then filtered and washed with hexanes, yielding 105 mg (79 %) of Catalyst 1 as a brown powder.
Methyl Oleate Ethynolysis (Cross-metathesis of methyl oleate with ethylene):
Catalyst 1: The ethynolysis of methyl oleate was used as a test to determine the activity of the (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-lH-inden-l-ylideneruthenium(II) dichloride complex (Catalyst 1). A
0.120 mM stock solution was made by dissolving Catalyst 1 in dichloromethane. Methyl oleate (0.87g, 1.0 mL), Catalyst 1 stock solution (125 nmol, 1.04 mL), dichloromethane (2.91 mL) and of tetradecane (0.152 g, used as an internal standard) were weighed out and then placed in a Fisher-Porter bottle equipped with a stir bar. The Fisher-Porter bottle was then filled with ethylene to 150 psig and placed in an oil bath heated to 40 C for 3 hours. The vessel was depressurized and 5 drops of ethyl vinyl ether was added to stop the reaction.
A sample was removed and analyzed by GC.
Comparative Catalyst A: Tricyclohexylphosphine[3-phenyl-lH-inden-1-ylidene][1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene]ruthenium(II) dichloride (Comparative Catalyst A) is a symmetrical annolog of Catalyst 1 and was purchased from Strem Chemicals. The structure of Comparative Catalyst A is shown below.
Ph Ru Cl1 PCy3 Comparative Catalyst A
A 0.139 mM solution of the Comparative Catalyst A complex in dichloromethane was prepared. Comparative Catalyst A stock solution (94.4 nmol, 0.679 mL), dichloromethane (3.12 mL), methyl oleate (0.87g, 1.0 mL) and tetradecane (0.152 g, used as an internal standard) were weighed out and then placed in a Fisher-Porter bottle equipped with a stir bar.
The Fisher-Porter bottle was filled with 150 psig of ethylene and heated to 40 C for 3 hours.
A sample was removed and analyzed by GC.
The results of the ethenolysis reactions are as follows:
Catalyst nmols % selectivity % yield TON (1-Decene) Catalyst Catalyst 1 125 91.2 28.6 6700 Comparative Catalyst A 94.4 89.8 3.84 1200 In the ethenolysis of methyl oleate, symmetrically substituted NHC carbene ligands ligated to ruthenium alkylidenes, such as tricyclohexylphosphine[3-phenyl-lH-inden-l-ylidene][1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene]
ruthenium(II) dichloride (Comparative Catalyst A), have displayed low activity resulting in comparatively low yields of 3.84% with correspondingly low turnover numbers of 1200.
The inventors have surprisingly discovered that by replacing one of the mesityl groups on the nitrogen of the NHC ligand ligated to the ruthenium alkylidene, as in Catalyst 1 above, the activity increased substantially as depicted by increased turnover numbers in excess of five-fold, with a corresponding increase in yield.
EXAMPLE 2:
Synthesis of Catalyst 2: 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenyl]
methylene}(1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride O
,-,,,NH2 H
&NH2 Br HBr & N,,,,-,NH2 &N`~N NaBH4 reflux benzene THE -C D
&N
N-/~N orthofohrmate NIN~ a) LiHMDS, CA
b) Zhan 1C
E F
N N~
CI-Ru-CI`'I
SO2N(CH3)2 Catalyst 2 Synthesis of Compound C: Nl-(2,6-diisopropylphenyl)ethane-1,2-diamine:
2,6-Diisopropylaniline (12 mL, 63.6 mmol) and 2-bromoethylamine hydrobromide (2.8 g, 14 mmol) were heated at reflux for 4 days. The liquid was cooled to room temperature and dissolved in ether. This solution was washed with IN sodium hydroxide and brine, then dried over magnesium sulfate, filtered and concentrated under reduced pressure. Unreacted diisopropylaniline was removed by vacuum distillation, followed by column chromatography with 30% acetone/hexane eluent. The pure diamine product, Compound A, was obtained as a pale yellow oil in quantitative yield: Rf 0.31 (30:70 acetone/hexane); IR (cm-1): 3359, 2961, 2868, 1667, 1458, 1364, 1252, 1113, 755; 1H NMR (500 MHz, C6D6) 6 1.29 (m, 12H), 1.79 (s, 2H), 3.14 (br s, 2H), 3.18 (m, 2H), 3.67 (qn, J = 10 Hz, 2H), 4.07 (br s, 1H), 7.14 (m, 3H);
13C NMR (125 MHz, C6D6) 24.5 (4C), 27.8 (2C), 51.2, 52.7, 123.8, 124.1, 143.0, 144.5, 166.8.
Synthesis of Compound D: Nl-cyclohexylmethylene-N2-(2,6-diisopropylphenyl)ethane-1,2-diamine:
Compound C (2.3 g, 10.4 mmol) and cyclohexylcarboxaldehyde (1.3 mL, 11 mmol) were dissolved in 20 mL benzene and refluxed for 1.5 hours, as water was collected in a Dean-Stark trap. The reaction was cooled and benzene removed under reduced pressure to give Compound D as a pale yellow oil, which was carried on to the next step without further purification.
Synthesis of Compound E: Nl-cyclohexylmethyl-N2-(2,6-diisopropylphenyl)ethane-1,2-diamine:
Compound D was dissolved in 50 mL THE Sodium borohydride (NaBH4) (1.9 g, 50 mmol) was added in portions. The reaction was allowed to reflux for 30 minutes, then cooled and quenched with methanol. Water was added, and then the mixture was concentrated and extracted with 3 portions of dichloromethane. The combined organic layers were washed with brine, dried over magnesium sulfate, and concentrated under reduced pressure. A crude yellow oil (Compound E) was obtained in 65% yield: Rf 0.46 (30:70 acetone/hexane); IR
(cm-1): 3359, 2960, 2924, 2851, 1447, 1362, 1254, 1111, 754; 1H NMR (250 MHz, C6D6) 6 1.23 (m, 20H), 1.67 (m, 5H), 2.30 (d, J = 6.5Hz, 2H), 2.60 (m, 2H), 2.92 (m, 2H), 3.54 (qn, J
= 6.8 Hz, 2H), 7.14 (m, 3H).
Catalyst nmols % selectivity % yield TON (1-Decene) Catalyst Catalyst 1 125 91.2 28.6 6700 Comparative Catalyst A 94.4 89.8 3.84 1200 In the ethenolysis of methyl oleate, symmetrically substituted NHC carbene ligands ligated to ruthenium alkylidenes, such as tricyclohexylphosphine[3-phenyl-lH-inden-l-ylidene][1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene]
ruthenium(II) dichloride (Comparative Catalyst A), have displayed low activity resulting in comparatively low yields of 3.84% with correspondingly low turnover numbers of 1200.
The inventors have surprisingly discovered that by replacing one of the mesityl groups on the nitrogen of the NHC ligand ligated to the ruthenium alkylidene, as in Catalyst 1 above, the activity increased substantially as depicted by increased turnover numbers in excess of five-fold, with a corresponding increase in yield.
EXAMPLE 2:
Synthesis of Catalyst 2: 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenyl]
methylene}(1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride O
,-,,,NH2 H
&NH2 Br HBr & N,,,,-,NH2 &N`~N NaBH4 reflux benzene THE -C D
&N
N-/~N orthofohrmate NIN~ a) LiHMDS, CA
b) Zhan 1C
E F
N N~
CI-Ru-CI`'I
SO2N(CH3)2 Catalyst 2 Synthesis of Compound C: Nl-(2,6-diisopropylphenyl)ethane-1,2-diamine:
2,6-Diisopropylaniline (12 mL, 63.6 mmol) and 2-bromoethylamine hydrobromide (2.8 g, 14 mmol) were heated at reflux for 4 days. The liquid was cooled to room temperature and dissolved in ether. This solution was washed with IN sodium hydroxide and brine, then dried over magnesium sulfate, filtered and concentrated under reduced pressure. Unreacted diisopropylaniline was removed by vacuum distillation, followed by column chromatography with 30% acetone/hexane eluent. The pure diamine product, Compound A, was obtained as a pale yellow oil in quantitative yield: Rf 0.31 (30:70 acetone/hexane); IR (cm-1): 3359, 2961, 2868, 1667, 1458, 1364, 1252, 1113, 755; 1H NMR (500 MHz, C6D6) 6 1.29 (m, 12H), 1.79 (s, 2H), 3.14 (br s, 2H), 3.18 (m, 2H), 3.67 (qn, J = 10 Hz, 2H), 4.07 (br s, 1H), 7.14 (m, 3H);
13C NMR (125 MHz, C6D6) 24.5 (4C), 27.8 (2C), 51.2, 52.7, 123.8, 124.1, 143.0, 144.5, 166.8.
Synthesis of Compound D: Nl-cyclohexylmethylene-N2-(2,6-diisopropylphenyl)ethane-1,2-diamine:
Compound C (2.3 g, 10.4 mmol) and cyclohexylcarboxaldehyde (1.3 mL, 11 mmol) were dissolved in 20 mL benzene and refluxed for 1.5 hours, as water was collected in a Dean-Stark trap. The reaction was cooled and benzene removed under reduced pressure to give Compound D as a pale yellow oil, which was carried on to the next step without further purification.
Synthesis of Compound E: Nl-cyclohexylmethyl-N2-(2,6-diisopropylphenyl)ethane-1,2-diamine:
Compound D was dissolved in 50 mL THE Sodium borohydride (NaBH4) (1.9 g, 50 mmol) was added in portions. The reaction was allowed to reflux for 30 minutes, then cooled and quenched with methanol. Water was added, and then the mixture was concentrated and extracted with 3 portions of dichloromethane. The combined organic layers were washed with brine, dried over magnesium sulfate, and concentrated under reduced pressure. A crude yellow oil (Compound E) was obtained in 65% yield: Rf 0.46 (30:70 acetone/hexane); IR
(cm-1): 3359, 2960, 2924, 2851, 1447, 1362, 1254, 1111, 754; 1H NMR (250 MHz, C6D6) 6 1.23 (m, 20H), 1.67 (m, 5H), 2.30 (d, J = 6.5Hz, 2H), 2.60 (m, 2H), 2.92 (m, 2H), 3.54 (qn, J
= 6.8 Hz, 2H), 7.14 (m, 3H).
Synthesis of Compound F: 1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-1H-imidazol-3-ium chloride:
Compound E (2 g, 6.3 mmol) was dissolved in 20 mL triethylorthoformate.
Ammonium chloride (360 mg, 6.6 mmol) was added and the reaction heated at reflux overnight, during which, it turned dark red and a precipitate formed. The mixture was cooled and filtered. Washing the solid with ether gave Compound F as a tan powder in 52% yield:
1H NMR (250 MHz, CDC13/DMSO) 6 1.09 (m, 18H), 1.60 (m, 5H), 2.27 (qn, J = 6.8 Hz, 2H), 3.64 (d, J = 7.3 Hz, 2H), 4.09 (m, 4H), 7.08 (d, J = 7.5 Hz, 2H), 7.27 (m, I
H), 9.63 (s, I H);
13C NMR (63 MHz, CDC13/DMSO) 23.5 - 25.5 (7C), 28.5 (2C), 29.5 (2C), 34.5, 48.7, 53.0, 53.6, 124.4 (2C), 129.7, 130.6, 146.2 (2C), 159.5.
Synthesis of Catalyst 2: 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenyl]
methylene}(1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride:
An oven dried 20 mL scintillation vial was charged with LiHMDS (lithium bistrimethylsilylamide) (40 mg, 0.24 mmol) and dissolved in 4 mL C6D6.
Compound F (88 mg, 0.24 mmol) was then added portion wise over 5 minutes. This mixture was allowed to stir for about 30 minutes until the solid ligand was mostly dissolved. Zhan 1C
(2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(tricyclohexylphosphine) ruthenium dichloride) (114 mg, 0.l6mmol) was then added in one portion and the mixture was allowed to stir at room temperature. After 1 hour, CuC1 (copper (I) chloride) (160 mg, 1.6 mmol) was added and allowed to stir overnight. The reaction mixture was loaded directly onto a silica column (loaded in 50% DCM/hexane) and eluted with 1% MeOH/DCM.
The pure fractions were concentrated in vacuo, yielding approximately 50 mg of Catalyst 2.
EXAMPLE 3:
Synthesis of Catalyst 3:
Compound E (2 g, 6.3 mmol) was dissolved in 20 mL triethylorthoformate.
Ammonium chloride (360 mg, 6.6 mmol) was added and the reaction heated at reflux overnight, during which, it turned dark red and a precipitate formed. The mixture was cooled and filtered. Washing the solid with ether gave Compound F as a tan powder in 52% yield:
1H NMR (250 MHz, CDC13/DMSO) 6 1.09 (m, 18H), 1.60 (m, 5H), 2.27 (qn, J = 6.8 Hz, 2H), 3.64 (d, J = 7.3 Hz, 2H), 4.09 (m, 4H), 7.08 (d, J = 7.5 Hz, 2H), 7.27 (m, I
H), 9.63 (s, I H);
13C NMR (63 MHz, CDC13/DMSO) 23.5 - 25.5 (7C), 28.5 (2C), 29.5 (2C), 34.5, 48.7, 53.0, 53.6, 124.4 (2C), 129.7, 130.6, 146.2 (2C), 159.5.
Synthesis of Catalyst 2: 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenyl]
methylene}(1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-lH-imidazole) ruthenium (II) chloride:
An oven dried 20 mL scintillation vial was charged with LiHMDS (lithium bistrimethylsilylamide) (40 mg, 0.24 mmol) and dissolved in 4 mL C6D6.
Compound F (88 mg, 0.24 mmol) was then added portion wise over 5 minutes. This mixture was allowed to stir for about 30 minutes until the solid ligand was mostly dissolved. Zhan 1C
(2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(tricyclohexylphosphine) ruthenium dichloride) (114 mg, 0.l6mmol) was then added in one portion and the mixture was allowed to stir at room temperature. After 1 hour, CuC1 (copper (I) chloride) (160 mg, 1.6 mmol) was added and allowed to stir overnight. The reaction mixture was loaded directly onto a silica column (loaded in 50% DCM/hexane) and eluted with 1% MeOH/DCM.
The pure fractions were concentrated in vacuo, yielding approximately 50 mg of Catalyst 2.
EXAMPLE 3:
Synthesis of Catalyst 3:
N, propionaldehyde &N ~ NaBH4 & N~
H,,,-NH2 N ~ H
CH2C12, MgSO4 THE
G H
triethyl I\
orthoformate NH4C1 Cl I
Synthesis of Compound G: N1-2,6-diisopropylphenyl-N2-propylideneethane-1,2-diamine:
Propionaldehyde (0.6 mL, 8.3 mmol) and 2,6-diisopropylphenylethane-1,2-diamine (1.5 g, 6.8 mmol) were dissolved in 20 mL dichloromethane. Magnesium sulfate was added and the mixture stirred for 19 hours, then filtered and concentrated. Compound G was obtained as a crude yellow oil which was carried on to the next step without further purification.
Synthesis of Compound H: N1-2,6-diisopropylphenyl-N2-propylethane-1,2-diamine:
Compound G was dissolved in 30 mL THE Sodium borohydride (NaBH4) (1.3 g, 34 mmol) was added in portions. The reaction was allowed to reflux for 30 minutes, then cooled and quenched with methanol. Water was added, and then the mixture was concentrated and extracted with 3 portions of dichloromethane. The combined organic layers were washed with brine, dried over magnesium sulfate, and concentrated under reduced pressure.
Compound H was obtained as a crude pale yellow oil in 35% yield: 1H NMR (250 MHz, C6D6) 6 0.85 (t, J = 7.3 Hz, 3H), 1.26 (m, 14H), 2.36 (t, J = 6.9 Hz, 2H), 2.58 (m, 2H), 2.90 (m, 2H), 3.52 (qn, J = 6.8 Hz, 2H), 7.12 (m, 3H).
Synthesis of Compound I: 3-(2,6-diisopropylphenyl)-1-propyl-4,5-dihydro-1H-imidazol-3-ium chloride:
Compound H (650 mg, 2.4 mmol) was dissolved in 7.9 mL triethylorthoformate.
Ammonium chloride (NH4C1) (141 mg, 2.64 mmol) was added and the reaction heated at reflux overnight. Removal of triethylorthoformate gave Compound I as a crude reddish brown oil in quantitative yield.
H,,,-NH2 N ~ H
CH2C12, MgSO4 THE
G H
triethyl I\
orthoformate NH4C1 Cl I
Synthesis of Compound G: N1-2,6-diisopropylphenyl-N2-propylideneethane-1,2-diamine:
Propionaldehyde (0.6 mL, 8.3 mmol) and 2,6-diisopropylphenylethane-1,2-diamine (1.5 g, 6.8 mmol) were dissolved in 20 mL dichloromethane. Magnesium sulfate was added and the mixture stirred for 19 hours, then filtered and concentrated. Compound G was obtained as a crude yellow oil which was carried on to the next step without further purification.
Synthesis of Compound H: N1-2,6-diisopropylphenyl-N2-propylethane-1,2-diamine:
Compound G was dissolved in 30 mL THE Sodium borohydride (NaBH4) (1.3 g, 34 mmol) was added in portions. The reaction was allowed to reflux for 30 minutes, then cooled and quenched with methanol. Water was added, and then the mixture was concentrated and extracted with 3 portions of dichloromethane. The combined organic layers were washed with brine, dried over magnesium sulfate, and concentrated under reduced pressure.
Compound H was obtained as a crude pale yellow oil in 35% yield: 1H NMR (250 MHz, C6D6) 6 0.85 (t, J = 7.3 Hz, 3H), 1.26 (m, 14H), 2.36 (t, J = 6.9 Hz, 2H), 2.58 (m, 2H), 2.90 (m, 2H), 3.52 (qn, J = 6.8 Hz, 2H), 7.12 (m, 3H).
Synthesis of Compound I: 3-(2,6-diisopropylphenyl)-1-propyl-4,5-dihydro-1H-imidazol-3-ium chloride:
Compound H (650 mg, 2.4 mmol) was dissolved in 7.9 mL triethylorthoformate.
Ammonium chloride (NH4C1) (141 mg, 2.64 mmol) was added and the reaction heated at reflux overnight. Removal of triethylorthoformate gave Compound I as a crude reddish brown oil in quantitative yield.
All documents described herein are incorporated by reference herein, including any priority documents and/or testing procedures to the extent they are not inconsistent with this text, provided however that any priority document not named in the initially filed application or filing documents is NOT incorporated by reference herein. As is apparent from the foregoing general description and the specific embodiments, while forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited thereby. Likewise, the term "comprising" is considered synonymous with the term "including" for purposes of Australian law.
Claims (25)
1. An asymmetrically substituted NHC metathesis catalyst compound represented by the formula:
where:
M is a Group 8 metal; preferably Ru or Os, preferably Ru;
X1 and X2 are, independently, any anionic ligand (preferably halogen, an alkoxide or an alkyl sulfonate), or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing ligand; preferably the heteroatom is N, 0, P, or S;
preferably P, optionally L may be joined to R7 and/or R8, preferably L is L*(R)q-1 when L is not bound to R7 or R8 or L is L*(R)q-2 when L is bound to R7 or R8, where q is 1, 2, 3, or 4 depending on the valence of L* (which may be 2, 3, 4, or 5) and L* is N, O, P, or S, (preferably P) and R is as defined for R3;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms; and wherein R1 and R2 are dissimilar to each other.
where:
M is a Group 8 metal; preferably Ru or Os, preferably Ru;
X1 and X2 are, independently, any anionic ligand (preferably halogen, an alkoxide or an alkyl sulfonate), or X1 and X2 may be joined to form a dianionic group and may form a single ring of up to 30 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms;
L is a heteroatom or heteroatom-containing ligand; preferably the heteroatom is N, 0, P, or S;
preferably P, optionally L may be joined to R7 and/or R8, preferably L is L*(R)q-1 when L is not bound to R7 or R8 or L is L*(R)q-2 when L is bound to R7 or R8, where q is 1, 2, 3, or 4 depending on the valence of L* (which may be 2, 3, 4, or 5) and L* is N, O, P, or S, (preferably P) and R is as defined for R3;
and R1, R2, R3, R4, R5, R6, R7, and R8 are, independently, hydrogen or a C1 to substituted or unsubstituted hydrocarbyl;
wherein any two adjacent R groups may form a single ring of up to 8 non-hydrogen atoms or a multinuclear ring system of up to 30 non-hydrogen atoms; and wherein R1 and R2 are dissimilar to each other.
2. The catalyst compound of claim 1, wherein M is ruthenium.
3. The catalyst compound of claim 1 or 2, wherein when R7 and R8 form an unsubstituted phenyl group and R1 is mesityl, then R2 is not methyl or ethyl.
4. The catalyst compound of any of claims 1 to 3, wherein X1 and X2 are C1, and/or the heteroatom in L is N, O, or P, and/or R1, R2, R7, and R8 are, independently, C1 to C30 hydrocarbyl, and/or R3, R4, R5, and R6 are, independently, hydrogen.
5. The catalyst compound of any of claims 1 to 4, wherein R1 is an aromatic hydrocarbyl or substituted hydrocarbyl and R2 is an aliphatic hydrocarbyl or substituted hydrocarbyl.
6. The catalyst compound of claim 1, wherein the metathesis catalyst compound comprises one or more of: 2-(i-propoxy)-5-(N,N-dimethylaminosulfonyl)phenylmethylene(1-cyclohexylmethyl-3-(2,6-diisopropylphenyl)-4,5-dihydro-1H-imidazole) ruthenium (II) chloride, (1-mesityl-3-methyl-2H-4,5-dihydroimidazol-2-ylidene)(tricyclohexylphosphine)-3-phenyl-1H-inden-1-ylidene ruthenium (II) dichloride, and mixtures thereof.
7. A process to produce alpha-olefin comprising contacting a feed material with the catalyst compound of any of claims 1 to 6.
8. The process of claim 7, wherein the feed material is selected from the group consisting of canola oil, corn oil, soybean oil, rapeseed oil, algae oil, peanut oil, mustard oil, sunflower oil, tung oil, perilla oil, tall oil, grapeseed oil, linseed oil, safflower oil, pumpkin oil, palm oil, Jathropa oil, high-oleic soybean oil, high-oleic safflower oil, high-oleic sunflower oil, mixtures of animal and vegetable fats and oils, castor bean oil, dehydrated castor bean oil, cucumber oil, poppyseed oil, flaxseed oil, lesquerella oil, walnut oil, cottonseed oil, meadowfoam, tuna oil, sesame oils and mixtures thereof.
9. A process to produce alpha-olefin comprising contacting a triacylglyceride with an alkene and the catalyst compound of any of claims 1 to 6, wherein the alpha olefin produced has at least one more carbon atom than the alkene.
10. The process of claim 9, wherein the triacylglyceride is contacted with alcohol and converted to a fatty acid ester or fatty acid alkyl ester prior to contacting with the catalyst compound of any of claims 1 to 6.
11. The process of claim 9, wherein the triacylglyceride is contacted with water and/or an alkaline reagent and converted to a fatty acid prior to contacting with the catalyst compound of any of claims 1 to 6.
12. A process to produce alpha-olefin comprising contacting an unsaturated fatty acid with an alkene and the catalyst compound of any of claims 1 to 6, wherein the alpha olefin produced has at least one more carbon atom than the alkene.
13. A process to produce alpha-olefin comprising contacting a triacylglyceride with the catalyst compound of any of claims 1 to 6, preferably wherein the alpha olefin produced has at least one more carbon atom than the alkene.
14. A process to produce alpha-olefin comprising contacting an unsaturated fatty acid ester and or unsaturated fatty acid alkyl ester with an alkene and the catalyst compound of any of claims 1 to 6, wherein the alpha olefin produced has at least one more carbon atom than the alkene.
15. The process of any of claims 7 to 14, wherein the alpha olefin is a linear alpha-olefin having 4 to 24 carbon atoms.
16. The process of any of claims 7 to 15, wherein the alkene is ethylene, propylene, butene, hexene, or octene.
17. The process of claim 15 or 16, wherein the fatty acid ester is a fatty acid methyl ester.
18. The process of any of claims 9 to 17, wherein the triacylglyceride, fatty acid, fatty acid alkyl ester, fatty acid ester is derived from biodiesel.
19. The process of any of claims 7 to 18, wherein the alpha-olefin is butene-1, decene-1, and/or heptene-1.
20. The process of any of claims 7 to 19, wherein the productivity of the process is at least 200 g of linear alpha-olefin per mmol of catalyst per hour.
21. The process of any of claims 7 to 20, wherein the selectivity of the process is at least 20 wt% linear alpha-olefin, based upon the weight to the material exiting the reactor.
22. The process of any of claims 7 to 21, wherein the turnover number of the process is at least 5,000.
23. The process of any of claims 7 to 22, wherein the yield, when converting unsaturated fatty acids, unsaturated fatty acid esters, unsaturated fatty acid alkyl esters, or mixtures thereof, is 30% or more, said yield being defined as defined as the moles of alpha olefin formed per mol of unsaturated fatty acids, unsaturated fatty acid esters, unsaturated fatty acid alkyl esters, or mixtures thereof introduced into the reactor.
24. The process of any of claims 7 to 23, wherein the yield, when converting TAGs as represented in the formula below, is 30% or more, said yield being defined as defined as the moles of alpha olefin formed divided by (the moles of unsaturated R a + moles of unsaturated R b + moles of unsaturated R c) introduced into the reactor, where R a, R b, and R c each, independently, represent a saturated or unsaturated hydrocarbon chain.
25. A process to produce C4 to C24 linear alpha-olefin comprising contacting a feed material with an alkene selected from the group consisting of ethylene, propylene butene, pentene, hexene, heptene, octene, nonene, decene, and mixtures thereof and a metathesis catalyst compound of any of claims 1 to 10, wherein the feed material is a triacylglyceride, fatty acid, fatty acid alkyl ester, and/or fatty acid ester derived from seed oil.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25952109P | 2009-11-09 | 2009-11-09 | |
US61/259,521 | 2009-11-09 | ||
US12/705,136 | 2010-02-12 | ||
US12/705,136 US8237003B2 (en) | 2009-11-09 | 2010-02-12 | Metathesis catalyst and process for use thereof |
US31438810P | 2010-03-16 | 2010-03-16 | |
US61/314,388 | 2010-03-16 | ||
PCT/US2010/055302 WO2011056874A2 (en) | 2009-11-09 | 2010-11-03 | Metathesis catalysts and processes for use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2777176A1 true CA2777176A1 (en) | 2011-05-12 |
CA2777176C CA2777176C (en) | 2014-05-20 |
Family
ID=46731240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2777176A Expired - Fee Related CA2777176C (en) | 2009-11-09 | 2010-11-03 | Metathesis catalysts and processes for use thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102655935B (en) |
CA (1) | CA2777176C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY172162A (en) * | 2013-03-14 | 2019-11-15 | Wilmar Trading Pte Ltd | Methods for treating a metathesis feedstock with metal alkoxides |
CN103464201B (en) * | 2013-09-25 | 2015-06-10 | 陕西合盛生物柴油技术开发有限公司 | Composite acid catalyst for esterification of biodiesel |
GB2522640B (en) * | 2014-01-30 | 2018-04-25 | Univ Court Univ St Andrews | Method of alkene metathesis |
EP3219778A1 (en) * | 2016-03-15 | 2017-09-20 | Umicore AG & Co. KG | Biofuel and method for preparation by isomerizing metathesis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000071554A2 (en) * | 1999-05-24 | 2000-11-30 | California Institute Of Technology | Imidazolidine-based metal carbene metathesis catalysts |
-
2010
- 2010-11-03 CA CA2777176A patent/CA2777176C/en not_active Expired - Fee Related
- 2010-11-03 CN CN201080055402.1A patent/CN102655935B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102655935A (en) | 2012-09-05 |
CA2777176C (en) | 2014-05-20 |
CN102655935B (en) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8063232B2 (en) | Metathesis catalyst and process for use thereof | |
US8809563B2 (en) | Metathesis catalyst and process for use thereof | |
EP2498909B1 (en) | Metathesis catalyst and process for use thereof | |
CA2785897C (en) | Metathesis catalyst and process for use thereof | |
US8329921B2 (en) | Metathesis catalyst and process for use thereof | |
US8227371B2 (en) | Class of olefin metathesis catalysts, methods of preparation, and processes for the use thereof | |
US8524930B2 (en) | Class of olefin metathesis catalysts, methods of preparation, and processes for the use thereof | |
US12065450B2 (en) | Compounds and the use thereof in metathesis reactions | |
WO2011056874A2 (en) | Metathesis catalysts and processes for use thereof | |
US8557902B2 (en) | Functionalizable synthetic hydrocarbon fluids and integrated method for production thereof | |
Bruneau et al. | Cross‐metathesis with acrylonitrile and applications to fatty acid derivatives | |
CA2777176C (en) | Metathesis catalysts and processes for use thereof | |
US9024034B2 (en) | Metathesis catalysts and processes for use thereof | |
US11840674B2 (en) | Biofuel and method for preparation by isomerizing metathesis | |
US9120736B2 (en) | Method for producing unsaturated compounds | |
WO2014004089A1 (en) | Metathesis catalyst and process for use thereof | |
WO2012040088A2 (en) | A novel class of olefin metathesis catalysts, methods of preparation, and processes for the use thereof | |
EP2714272A2 (en) | A novel class of olefin metathesis catalysts, methods of preparation, and processes for the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20201103 |